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Summary 
 
Na+/Ca2+ exchanger (NCX) is a membrane protein which can mediate either Ca2+ entry 
(reverse mode) or exit (forward mode) in cells depending on the Na+ electrochemical 
gradient and membrane potential. The coupling ratio for NCX1 in vascular smooth 
muscle cell is: 3 Na+:1 Ca2+. The NCX molecule comprises nine transmembrane 
segments and a large intracellular hydrophilic loop. NCX can be activated by cytoplasmic 
Ca2+, and inhibited by cytoplasmic Na+; it can also be modulated by protein kinases and 
ATP on the intracellular hydrophilic loop. In vascular smooth muscle cells, the final 
trigger for contraction is an increase in intracellular calcium, and thus the regulation of 
cytosolic calcium is crucial for the cell activity. As one of the major Ca2+ transport 
systems, NCX is postulated to play a critical role in the vascular smooth muscle cell. The 
aims of the present study are to firstly demonstrate the functional existence of NCX in 
vascular smooth muscle (including aorta and arteriole); to clarify the modulation of NCX; 
to explore the selectivity of NCX inhibitor KB-R7943;  and lastly to investigate the role 
of NCX in the myogenic response.  
 
Exploration of the physiological significance of NCX requires tools to inhibit the 
exchanger selectively. KB-R7943 has been widely used as a NCX inhibitor. Given its 
mixed and contradictory reports of selectivity for NCX, the study in chapter 2 was to 
assess its pharmacological actions in rat aorta on a variety of Ca2+ dependent systems. 
Rat aortic rings were used. In endothelium-denuded and intact aorta with normal 
physiological salt solution containing Ca2+, KB-R7943 (10 µM) inhibited phenylephrine-
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induced constriction. The phenylephrine-induced constriction in the absence of Ca2+ was 
not significantly affected by KB-R7943 (10 µM) in both endothelium-denuded and intact 
vessels. In endothelium denuded rat aortic rings, KB-R7943 (10 μM) significantly 
attenuated the constriction induced by Bay K8644, high K+, cyclopiazonic acid, ouabain 
and low-Na+ respectively. However, KB-R7943 at lower concentration (1 μM) exhibited 
negligible effects in all cases except the low Na+ constriction.  The constriction to low 
Na+ is a functional response mediates by NCX operating in reverse mode to increase Ca2+ 
entry. The data demonstrate that 10 μM KB-R7943 affected L-type Ca2+ channel, the 
capacitative Ca2+ entry and α adrenergic receptor pathway. Nevertheless, KB-R7943 can 
be used as a selective inhibitor of NCX at the concentration of 1 μM in rat aortic rings. 
Given the important role of the vascular endothelium in modulating vascular smooth 
muscle contractility, the aim of the study in chapter 3 was to investigate whether the 
operation of NCX could be affected by the endothelium in rat aortic rings using the organ 
bath technique. Lowering extracellular [Na+] to 1.18 mM induced immediate constriction 
and vessel motion in endothelium denuded rat aortic rings, but only a small constriction 
in endothelium intact rat aortic rings. In endothelium intact rat aortic rings, the guanylate 
cyclase inhibitor ODQ (1 μM) and nitric oxide synthase inhibitor L-NAME (50 μM) 
greatly amplified the vasoconstriction to lowering extracellular Na+, but had no effect 
when the endothelium was removed. The adenylate cyclase blocker: SQ 22536 (100 μM) 
and the COX inhibitor indomethacin (10 μM), showed no significant effect on low-Na+ 
induced vasoconstriction in either endothelium denuded or intact aortic rings. The results 
suggest that endothelium modulated the NCX operation via the guanylate cyclase, not the 
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adenylate cyclase system; the release of nitric oxide, not prostacyclin was involved.  Thus 
NCX may be another mechanism by which the endothelium-derived nitric oxide 
modulates contractility in vascular smooth muscle. The interaction between nitric oxide 
and NCX was further explored using the nitric oxide donor sodium nitroprusside. 
Endothelium denuded rat aortic rings were preconstricted to the same extent with either 
low Na+ (1.18 mM), or the thromboxane A2 agonist U46619 (0.1 μM) or high K+ (80 
mM). The vasorelaxation of SNP (30 nM) in low Na+ constriction was significantly 
larger compared to other agents.  This indicates that NO has a special antagonism of low 
Na+ constriction and a hypothesis is proposed involving Na+/K+ ATPase. 
The chapters above demonstrated the pharmacological functionality of NCX in arterial 
smooth muscle. However, the investigation of NCX is mainly conducted in large vessels; 
much less evidence is available for small resistance vessels. Small vessels such as 
arterioles exhibit a myogenic constriction in response to a pressure rise. The aim of study 
in chapter 4 was to explore the role of NCX on myogenic response. First order cremaster 
muscle arterioles were isolated, cannulated and pressurized to 70 mmHg. Reducing 
extracellular Na+ from 137 to 75 and then 25 mM resulted in graded vasoconstriction 
which was inhibited by NCX inhibitor SEA0400 (1 μM). Myogenic responses were 
induced by a transmural pressure increase from 70 to 120 mmHg, the diameter was 
significantly decreased and this effect was prevented by NCX inhibitor: 1μM SEA0400. 
In fura 2-AM loaded arterioles the increase of transmural pressure from 70 to 120 mmHg 
was accompanied by a rise in intracellular [Ca2+] and this was attenuated by SEA0400 (1 
μM). In conclusion, the myogenic response in cremaster arteriolar includes multiple 
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mechanisms. The underlying pathways in the literature suggest that these may involve 
stretch-activated channel, L-type calcium channel, store-operated Ca2+ channel; the 
results of the present study suggest that the contribution from NCX through the reverse 
mode needs to be especially considered in cremaster arteriole. 
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CHAPTER 1  GENERAL INTRODUCTION 
1.1 CYTOSOLIC CALCIUM HOMEOSTASIS 
1.1.1 Summary 
In vascular smooth muscle cells (VSMC), vasoreactive substances exert their effects through 
affecting intracellular [Ca2+] level as well as the Ca2+ sensitivity, and thus the regulation of 
cytosolic Ca2+ and Ca2+ sensitivity is crucial for the cell activity (Blaustein, 1989; Karaki et 
al., 1997; Marin et al., 1999). 
Under resting conditions, the primary messenger cytosolic Ca2+ concentration is probably not 
higher than 100 nM, which is 10,000 times lower than that in extracellular space (Poburko et 
al., 2004). Upon stimulation intracellular [Ca2+] rises up to 1-10 μM. This is partly as a result 
of an influx of extracellular Ca2+ through ion channels, and partly due to the release of Ca2+ 
from internal stores. Ca2+ activates a variety of cellular processes to induce contraction. 
Principal among these is the binding of Ca2+ to calmodulin (CaM) and the activation of 
myosin light-chain kinase (MLCK), see 1.2.2. The modulation of Ca2+ sensitivity has been 
shown to play a critical role in the contraction/relaxation of smooth muscle cell (refer to 
1.1.4). 
To induce relaxation, removal of Ca2+ from the contractile machinery is accomplished by 
Ca2+ resequestration into the SR, and by extrusion of Ca2+ across the plasma membrane. 
There are two main mechanisms to remove Ca2+ from cytoplasm. The first relies on the 
direct utilization of energy from ATP (the plasma membrane Ca2+ pump, and  the 
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sarcoplasmic reticulum Ca2+ pump), and the second uses the Na+ electrochemical gradient to 
drive the extrusion of Ca2+ in exchange for Na+ entry (NCX) in the plasma membrane. The 
term superficial buffer barrier is suggested to describe the function of sarcoplasmic reticulum 
which is located between the plasma membrane and contractile systems and it serves as a 
barrier to the Ca2+ influx as it accumulates large amount of Ca2+ which enters the cell (Marin 
et al., 1999). The Ca2+ buffering function of the cytosolic high-affinity calcium-binding 
proteins (e.g. calmodulin, troponin C, calpain, the annexin family and parvalbumin) is 
thought to play a minor role in cytosolic calcium homeostasis, and therefore will not be 
covered here (Carafoli, 1987).  
The Ca2+ transport systems which have been demonstrated in the plasma membrane 
(Carafoli, 1987; Marin et al., 1999) are the voltage-gated calcium channel, the  Na+/Ca2+ 
exchanger (NCX), the calcium release-activated calcium channel (store-operated Ca2+ entry), 
the plasma membrane Ca2+ pumps, the nonselective cation channel and calcium-activated 
potassium channel (BKCa); and in the intracellular organelles which involve mainly the 
endoplasmic (sarcoplasmic) reticulum Ca2+ pump and also Ca2+ release from internal store 
via IP3-receptors and ryanodine-receptors (See reviews Carafoli, 1987; Marin et al., 1999). 
The major systems are discussed below. 
1.1.2 Ca2+ transport systems on the plasma membrance  
The principle pathways involved in the movement of Ca2+ into and out of the cell membrane 
are shown in Figure 1.1. 
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Figure 1.1 The calcium movement across the plasma membrane in a smooth muscle cell 
The major calcium transport mechanisms across the cell membrane in a smooth muscle cell are 
shown. A indicates the Na+/Ca2+ exchanger  (forward mode) which is discussed in 1.4; B 
indicates the calmodulin-regulated ATP-driven plasma membrane Ca2+ pump which is 
discussed in 1.1.2.4; C indicates the voltage-gated calcium channel which is discussed in 
1.1.2.1, see reviews (Carafoli, 1987; Marin et al., 1999). 
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1.1.2.1  Voltage-gated calcium channel (VGCC) 
1.1.2.1.1 General characteristics 
As implied by its name, the opening of any type of voltage-gated calcium channel (VGCC) is 
controlled by membrane potential. Membrane depolarization causes a structural change in 
the channel pore allowing Ca2+ to flow down its concentration gradient into excitable cells. 
(See reviews Carafoli, 1987; Meininger et al., 1992; Wang et al., 2004). Repolarization of 
the membrane closes the channel. Once open, VGCC mediates the calcium influx which 
initiates the intracellular response such as contraction, secretion, neurotransmission and gene 
expression (Eisenberg et al., 2004; Godfraind, 1988; Moreno Davila, 1999). In smooth 
muscle cells, VGCC is well known as a critical determinant of vascular tone (Beech, 1997; 
Carafoli, 1987; Carbone et al., 2001; Knot et al., 1998; Meininger et al., 1992). 
The VGCC family shares a general structure of a heteromultimer that is formed of four or 
five distinct subunits (α1, β, α2,δ, and γ) (Bielefeldt, 1999; Keef et al., 2001; Wang et al., 
2004), and which are encoded by multiple genes (see Table 1.1). The α1 subunit, the largest 
subunit (about 190-240 kDa), controls the properties of conduction pore, voltage sensor, and 
drug/toxin binding site (Birnbaumer, 1998; Halling et al., 2005; Striessnig, 1999; Wang et 
al., 2004). The accessory (auxiliary) subunits include cytoplasmic globular β subunit and 
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extracellular α2,δ subunit (Keef et al., 2001). In skeletal muscle cells, a distinctive γ subunit 
is exclusively expressed. (See reviews Black, 2003; Striessnig, 2004). All the subunits work 
in concert as a whole functional channel complex. 
Calcium currents recorded in different cell types have diverse physiological and 
pharmacological properties, and an alphabetical nomenclature has evolved for the distinct 
classes: L-type, T-type, N-type, P/Q-type, and R-type (Carbone et al., 2001; Striessnig, 
1999). Each class has distinct α subunits (Keef et al., 2001). The properties of different 
calcium channels are summarized in Table 1.2. 
1.1.2.1.2 Subtypes of VGCC 
The predominant type in smooth muscle cell is the long lasting L-type calcium channel 
(LTCC); the isoform for smooth muscle cell is Cav1.2 (Table 1.1). LTCC requires a strong 
depolarization for activation; for example, the activation voltage is -4 mV (in 15 mM Ba2+, 
HEK cells) for Cav1.2 (see review Catterall et al., 2005). LTCC differs from other types of 
VGCC (non-LTCC) in the unique feature that the organic L-type calcium channel 
antagonists, including dihydropyridine (DHP), phenylalkylamine, and benzothiazepine can 
block it (Striessnig, 2004). There are four isoforms (Cav1.1-Cav1.4), their 
electrophysiological properties and tissue expressions are summarized in Table 1.1.  N-type,  
P/Q-type, and R-type calcium currents do not exist in smooth muscle cells,  they are 
expressed primarily in neurons (Beech, 1997). They also require strong depolarization for 
activation, for example, the activation voltage is +7.8 mV for N-type in HEK 293 cells; -5 
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mV for native P-type; -11 mV for native Q-type; and +3.5 mV for R-type in HEK 293 cells 
(see review Catterall et al., 2005). They are blocked by specific polypeptide toxins from 
snail and spider venoms, such as ω-conotoxin GVIA, ω-agatoxin IVA & IVB, ω-conotoxin 
MVIIC, Ni2+, SNA-482 etc. 
The transient T-type calcium current is also expressed in smooth muscle cells (Cav3.1 and 
Cav3.2 only) (see reviews Bielefeldt, 1999; Catterall et al., 2005), as well as many other 
types of tissues (see Table 1.2). It is activated by weak depolarization, for example, the 
activation voltage is -44 ~ -46 mV for three isoforms of T-type VGCC: Cav3.1 Cav3.2 and 
Cav3.3.  In vascular smooth muscle cell, T-type calcium channels do not contribute 
considerably to vasoconstriction (Cribbs, 2006). 
1.1.2.1.3 Regulation of VGCC 
VGCC is critical in the activity of cells and as such are tightly modulated by a variety of 
intracellular signaling processes which is briefly introduced below. Because the predominant 
type in smooth muscle cells is the L-type calcium channel, we focus our attention on this 
type of VGCC. 
Ca2+ has dual effects on VGCC, Ca2+-dependent facilitation (CDF) is a process by which 
increased basal Ca2+ or repeated transient depolarization induce increased channel opening 
(Anderson, 2001; Halling et al., 2005). The repolarization closes the channel which can takes 
place in a voltage-dependent or Ca2+-dependent manner (Halling et al., 2005; Sanchez et al., 
2001). Ca2+-dependent inactivation (CDI) is the mechanism that closes the channel during 
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Table 1.1 The features of distinctive L-type calcium channel 
Channel 
name 
α1 subunit 
isoform 
Tissue expression Function 
Cav1.1 α1S Skeletal muscle 
transverse tubule 
Excitation-contraction (EC) 
coupling and Ca2+ homeostasis 
 
Cav1.2 α1C Cardiomyocyte, SMC, 
neuron, sensory and 
endocrine cell 
EC coupling, synaptic plasticity, 
hormone secretion, action 
potential propagation 
 
Cav1.3 α1D Sensory and  endocrine 
cells, low density in heart 
and VSMC, neuron 
Neurotransmitter release, 
synaptic plasticity, hormone 
secretion, control cardiac 
rhythm and conductance at rest 
 
Cav1.4 α1F Retinal photoreceptor and 
ganglion cell 
Neurotransmitter release in 
retinal cell 
 
 
For the references in the Table 1.1 above, please refer to the review papers (Halling et al., 
2005; Striessnig, 1999) and the tenth edition of 1999 Receptor & Ion Channel Nomenclature 
Supplement (compiled by S.P.H. Alexander & J. A. Peters). 
 
8 
Table 1.2 Different types of Ca2+ channels  
Type of 
VGCC 
T(Cav3.1- 
Cav3.3) 
L(Cav1.1-
Cav1.4) 
N(Cav2.2) P/Q(Cav2.1) R(Cav2.3) 
Current Ir IL IN IP/Q IR 
Conductance 
(pS) 
5-9 pS 25 pS 20 pS 9, 14, 19  
 
- 
Agonists - DHP, 
phenylalkylami
ne, 
benzothiazepine 
- - - 
Blockers Mibefradil, 
Ni2+, 
kurtoxin 
Nifedipine, 
diltiazem, 
verapamil, 
calciseptine 
toxins from 
snail and 
spider 
venoms  
toxins from 
snail and 
spider 
venoms  
toxins 
from snail 
and spider 
venoms 
Activation 
Voltage 
 
Low  
 
 
High  
 
High  
 
High  
 
High  
 
 
Location Various 
types of 
tissues 
Mainly muscle 
and endocrine 
cells 
Mainly 
neurons  
Mainly 
neurons  
Mainly 
neurons  
 
For the content in the Table 1.2 above, please refer to the review papers (Grassi et al., 2004; 
Halling et al., 2005; Striessnig, 1999) and the tenth edition of 1999 Receptor & Ion Channel 
Nomenclature Supplement (compiled by S.P.H. Alexander & J. A. Peters). 
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sustained depolarization (Halling et al., 2005; Keef et al., 2001; Pott et al., 2006). CaM is 
involved in both Ca2+-dependent inactivation and Ca2+-dependent facilitation processes 
(Anderson, 2001; Halling et al., 2005). 
In cardiac myocytes, L-type calcium channel opening can be dramatically potentiated by 
sympathetic nerve or sympathomimetic drugs stimulation via β-adrenergic receptors and 
related cAMP-dependent phosphorylation by protein kinase A (cAMP/PKA) (Carbone et al., 
2001; Godfraind, 1988; Schroder et al., 2003; van der Heyden et al., 2005). However, the 
action of β-adrenergic receptors on L-type calcium channel in smooth muscle cell remains a 
matter of debate (Beech, 1997; Keef et al., 2001), and mainly inhibitory, as recently reported 
in guinea-pig detrusor smooth muscle cells (Kobayashi et al., 2003). 
Activation of cGMP-dependent protein kinase (PKG) in smooth muscle cells was reported to 
produce inhibitory effects on L-type calcium channel in rat pulmonary artery, the A7γ5 SMC 
line, and rabbit portal vein. (See reviews Beech, 1997; Keef et al., 2001). Since NO 
stimulates cGMP production, this process is a potential mechanism whereby NO induces 
vasorelaxation. (See reviews Fischmeister et al., 2005; Grassi et al., 2004; Mironov et al., 
2006; Schroder et al., 2003). 
Protein kinase C (PKC) was reported to mostly stimulate VGCC, and it was suggested to be 
the underlying mechanism of a variety of hormones (including endothelin, norepinephrine, 
serotonin, arginine-vasopressin and angiotensin II), as well as intracellular ATP to cause 
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vasoconstriction. (See reviews Beech, 1997; Keef et al., 2001; Striessnig, 1999; van der 
Heyden et al., 2005). For example, PKC was reported to be activated by the Ca2+ entry 
through VGCC, and in turn stimulates the activity of VGCC in porcine coronary artery 
(Korzick et al., 2004).  However, the inhibitory effects of PKC on VGCC were also 
demonstrated, such as a recent study in rat pheochromocytoma cell line (PC12 cells) 
(Fontainhas et al., 2005) (see also reviews Beech, 1997; Striessnig, 1999).  
 The conflicting effect of each modulator might be due to the intracellular calcium 
concentration (Anderson, 2001; Beech, 1997; Halling et al., 2005; Sanchez et al., 2001), the 
species, and the experimental condition (Beech, 1997). 
1.1.2.2 Na+/Ca2+ exchanger (NCX) 
The plasma membrane Na+/Ca2+ exchanger is discussed at length in section 1.4.8. It can 
transport Ca2+ in one direction coupled with the transport of Na+ in the opposite direction. It 
operates in parallel with several Ca2+ transport systems in the plasma membrane (e.g., the 
plasma membrane Ca2+ pump and voltage-gated Ca2+ channels), and in series with other Ca2+ 
transport systems that are located in organellar membranes (e.g., SR/ER Ca2+ pumps, 
mitochondrial Ca2+ transport) in the regulation of calcium level (see reviews Annunziato et 
al., 2004; Blaustein, 1989).  
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1.1.2.3 Store-operated Ca2+ entry 
Store-operated Ca2+ entry involves the regulation of plasma membrane Ca2+ channels by the 
filling state of intracellular Ca2+ stores in the sarcoplasmic reticulum (SR) or endoplasmic 
reticulum (ER). In other words, the depletion of intracellular stores due to the action of IP3 or 
other Ca2+-releasing signals activates a signaling pathway leading to the opening of some 
plasma membrane Ca2+ channels. Please refer to 1.3 for details and references. 
1.1.2.4 Plasma membrane Ca2+ pump (PMCA pump) 
The plasma membrane Ca2+ pump, also called plasma membrane Ca2+-ATPase has the 
function to pump Ca2+ out of the cell and is driven by ATP (Furukawa et al., 1988). It is a 
multigene family consisting of at least four gene products: PMCA1, PMCA2, PMCA3, 
PMCA4. The plasma membrane Ca2+-ATPase has the role of counteracting the Ca2+ influx 
due to electrochemical gradient in order to maintain a steady state with regard to the total 
intracellular Ca2+ content. The electroneutral Ca2+ efflux of this pump is accomplished via 
the coupling influx of two H+ (see review Carafoli, 1987).  
1.1.2.5 Other Ca2+ transport channels on the plasma membrane 
Ca2+-activated potassium channels are believed to play an important role in the modulation 
of vascular smooth muscle cell (VSMC) relaxation (see reviews Ghatta et al., 2005; Ledoux 
et al., 2006). Ca2+-activated potassium channel is classified into three categories according to 
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its conductance: large-conductance (100-300 pS, BKCa), intermediate-conductance (25-100 
pS, IKCa) and small-conductance (2-25 pS, SKCa) (see also review Ghatta et al., 2005; Sollini 
et al., 2002). BKCa exists in vascular smooth muscle, and is activated by increased 
intracellular Ca2+ or membrane depolarization (see reviews Cox, 2002; Quast et al., 1994). In 
VSMC, Ca2+ entry via the opening of VGCC has the potential to activate BKCa which 
induces membrane hyperpolarization and the inhibition of VGCC as a negative feedback 
system (see reviews Ghatta et al., 2005; Ledoux et al., 2006)(Nishimura, 2006). 
Calcium permable channels include not only voltage-dependent Ca2+ channels, but voltage-
independent Ca2+ channels as well, such as the nonselective cation channel (NSCC) which is 
poorly selective for Ca2+, Na+ and other cations (Albert et al., 2002b; Matsuoka et al., 1997b; 
Trepakova et al., 2001). The store-operated channel (SOC), stretch-activated channels (SAC) 
and receptor-operated channel (ROC) are members of the superfamily of voltage-
independent Ca2+ channels which are believed to be encoded by transient receptor potential 
(TRP) genes (See reviews Belkacemi et al., 2005; Dietrich et al., 2006; Inoue et al., 2002; 
Okuhara et al., 2007; Remillard et al., 2006)(Tiruppathi et al., 2006; Tiruppathi et al., 2002). 
The voltage-independent Ca2+ channels also contribute to the control of vascular smooth 
muscle contraction, cell proliferation and migration (Okuhara et al., 2007; Remillard et al., 
2006; Yao, 2007).  
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1.1.3 Intracellular Ca2+ transport systems 
1.1.3.1 Calcium release from the sarcoplasmic reticulum (SR) 
The sarcoplasmic reticulum in excitable cells or the endoplasmic reticulum (ER) in 
nonexcitable cells are the main intracellular Ca2+ storage organelles from which Ca2+ can be 
released to increase the [Ca2+]i (Marin et al., 1999). In the SR, there are two types of Ca2+ 
channels: one is sensitive to IP3, and the other sensitive to ryanodine and caffeine. 
(1) Inositol 1,4,5-trisphosphate receptor (IP3R) 
The inositol 1,4,5-trisphosphate (IP3) is produced through the classical inositol lipid pathway 
(PLC-IP3 pathway). Plasma membrane phospholipase C (PLC) hydrolyzes the 
phosphatidylinositol-4,5 bisphosphate (PIP2) that presents in the inner cell membrane of lipid 
bilayer and forms two important secondary messengers: the diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3) (Rosendorff, 1997). The hydrophilic IP3 diffuses into the 
cytoplasm and interact with the IP3-sensitive Ca2+ channel in the SR membrane causing the 
calcium release from the SR or ER (Marin et al., 1999). The hydrophobic DAG remains in 
the plasma membrane, and together with Ca2+, activates protein kinase C. The major steps of 
PLC-IP3 pathway is depicted in Figure 1.2. 
The activation of cell-surface receptors in the plasma membrane by agonists, such as 
noradrenaline, acetylcholine, or serotonin evokes interdependent and closely coupled 
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biphasic increase in cytosolic free Ca2+. The rapid phase reflects Ca2+ release from internal 
stores upon stimulation of IP3R, whereas the sustained phase is due to calcium influx into the 
cell (Elliott, 2001; Laher et al., 1989). The quantal Ca2+ release from ER or SR store through 
IP3R causes depletion of the store and induces Ca2+ entry from the extracellular space, is 
referred to store-operated Ca2+ influx (formerly capacitative Ca2+ entry, CCE), please refer to 
1.3 for details and references. 
(2)  Ryanodine receptor (RyR) 
Ryanodine is a neutral plant alkaloid and a naturally occurring insecticide. RyR forms a 
family of intracellular Ca2+ release channels on the ER/SR that can be activated and opened 
by ryanodine, caffeine and micromolar order of Ca2+. Once open, it induces calcium release 
from internal store, and it is responsible for Ca2+ –induced Ca2+ release in some tissues 
(Bolton, 2006; Dabertrand et al., 2006; Karaki et al., 1997; Wang et al., 2004; Zhang et al., 
2006). Its function can be inhibited by ruthenium red and millimolar Ca2+ (Marin et al., 
1999). 
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Figure 1.2 The modulation of contractile system by the classical inositol lipid 
pathway (PLC-IP3 pathway) 
This above graph depicts the PLC-IP3 pathway which is discussed in section 
1.1.3.1(1). PLC breaks down PIP2 into IP3 and DAG. IP3 acts on the IP3 receptor on 
the SR and induces the Ca2+ release from SR. DAG activates PKC in the presence of 
Ca2+, and then regulates the activity of contractile system. 
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1.1.3.2 The sarcoplasmic reticulum Ca2+ pump (SERCA pump) 
The SERCA pump is a protein which exists in the SR membrane, has a high affinity for Ca2+ 
and can transport significant amounts of intracellular Ca2+ into the lumen of the SR in an 
ATP-dependent manner. This is the principal way in which Ca2+ is sequestered into internal 
stores. For each ATP molecule hydrolyzed, two Ca2+ ions are sequestered to the SR. The 
activity of the SERCA pump is tightly controlled by phosphorylation of phospholamban 
(Marin et al., 1999). Phospholamban is believed to attach to the pump with the stoichiometry 
of 1:1, and to inhibit it. Upon phosphorylation of phospholamban by cAMP-dependent 
and/or Ca2+-calmodulin dependent protein kinases, phospholamban detaches from the pump 
and activates it.  (See review Carafoli, 1987). 
The inhibitors of the SERCA pump, such as thapsigargin, cyclopiazonic acid (CPA), and 
caffeine can block the pump, deplete the internal Ca2+ store, and therefore increase the 
cytosolic Ca2+ concentration (Holzapfel, 1968; Luo et al., 2000; Mitamura et al., 2002; 
Seidler et al., 1989). 
1.1.3.3 Mitochondrion 
The role of mitochondria in the regulation of calcium homeostasis is less important and not 
well elucidated. However, there are reported activities for mitochondria in the calcium 
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transport. There is uptake of Ca2+ into the matrix of mitochondria through a Ca2+ uniporter 
(Crompton, 1985; Gunter et al., 1990). There are also suggested mechanisms by which 
calcium efflux from the mitochondrial matrix may occur: Na+-Ca2+ carrier, Na+-independent 
efflux mechanism, and a Ca2+-induced increase of membrane permeability (Crompton, 1985; 
Gunter et al., 1990). It is generally believed that mitochondria play no central role in the 
regulation of cytosolic Ca2+ homeostasis (Marin et al., 1999). 
1.1.4 Ca2+ sensitivity of the contractile apparatus 
The contraction induced by some agonists (such as phenylephrine and U46619) can occur 
without a change in [Ca2+]i indicating that their action involves an increased sensitivity of the 
contractile process for Ca2+(See reviews Himpens, 1992; Salamanca et al., 2005). The ratio 
of myosin light chain kinase to myosin light chain phosphatase activity affects the sensitivity 
to Ca2+. The higher the ratio the more sensitive the contracile apparatus to Ca2+. It is 
suggested that the underlying mechanism for increasing Ca2+ sensitivity might include Rho-
kinase and PKC (See reviews Dallas et al., 2003; Himpens, 1992; Salamanca et al., 
2005)(Rikitake et al., 2005).  
The protein kinase C (PKC) family includes three major groups. The conventional PKCs 
(cPKC): α, βI, βII, and γ, are Ca2+–dependent; the novel PKCs (nPKC): δ, ε, η(L) and θ, are 
Ca2+–independent and the atypical PKCs (aPKC): ζ and ι , are also Ca2+–independent 
(Horowitz et al., 1996; Salamanca et al., 2005). A variety of excitatory agonists bind to G-
protein coupled receptors and induces biphasic tonic constriction in smooth muscle. The 
initial rapid phasic component is believed to be induced by Ca2+ released from SR by inositol 
1,4,5-trisphosphate (IP3) after cleavage of PIP2 by phospholipase C. The sustained phasic 
18 
contraction is maintained by the increased Ca2+ sensitivity via the inhibition of myosin light 
chain kinase phosphatase (MLCP) by PKC and Rho kinase (See reviews Dimopoulos et al., 
2007; Hirano et al., 2004; Lincoln, 2007; Salamanca et al., 2005). 
 
MLCP is comprised of a catalytic subunit, classified as a PP1c δ isoform; a myosin binding 
regulatory subunit known as MYPT1 and a third subunit whose function remains unclear 
(See reviews Dimopoulos et al., 2007; Lincoln, 2007). There are two pathways that inhibit 
MLCP, one is the phosphorylation of MYPT1 (Thr696 and Thr853 sites), and the other is the 
phosphorylaton of MLCP inhibitor protein CPI-17(See review Hirano et al., 2004). Several 
kinases were proposed to mediate the above pathways, the most investigated are protein 
kinase C (See reviews Dallas et al., 2003; Dimopoulos et al., 2007; Himpens, 1992; Lincoln, 
2007; Salamanca et al., 2005; Walsh et al., 1996) and the small molecular weight G-protein, 
RhoA which activates Rho-activated kinase (ROK) (See reviews Dimopoulos et al., 2007; 
Lincoln, 2007; Murthy, 2006)(Hu et al., 2005). 
 
On the other hand, the process of desensitization is believed to be mediated by cGMP which 
activates PKG leading to the dephosphorylation of CPI-17 and the phosphorylation of 
MYPT1 (S695 site) (See reviews Dimopoulos et al., 2007; Lincoln, 2007). 
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1.2 MECHANISM OF CONTRACTION AND RELAXATION IN VASCULAR 
SMOOTH MUSCLE CELLS 
1.2.1 Structure of smooth muscle cells (SMC) 
Smooth muscle locates chiefly in the walls of hollow organs, and is controlled involuntarily. 
Smooth muscle fibers are small, spindle shaped uninucleate cells and display no striation. 
They contain thick filament (myosin), thin filament (actin) and non-contractile intermediate 
filament (Ham, 1969; Shepro et al., 1974; Tortora et al., 1981).  
1.2.2 Mechanism of contraction in the smooth muscle cell 
The mechanism of contraction in the smooth muscle cell parallels that of skeletal muscle. 
The common features are: (1) The contraction is triggered by the rise of intracellular Ca2+; 
(2) actin and myosin interact via the sliding mechanism; (3) The sliding process is fueled by 
ATP (Allen et al., 1994; Murphy et al., 2002a; Zou et al., 1995; Zou et al., 2000).  
However, the smooth muscle cell is distinctive in many ways. In SMC, Ca2+ triggers muscle 
contraction by calmodulin-dependent myosin light chain kinase (MLCK) and subsequent 
phosphorylation of the 20-kDa regulatory myosin light chains (Allen et al., 1994; Murphy et 
al., 2002a; Zou et al., 1995). 
The major steps of contraction in SMC are as follows (Lincoln et al., 2001): (1) Ca2+ binds 
to calmodulin and activates it; (2) activated calmodulin activates the kinase enzyme in the 
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myosin filament: MLCK; (3) phosphorylation of the 20-kDa regulatory myosin light chains; 
(4) cross-bridge cycling and the force generation. The sequence of events during contraction 
is shown in Figure 1.3. 
When [Ca2+]i drops, the myosin binding sites on actin are physically blocked by tropomyosin 
molecules, and the resulting myosin dephosphorylation by MLC phosphatase causes 
relaxation (Allen et al., 1994).   
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Figure 1.3 The sliding filament model of muscle contraction 
 
A. ATTACHED-myosin head (cross bridge) attaches to an actin filament. 
B. FORCE GENERATING-myosin head pivots and causes the movement of the 
actin filament, two types of filaments slide against each other. Muscle 
contraction takes place. 
C. RELEASED-a new ATP molecule binds to myosin head, cross bridge 
detaches. 
D. COCKED-ATP hydrolyzes to ADP and Pi, myosin head cocks. 
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1.3 STORE-OPERATED Ca2+ CHANNELS (SOC) 
It is firmly established that depletion of intracellular calcium stores in the SR/ER in a wide 
range of cells could activate Ca2+ influx into the cell through store-operated Ca2+ channels 
(SOC), which is termed capacitative Ca2+ influx (See reviews Arnon et al., 2000; Bolotina, 
2004; Parekh et al., 1997a; Venkatachalam et al., 2002). These plasma membrane Ca2+ 
channels are regulated by the filling state of intracellular Ca2+ stores in the sarcoplasmic 
reticulum (SR) or endoplasmic reticulum (ER). This Ca2+ current was termed Ca2+-release-
activated Ca2+ current (ICRAC) (See reviews Hoth et al., 1992; Parekh et al., 1997a).  
The SOC is believed to be encoded by transient receptor potential (TRP) genes (Trepakova 
et al., 2001),(See also reviews Dietrich et al., 2006; Inoue et al., 2002; Okuhara et al., 2007; 
Remillard et al., 2006)(Tiruppathi et al., 2006; Tiruppathi et al., 2002). In comparison to the 
clear identity of SOC, the mechanism linking depletion of intracellular Ca2+ stores to the 
activation of plasma membrane Ca2+ channels remains a mystery. There is accumulating 
evidence for a conformational coupling theory. It suggests that inositol 1,4,5-trisphosphate 
(IP3) receptor (IP3R) is coupled to the plasma membrane Ca2+ entry channel. Depletion of 
intracellular Ca2+ stores induces a conformational change in IP3R, which interacts with and 
activates a plasma membrane Ca2+ channel (See reviews Bolotina, 2004; Parekh et al., 
1997b; Putney et al., 2001). This pathway is IP3-dependent, no store depletion is needed. 
However, there is also a convincing body of evidence indicating that the aforesaid 
mechanism can not account for the activation of store-operated channels in all 
circumstances. Thus, the pathway by a diffusible Ca2+-influx factor, Ca2+-independent 
phospholipase A2 (iPLA2) and its lysophospholipid products was suggested (See reviews 
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Putney et al., 2001; Smani et al., 2003). Apparently, IP3 is not needed for this mechanism. 
This can explain why SOC operates normally in the triple IP3R knockout DT40 cells that 
lack IP3R1, IP3R2, and IP3R3 (Bakowski et al., 2001; Ma et al., 2001; Prakriya et al., 2001). 
Taken together, one tentative conclusion is that there is a co-existence of two functionally 
distinct mechanisms with regard to the activation of SOC in excitable and nonexcitable cells. 
Thapsigargin, cyclopiazonic acid (CPA), and 2,5-di-(tert-butyl)-1,4-benzohydroquinone 
(tBHQ) are inhibitors of ATP-dependent Ca2+ pumps of the sarcoplasmic reticulum or 
endoplasmic reticulum, and can thereby be employed to activate SOC by depleting the Ca2+ 
stores (Gomez-Viquez et al., 2005; Liu et al., 2006; Lopes et al., 2006; Mitamura et al., 
2002; Sohoel et al.).  
1.3.1 Store-operated Ca2+ channels in nonexcitable cells 
In most non-excitable cells like epithelial cells, endothelium cells, lymphocytes, and 
hepatocytes, the activation of cell-surface receptor stimulates inositol 1,4,5-trisphosphate 
(IP3) production and induce interdependent and closely coupled biphasic cytosolic calcium 
signal (Elliott, 2001). The rapid phase reflects Ca2+ release from internal stores, whereas the 
sustained phase is due to Ca2+ influx from the extracellular space. The release from ER stores 
is believed to be mediated by IP3 receptors or other Ca2+-releasing signals leading to the 
opening of plasma membrane store-operated Ca2+ channels (See reviews Elliott, 2001; 
Parekh et al., 1997b; Putney et al., 2001). Therefore, the SOC is the dominant calcium entry 
pathway in nonexcitable cells. Growing evidence describes a highly calcium-selective 
current in nonexcitable cells, which is called Ca2+-SOC (See reviews Bolotina, 2004; Hoth et 
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al., 1992). Ca2+-SOC might be the mechanism by which nonexcitable cell maintains raised 
intracellular calcium level and refills the empty calcium store. 
As the main calcium entry pathway in non-excitable cells such as mast cells, rat basophilic 
leukemia cells and Jurkat T cells, the SOC modulates diverse processes, such as, exocytosis, 
enzyme control, gene regulation, cell proliferation and apoptosis (See reviews Hoth et al., 
1992; Parekh et al., 1997a; Parekh et al., 1997b). 
1.3.2 Store-operated Ca2+ channels in excitable cells 
There is very limited information with respect to the SOC in excitable cells due to the 
difficulty of electrophysiological recording of SOC (McFadzean et al., 2002). 
In excitable cells like neurons, muscle, and endocrine cells, it is widely agreed that the 
dominant calcium entry pathway is the well-characterized voltage-operated calcium channel 
(See reviews Carafoli, 1987; Godfraind, 1988; IUPHAR, 2005; Poburko et al., 2004).  
Characteristics of SOC in excitable cell: SOC in nonexcitable cell is highly selective for 
Ca2+. However, the SOC in excitable cells is poorly selective to cation channel (Cat-SOC), 
and permeable to Ca2+ as well as Na+ (See reviews Albert et al., 2003; Bolotina, 2004). Na+ 
entry through Cat-SOC might act as a trigger to evoke secondary calcium influx through 
NCX by elevating intracellular Na+ (See reviews Arnon et al., 2000; Bolotina, 2004). In 
addition, Cat-SOC was shown to be activated via G-protein-coupled receptors, instead of IP3 
receptor on SR. In this case, Cat-SOC is therefore a receptor-operated channel (ROC) 
25 
(Albert et al., 2002a). 
The direct function of SOC in excitable cells is replenishing the depleted calcium store 
stimulated by the G-protein-coupled receptors after agonist application. Indirectly, it is 
involved in the regulation of contraction and cell proliferation (Albert et al., 2003; Arnon et 
al., 2000). 
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1.4 Na+/Ca2+ EXCHANGER 
1.4.1 General introduction of Na+/Ca2+ exchanger 
The Na+/Ca2+ exchanger (NCX) is an integral membrane protein responsible for the 
countertransport of Na+ and Ca2+ across the plasma membrane of virtually all animal cells. It 
is one of several mechanisms that mediate Ca2+ flow across the plasma membrane. It acts in 
series with the plasma membrane ATP-driven Ca2+ pump to extrude Ca2+. As a reversible 
transporter, it can, under some circumstances, mediate Ca2+ entry in parallel with various ion 
channels. The energy and direction for net Ca2+ movement across the NCX depends on the 
electrochemical gradient of Na+, Ca2+, and K+, the membrane potential, and the transport 
stoichiometry. (For review, see Philipson, 2002).  
1.4.2 The structure of NCX 
In 1988, the first cardiac NCX (NCX1) was isolated (Philipson et al., 1988). In 1990, the 
first NCX1 was cloned and sequenced from cardiac sarcolemma (Nicoll et al., 1990). Each 
functional NCX1 isoform comprises nine transmembrane segments and a large intracellular 
hydrophilic loop between the fifth and sixth transmembrane segments (Figure 1.4) (Philipson 
et al., 2000; Shigekawa et al., 2001). This replaces the initial suggestion of twelve 
transmembrane segments which include the signal peptide (Philipson et al., 2000). The 
glycosylated N-terminal includes five transmembrane segments, and the C-terminal the other 
four transmembrane segments. The protein contains two internal repeat sequences (α-1 and 
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α-2) that are highly conserved in all members of NCX family and critically involved in ion 
transportation (Nicoll et al., 1996a; Shigekawa et al., 2001). The mature NCX1 protein is 
composed of 938 amino acids after the cleaving of the first 32 amino acid-long signal 
peptide. The cytoplasmic loop (about 550 amino acids long) is a Ca2+ binding site (also 
called Ca2+ regulatory site) and does not participate in ion transportation, but is involved in 
the regulation of NCX by intracellular Na+, Ca2+ and PIP2 (Maack et al., 2005).  
1.4.3 Isoforms of NCX 
Nine genes that code for the NCX have been identified in mammals: three in the Na+/Ca2+ 
exchanger family: NCX1 (Nicoll et al., 1990), NCX2 (Li et al., 1994), and NCX3 (Nicoll et 
al., 1996b) and six in the Na+/Ca2+ plus K+ family (NCKX1 -  NCKX6) (see Dong et al., 
2006; Reilander et al., 1992).  
NCX1 is widely expressed in diverse tissues including heart, brain, skeletal muscle, smooth 
muscle, kidney, spleen, and lung. The cloned cardiac NCX1 has been elucidated in heart 
(Nicoll et al., 1990), aorta (Nakasaki et al., 1993), and many other tissues (Iwamoto et al., 
1995). Six exons (A, B, C, D, E, and F) code for the alternatively spliced NCX1 isoforms 
(Lee et al., 1994)(Kofuji et al., 1994; Nakasaki et al., 1993; Nicoll et al., 1990). Exon A-
containing transcripts are predominantly expressed in excitable cells (e.g. NCX1.1 containing 
exons A,C,D,E and F in cardiomyocyte: NCX1.4 containing exons A and D (Ander et al., 
2007; Dunn et al., 2002; Hurtado et al., 2006; Schulze et al., 2002) and NCX1.5 containing 
exons A, D and F in neurons of the brain) (Dunn et al., 2002; Hryshko, 2002; Sergeeva et al., 
2003); Exon B-containing transcripts are mainly expressed in nonexcitable cells (e.g. NCX1.3 
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containing exons B and D is abundant in kidney as well as vascular smooth muscle cells) 
(Iwamoto et al., 2004b; Karashima et al., 2007; Ruknudin et al., 2000; Szewczyk et al., 
2007; Zheng et al., 2007). Comparatively, NCX2 and NCX3 are exclusively distributed in 
brain and skeletal muscle respectively (Quednau et al., 1997). The present study focuses on 
NCX1 in rat aorta. There is a high homology of the NCX1 clones in various tissues. For 
example, the NCX1 in rat aorta shares the same structure with canine cardiac NCX except 
for the central loop domain amino acid 570-631 and N-terminal portion (Nakasaki et al., 
1993). There are no distinctive functional differences among tissue-specific NCX isoforms 
(Linck et al., 1998), (see review Blaustein et al., 1999).   
1.4.4 Coupling ratios of NCX 
In most cells, three Na+ ions are moved in exchange for one oppositely directed Ca2+ ion. 
Due to the difference between charges of imported and exported ions (3 Na+ : 1 Ca2+), NCX 
is electrogenic and can be measured as an ionic current: Na+/Ca2+ exchange current (INCX) 
(Chin et al., 1993; Kimura et al., 1986; Philipson, 2002). Both outward (Ca2+ entry mode) 
and inward current (Ca2+ exit mode) are detectable using the method of giant patch voltage 
clamp combined with internal perfusion (Hilgemann, 1989; Kimura et al., 1987; Kimura et 
al., 1986; Matsuoka et al., 1995). However, in vertebrate photoreceptors, some neurons, and 
certain other cells, K+ is transported in the same direction as Ca2+, with a coupling ratio of 
four Na+ to one Ca2+ plus one K+ (NCKX) (Dong et al., 2006). The exchanger kinetics are 
affected by nontransported Ca2+, Na+, protons, ATP, and other modulators. (For review, see 
Blaustein, 1989). Some conspicuous features of NCX are summarized in Table 1.3. 
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Figure 1.4 Model of Na+/Ca2+ exchanger protein 
The nine transmembrane segments are indicated as cylinders, numbered from 1 to 9. 
The α-repeat regions in transmembrane segments 2, 3, and 7 are shaded. N terminus of 
the protein is located in the external side of the plasma membrane; C terminus and 
hydrophilic loop are in the internal side. On the loop, self-inhibitory XIP region, the 
binding site for regulatory Ca2+, and alternatively spliced region are identified. GIG 
represents a conserved GIG motif. 
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TYPE OF NCX 
 
COUPLING RATIO
 
ISOFORMS 
 
K+-independent 
(Cardiac/neuronal/renal type) 
 
3Na+ : 1Ca2+ 
 
NCX1-NCX3 
 
K+-dependent 
(Vertebrate photoreceptor type) 
 
4Na+ : (1Ca2+ : 1K+) 
 
NCKX1-NCKX6 
 
Please refer to 1.4.4 for details and references. 
Table 1.3 The properties of difference types of NCX. 
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1.4.5 Modes of operation 
The transport of ions mediated by NCX is bi-directional. NCX can move Ca2+ either 
outwardly or inwardly depending on the prevailing electrochemical driving forces (i.e. the 
Na+ and Ca2+ concentration gradients and the membrane potential). These two modes of 
Na+/Ca2+ exchange (see Figure 1.5 and Figure 1.6) are generally referred to as "Ca2+ entry 
mode" (reverse mode) and "Ca2+ exit mode" (forward mode) respectively. 
The net Ca2+ transport [JCa(Na/Ca)] is decided by the difference between the membrane 
potential (VM), the reversal potential of the exchanger (ENa/Ca), as well as the complex kinetic 
parameter (k) which is described in the following equation: JCa(Na/Ca) = k (VM - ENa/Ca) (see 
review Blaustein, 1989). 
For the K+-independent exchanger, the coupling ratio is 3Na+ : 1Ca2+.  
Eq. 1            ENa/Ca = 3ENa – 2ECa  
Eq. 2  ENa = (RT/F)ln([Na+]o/[Na+]i)  
Eq. 3  ECa = (RT/2F)ln([Ca2+]o/[Ca2+]i) 
The parameter k is related to the number of carriers; the fractional saturation of the carrier 
binding sites by the activating ions and transported ions; VM; and ATP. 
R: gas constant; T: absolute temperature; F: Faraday’s number 
The thermodynamic driving force (ΔV) for NCX is: VM - ENa/Ca (see reviews Blaustein et al., 
1999; Sipido et al., 2002). This force is clearly demonstrated in the action potential of 
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cardiomyocyte. When ENa/Ca is more negative than VM during the early cardiac action 
potential, ΔV drives the NCX to mediate Ca2+ entry.  When VM is more negative than ENa/Ca 
during the later part of action potential plateau, ΔV drives the NCX to mediate Ca2+ exit (see 
reviews Blaustein, 1989; Blaustein et al., 1999; Sipido et al., 2002). 
1.4.5.1 Ca2+ entry mode (reverse mode) 
The Ca2+ entry mode of exchange (Figure 1.5) is usually identified as an internal Na+ (Nai)-
dependent Ca2+ influx and an external Ca2+(Cao)-dependent, ouabain-insensitive Na+ efflux 
(Furukawa et al., 1991; Kimura et al., 1987)  {See also review \Blaustein, 1999 #7}}.  
1.4.5.2 Ca2+ exit mode (forward mode) 
Ca2+ exit mode (Figure 1.6) exchange is defined operationally as an external Na+(Nao)-
dependent Ca2+ efflux and an internal Ca2+(Cai)-dependent ouabain- and tetrodotoxin (TTX)-
insensitive Na+ influx (Furukawa et al., 1991; Kimura et al., 1987), (See also review 
Blaustein et al., 1999)}.  
There are also two other types of modes, namely: Ca2+/Ca2+ exchange and Na+/Na+ exchange 
mediated by the Na+/Ca2+ exchanger (Blaustein et al., 1977). It is assumed that these two 
modes of exchange are perhaps not functionally important in terms of net ion translocation. 
It is clear that NCX can only mediate coupled countertransport, does not mediate 
"uncoupled" transport of either Na+ or Ca2+ (see review Blaustein et al., 1999).   
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Figure 1.5 The model of Ca2+ entry (reverse mode)  
From the equations Eq. 1, Eq. 2 and Eq. 3, increasing intracellular Na+ or decreasing 
extracellular Na+ from the physiologic level can, in some circumstances, cause the 
exchanger to transport Ca2+ into cells and this is referred as Ca2+ entry mode or reverse 
mode (Schweda et al., 2001). 
Figure 1.6 The model of Ca2+ exit (forward mode)  
From the equations Eq. 1, Eq. 2, and Eq. 3 , the physiological level of Na+ inside and 
outside the cell favors Ca2+ extrusion from the cell through the exchanger and this is 
defined as Ca2+ exit mode or forward mode operation (Schweda et al., 2001).  
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1.4.6 Inhibitors of NCX 
Inhibitors of NCX are dealt with in chapter 2.1. 
1.4.7 The modulation of NCX 
There is abundant evidence showing that NCX can be regulated on the intracellular 
hydrophilic loop that occurs at two major levels: (i) modulation by ions (Na+-inactivation, 
[Ca2+]i activation, and proton inhibition); and (ii) modulation by signal transduction 
processes (DiPolo et al., 2002). 
1.4.7.1 The ionic modulation of NCX by regulatory ionic ligands (Na+, Ca2+, and H+) 
The activity of NCX can be activated by cytoplasmic Ca2+, and inhibited by cytoplasmic Na+ 
( for reviews see Annunziato et al., 2004; Blaustein, 1989; DiPolo et al., 2002; Philipson et 
al., 2000; Shigekawa et al., 2001). 
Intracellular Ca2+ plays a key role for the function of NCX, as not only a transport substrate 
but an activator as well (DiPolo et al., 1987a; DiPolo et al., 1987b; DiPolo et al., 1987c). 
Independent of the mode (forward or reverse mode), cardiac NCX activity can only be 
switched on when the intracellular Ca2+ binds to the Ca2+ regulatory site on central 
hydrophilic loop (see Figure 1.4) (DiPolo et al., 2002).  The loop is a regulatory domain, and 
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separate from the Ca2+ transport parts of the molecule (Shigekawa et al., 2001). The 
intracellular Ca2+- dependent activation is a critical feature of NCX (DiPolo et al., 2002; 
Linck et al., 1998; Matsuoka et al., 1995). The [Ca2+]i required for half-maximal activation 
(K1/2) of Ca2+ entry mode exchange in squid axons (DiPolo, 1979) and cardiac myocyte giant 
patches (Kimura et al., 1987) is of the order 1 µM under physiological conditions. As such, 
exchangers are only partially active at the normal resting [Ca2+]i (~100 nM) in most cells. 
There is a requirement of micromolar [Ca2+]i above resting level for the full NCX function. 
The exchanger is fully activated when [Ca2+]i is in the low micromolar range (i.e., at about 
the [Ca2+]i expected during peak activity in many types of excitable and secretory cells). The 
intracellular Ca2+- dependent activation might be a protective mechanism allowing NCX to 
be turned on when [Ca2+]i is high and off when [Ca2+]i is low (DiPolo et al., 2002). 
In sharp contrast with Ca2+, high [Na+]i reduces the exchanger-mediated Ca2+ transport. High 
[Na+]i was observed to induce an initial peak of the exchanger current and the subsequent 
decaying to steady state (Hilgemann et al., 1992). This process, which is referred to as Na+-
dependent inactivation, is believed to involve Na+ ion interacting with the auto inhibitory 
region of endogenous exchanger inhibitory peptide (XIP), (see reviews DiPolo et al., 2002; 
Philipson et al., 2000).  
The activity of NCX was demonstrated to be pHi dependent and inhibited by H+. The 
intracellular alkalinization causes a dramatic increase in NCX affinity for Ca2+ (DiPolo et al., 
1987a; Hilgemann et al., 1992). Proton inhibition of NCX activity is assumed to occur via its 
competing with Ca2+ at a Ca2+ binding site on intracellular loop (Blaustein et al., 1977; 
DiPolo et al., 2002). 
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Given that intracellular Ca2+-dependent activation is a prerequisite for NCX function, 
intracellular Na+ and H+ synergistic inhibition take place by competing with Ca2+ at a 
calcium-binding site on the central loop (DiPolo et al., 2002; DiPolo et al., 1999a). 
1.4.7.2 The modulation of NCX by signal transduction processes 
Multiple cellular signal pathways have been demonstrated to participate in the modulation on 
NCX, such as protein kinase C (PKC), protein kinase A (PKA), ATP, and nitric oxide. The 
interaction between nitric oxide and NCX is discussed in 3.1. The other modulators are 
discussed below. 
(1) The modulation of NCX by protein kinases 
With regard to the modulation of NCX by protein kinase C, some convincing data have been 
obtained in smooth muscle cells. The phosphorylation sites for PKC and PKA in the 
intracellular loop of NCX in rat aorta had been reported (Nakasaki et al., 1993). This may 
have functional significance. In rat aortic VSMC from the A7r5 cell line, phorbol ester 
stimulated the NCX activity (Vigne et al., 1988). Iwamoto and co-workers provided direct 
evidence that PKC-dependent phosphorylation activated NCX in both quiescent and growth 
factor-stimulated cultured aortic smooth muscle cells of rat (Iwamoto et al., 1995). Again, 
PKC-catalyzed phosphorylation up-regulated the activity of both cloned and native NCX in 
both NCX overexpressed canine cardiomyocytes and rat neonatal cardiomyocytes (Iwamoto 
et al., 1996a). 
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Yamanaka et al showed that the cAMP/PKA system stimulated NCX activity in porcine 
coronary artery smooth muscle cells (Yamanaka et al., 2003). This is consistent with the up-
regulatory effect of cAMP/PKA system on NCX in rat neurons (He et al., 1998). However, 
both PKA and PKG were shown to inhibit the activity of NCX in cultured human mesangial 
cells (Mene et al., 1993). In another case, the adenylate cyclase activator: forskolin inhibited 
the NCX mRNA and activity in cultured rat aortic myocyte (Smith et al., 1995). Clearly, the 
modulation of NCX by cyclic nucleotide depends on the tissue and the experimental 
condition. This needs to be further elucidated.  
(2) The modulation of NCX by ATP 
The operation of NCX is not ATP-driven, the hydrolysis of ATP is therefore not required to 
power net Ca2+ movement and Na+/Ca2+ exchange can be demonstrated in ATP-depleted 
cells (Blaustein et al., 1969; Blaustein et al., 1977). Nevertheless, there is a growing body of 
evidence showing that ATP alters the exchanger kinetics (Blaustein et al., 1977; Caroni et 
al., 1983; Linck et al., 1998; Poburko et al., 2006), presumably by promoting 
phosphorylation of regulatory sites on the exchanger protein (DiPolo et al., 1987b; Hinde et 
al., 1999).  In dialyzed squid axon, ATP activated the reverse Na+/Ca2+ exchange (DiPolo et 
al., 1987a). ATP-depletion inhibited NCX activity in both overexpressed canine 
cardiomyocytes and rat neonatal cardiomyocytes (Iwamoto et al., 1996a).  In stably 
transfected BHK cells, ATP stimulated NCX1 activity and ATP-depletion inhibited NCX1 
and NCX2 (Linck et al., 1998). Clearly, ATP up-regulates the invertebrate and mammal 
38 
NCX activities by changing the affinity for Na+ and Ca2+ at transporting and regulatory sites 
(DiPolo et al., 1987a; DiPolo et al., 1998; DiPolo et al., 1987b); (for review see DiPolo et 
al., 1999b). 
NCX1 was shown to be up-regulated by the level of membrane phosphatidylinositol 4,5-
bisphosphate (PIP2) (Hilgemann et al., 1996). It was suggested that ATP exerts its indirect 
regulatory effect on NCX through the forming of PIP2 from phosphatidylinositol (PI). The 
further experimental data in favor of this hypothesis was shown by (Berberian et al., 1998).  
 (3) The metabolic modulation of NCX by other high energy compounds 
Apart from ATP, another phosphoryl donor reported to be a regulator of NCX is 
phosphoarginine (Pa). Phosphoarginine, as well as ATP was reported to up-regulate the NCX 
activity through phosphorylation in dialysed squid axons (DiPolo et al., 1998). 
1.4.8 Physiological function of NCX 
1.4.8.1 NCX in vascular smooth muscle cell (VSMC) 
Early investigation of NCX function in affecting contractility can be traced back to the late 
1950s (Hagiwara et al., 1967; Luttgau et al., 1958). It is now widely accepted that NCX 
makes critical contributions to the maintenance of calcium homeostasis in a variety of tissues 
(Chapman et al., 1983). The primary function of NCX is removing the Ca2+ out of the cells 
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(operating in forward mode), although it also mediates Ca2+ influx (operating in reverse 
mode) in some circumstances (Linck et al., 1998). See also 2.4, 3.4 and 4.4.  
Unlike the uniformly distributed plasma membrane Ca2+ pump that serves a housekeeping 
role by maintaining a low [Ca2+]i (Furukawa et al., 1988), NCX was found to distribute 
focally in reticular pattern over the cell surface of the plasma membrane that is close to SR 
or ER (subsarcolammal domain), e.g. surface sarcolemmal or disk region, in the T-tubules 
only at the level of the Z-line (Blaustein et al., 1992; Juhaszova et al., 1994; Juhaszova et al., 
1996). The co-localization of NCX with SR may give clues about its function (Juhaszova et 
al., 1994; Juhaszova et al., 1996). Under resting conditions, NCX may have access to SR 
regulating the content of Ca2+ stored in the SR and, be available for contractions (Busselen et 
al., 1991; Evans et al., 1997; Goldman et al., 1994; Lewartowski et al., 1990; Litwin et al., 
1996), (see also reviews Blaustein et al., 1999; Sipido et al., 2002). When the cell is 
activated, much of the trigger Ca2+ for contraction may enter the cells via voltage-gated Ca2+-
selective channels (Davis et al., 1999; Hagiwara et al., 1967; Jaggar, 2001; Wesselman et al., 
1996), but some may also enter via the exchanger when the cells are depolarized and [Ca2+]i  
rises (Bova et al., 1990; DiPolo et al., 1987c; Rebolledo et al., 2006; Zhu et al., 1994). NCX 
may help to keep Ca2+ elevated during tonic contractions.  
To facilitate the relaxation of smooth muscle cells after contraction is initiated, Ca2+ must be 
extruded rapidly (Hill et al., 2003; Philipson, 2002). This Ca2+ extrusion is against a 
tremendous electrochemical gradient, due to the free [Ca2+]i at rest in arterial SMC is around 
100-200 nM as opposed to 1.8 mM externally (Ashida et al., 1987). Whilst a large fraction of 
Ca2+ is sequestered back into sarcoplasmic reticulum (SR), a significant portion of it is 
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pumped out of the cytoplasm via NCX (Liang et al., 2004; Wang et al., 2002b). NCX pumps 
out Ca2+ ions about tenfold more rapidly (>1000 sec-1) (Cheon et al., 1988) than the ATP-
driven Ca2+ extrusion pump (∼50-150 sec-1), (see review Blaustein et al., 1999), far fewer 
exchanger molecules would be required to lower [Ca2+]i  rapidly (Ashida et al., 1987). Based 
on the different Ca2+–buffering ability of NCX and Ca2+ pump, it is broadly agreed that the 
exchanger plays an important role in the extrusion of Ca2+ in many types of cells, particularly 
following a rise in [Ca2+]i when cell activity is increased (Ashida et al., 1987; Nazer et al., 
1998; Smith et al., 1987). (See reviews Blaustein et al., 1999; DiPolo et al., 1987c; DiPolo et 
al., 1987d; Shigekawa et al., 2001). 
In cardiomyocytes from NCX knockout (NCX-/-) mice, decreased Ca2+ influx through L-type 
Ca2+ channel, increased plasma membrane Ca2+ pump activity, increased transient outward 
current through potassium channel and increased excitation-contraction coupling were able 
to compensate for the reduced Ca2+ extrusion capacity under basal conditions, and there were 
no change of any Ca2+ transport systems at the protein expression level (Pott et al., 2005; 
Pott et al., 2007; Sarai et al., 2006). However, when the cell activity is increased (e.g. after 
the addition of caffeine, isoproterenol), the NCX-/- heart tube was unable to maintain Ca2+ 
homeostasis (Reuter et al., 2003). There have been no studies in vascular smooth muscle 
using NCX knockouts. 
1.4.8.2 NCX in vascular endothelial cells (ECs) 
The existence of endothelial NCX has been reported in cardiac microvascular ECs (Kaye et 
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al., 1999), in cultured rat aortic ECs (Dong et al., 2004; Juhaszova et al., 1994; Quednau et 
al., 1997), in cultured human pulmonary arterial ECs (Mizuno et al., 2002) and in cultured 
pig coronary arterial ECs (Szewczyk et al., 2007). NCX has been shown to modulate 
calcium homeostasis in vascular endothelial cells of rabbit aorta (Liang et al., 2004; Wang et 
al., 2002b), porcine aorta (Schneider et al., 2002a; Teubl et al., 1999), calf pulmonary artery 
(Sedova et al., 1999), human umbilical vein (Ogura et al., 2004; Paltauf-Doburzynska et al., 
2000) and rat epicardial artery (Moccia et al., 2002). It is generally accepted that there is a 
tight interaction between endothelial NCX and endothelium-released nitric oxide (NO) 
(Dong et al., 2004; Kim et al., 2005; Mizuno et al., 2002; Ogura et al., 2004; Schneider et 
al., 2002a; Szewczyk et al., 2007). In EC, NCX can facilitate the Ca2+-dependent activation 
of endothelial nitric oxide synthase (eNOS) and the subsequent production of NO (Dong et 
al., 2004; Mizuno et al., 2002; Schneider et al., 2002a; Teubl et al., 1999). Interestingly, an 
increase in [Ca2+]i in EC and SMC has opposite effect. Whilst increased [Ca2+]i in EC causes 
vasorelaxation via activating eNOS,  increased [Ca2+]i  in SMC causes vasoconstriction via 
controlling contractility (See reviews Ledoux et al., 2006)(Szewczyk et al., 2007). 
In summary, NCX appears to play a central role in the regulation of the cytosolic [Ca2+]i, the 
SR Ca2+ store and the contractility, in both normal smooth muscle function and a variety of 
pathological conditions (Hill et al., 2003). 
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CHAPTER 2 THE INHIBITORY EFFECTS OF KB-R7943 ON MULTIPLE MODES 
OF VASOCONSTRICTION IN RAT AORTAE 
2.1 INTRODUCTION 
The actions of the Na+/Ca2+ exchanger (NCX) in Ca2+ homeostasis has been discussed in 
Section 1.4. Exploration of the physiological significance of NCX proteins requires tools to 
either activate or inhibit the exchanger selectively. This has led to a variety of approaches to 
manipulate the exchanger, which is discussed below. 
2.1.1 Inorganic cations 
Ca2+ is a critical ion in the modulation of cellular activity and there are a variety of ion 
channels, membrane pumps, enzymes and other proteins which have Ca2+ binding or 
transport functions, including Ca2+ channels, ATP-dependent Ca2+ pumps, and the Na+/Ca2+ 
exchanger (NCX). Ions with similar characteristics to Ca2+ may competitively inhibit Ca2+ 
binding to the Na+/Ca2+ exchanger and thus act as inhibitors. These have been used in a 
variety of studies (Bondarenko, 2004; Deval et al., 2002; Hagiwara et al., 1967; Hinde et al., 
1999; Kimura et al., 1987; Subramani et al., 2005; Trosper et al., 1983). The IC50 values to 
inhibit NCX1 in Chinese hamster lung fibroblasts are: La3+(22 μM) < Cd2+(33 μM) < 
Ni2+(52 μM) < Co2+(105 μM) < Mn2+(166 μM) < Mg2+(4.6 mM) (Iwamoto et al., 1998). 
LaCl3 (0.5 mM) inhibited the Na+-induced Ca2+ uptake in microsomal fractions from the 
longitudinal smooth muscle of the guinea-pig ileum and the rat aorta which is NCX mediated 
(Morel et al., 1984). Ni2+ was used as NCX inhibitor in cultured rat aortic endothelial cells at 
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the concentration of 5 mM (Dong et al., 2004), in endothelium-denuded rat mesenteric artery 
at the concentration of 30 - 300 μM (Tsang et al., 2003), and in guinea-pig ventricular 
myocytes at the concentration of 10 mM (Hinde et al., 1999). 
Selectivity is a major issue as many of these polyvalent cations inhibit a number of other 
Ca2+ transport and permeability mechanisms. La3+ is a good example, and La3+ (50 - 250 
μM) suppressed 80 to 95% of active calcium extrusion through a Ca2+-ATPase mechanism in 
intact human red blood cells (Sarkadi et al., 1977). Additionally, La3+ (0.1 mM) was used as 
a selective inhibitor of Ca2+ pump and blocked the Ca2+ efflux in human erythrocyte ghosts 
(Quist et al., 1975). Further, in cultured arterial myocytes, La3+ (0.25 mM) inhibited the 
calcium pump (Slodzinski et al., 1998a). It has in fact been suggested that low [La3+]o (0.06-
0.25 mM) inhibited the plasma membrane Ca2+ pump and not the NCX in arterial myocytes 
(Shimizu et al., 1997). A similar profile has been observed for other inorganic ions.  
A further issue in trying to use heavy metal inhibitors is that these polyvalent cations could 
be transported into cells as surrogates for Ca2+ eliciting other effects by acting on 
intracellular membrane. For example, La3+ (0.25 mM) entered arterial myocytes (Shimizu et 
al., 1997). Further the intracellular transported La3+ was found to replace regulatory Ca2+ and 
potently activate the exchanger activity even at picomolar concentrations in Chinese hamster 
ovary cells expressing the bovine cardiac Na+/Ca2+ exchanger (NCX1.1) (Reeves et al., 
2003). Taken together, these results indicate that inorganic ions are unsuitable in NCX 
studies. 
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2.1.2 Amiloride  
Amiloride, has been widely used as a blocker of Na+/H+ exchanger (NHE) (Bondarenko et 
al., 2005; Kleyman et al., 1988; Murphy et al., 1991) but is also  a weak inhibitor of 
Na+/Ca2+ exchanger at the concentration of 1 mM in rat heart (Murphy et al., 1991), and at 
the concentration of 5 μM – 500 μM in guinea-pig aorta (Bova et al., 1988). Amiloride has 
poor selectivity for NCX. For example, a study on the inhibition of Na+ transport across tight 
epithelia through Na+ channel by amiloride was shown at the IC50 of 0.34 μM. In the same 
study, much weaker inhibition on NHE and NCX were demonstrated with an IC50 of 83.8 
and 1100 μM respectively (Kleyman et al., 1988). Thus amiloride cannot be claimed to be 
selective.  This may affect interpretation of results.  Blockade of NHE by amiloride may 
affect NCX operation. For example, it is known that increased Na+ loading via NHE can 
induce NCX to operate in reverse mode by altering intracellular [Na+] (Kuramochi et al., 
2004; Palandoken et al., 2005; Schafer et al., 2001). This may give confusing results such as 
in ischemia-reperfusion injury where both NHE and NCX are involved. Therefore it is not 
clear if the cardiac protective effect by amiloride in this condition is through its inhibition on 
NCX or NHE (Bondarenko et al., 2005). 
2.1.3 Amiloride analogues  
Among approximately one thousand types of amiloride derivatives, benzamil and DCB (see 
Figure 2.1) have been demonstrated to inhibit the Na+/Ca2+ exchanger more potently and 
have been used to block NCX activity (Hegde et al., 2004; Plasman et al., 1991; Siegl et al., 
1984; Watano et al., 1996). In pancreatic islet cells, DCB (IC50: 18 μM) potently inhibited 
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the 45Ca uptake mediated by the reverse mode of NCX (Plasman et al., 1991); In single 
cardiac ventricular cells of guinea-pig, DCB (3-30 μM) depressed the inward Na+/Ca2+ 
exchange current with IC50 of 17 μM (Watano et al., 1996); With the same IC50 (17 μM), 
DCB was shown to be a potent inhibitor of Na+-dependent Ca2+ influx in both guinea pig 
cardiac membrane vesicles and papillary muscles (Siegl et al., 1984). Likewise, benzamil 
was used to selectively inhibit NCX at the concentration of 100 μM in intact endothelial cells 
from rat aorta (Bondarenko, 2004), at 20 μM in endothelium-denuded rat mesenteric artery 
(Tsang et al., 2003), at 10 μM in cultured rat aortic endothelial cells (Dong et al., 2004) and 
at 1 mM in both rat aortae and cultured porcine aortic endothelial cells (Schneider et al., 
2002a). However, the DCB and benzamil may have limited specificity. For example, Suarez-
Kurtz et al demonstrated that DCB dose-dependently (1 - 25 μM)) inhibited the T-type and 
slowly-inactivating L-type Ca2+ channels in GH3 clonal pituitary cells (Suarez-Kurtz et al., 
1988). DCB (30 μM) also inhibited the endothelin-induced constriction in intact rat aortic 
rings (Criscione et al., 1989). Furthermore, in cultured aortic myocytes, both DCB (IC50 = 10 
μM) and benzamil (IC50 = 30 μM) inhibited the monovalent cation channel induced by 
palytoxin (van Renterghem et al., 1993). Thus these agents whilst inhibiting NCX potently 
are not selective.  
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Figure 2.1 The chemical structure of amiloride and its analogues  
Panel A shows the structure of amiloride; panel B shows the structure of DCB (3’, 4’-
dichlorobenzamil); and panel C shows the structure of benzamil. 
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2.1.4 Exchanger inhibitory peptide (XIP) 
As introduced in the previous chapter 1.3., the NCX protein comprises 9 transmembrane 
segments and a large hydrophilic loop (Figure 1.4). The cytoplasmic loop (about 550 amino 
acids long) is a calmodulin binding site and does not participate in ion transportation, but is 
involved in the regulation of NCX by intracellular Na+, Ca2+ and PIP2 (Maack et al., 2005). 
The loop is a regulatory domain, and separate from the Ca2+ transport parts of the molecule 
(Shigekawa et al., 2001). High [Na+]i was observed to induce an initial peak of  the 
exchanger current and the subsequent decaying to steady state (Hilgemann et al., 1992). This 
process, which is referred to as Na+-dependent inactivation, is believed to interact with the 
endogenous XIP auto inhibitory region (Philipson et al., 2000).  
A synthetic polypeptide (XIP) that mimics a 20 amino acid sequence of the large 
intracellular loop of NCX molecule (Li et al., 1991; Nicoll et al., 1991), was reported to be a 
selective inhibitor of NCX (Chin et al., 1993; Li et al., 1991). This supports the notion that 
the calmodulin-binding site on intracellular loop serves as autoinhibitory structure.  
One issue is that the binding site for this synthetic peptide on NCX is on the cytoplasmic 
surface of the membrane and XIP does not appear to permeate through the cell membranes, 
therefore XIP must be delivered to the inside of the cell to exert its effect. This limits its 
application to a limited range of studies where intracellular access is not an issue, for 
example, patch-clamp electrophysiology in cardiac sarcolemmal vesicles (Li et al., 1991; 
Matsuoka et al., 1997a), in guinea pig ventricular cell (Chin et al., 1993) and in cardiac 
myocytes (Maack et al., 2005). In these studies, intracellularly delivered XIP inhibited NCX 
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operation. 
2.1.5 Antisense oligonucleotides (AS-oligos) 
With the aid of advanced molecular biological techniques, some research groups have 
attempted to synthesize antisense oligonucleotides directed against the NCX mRNA to 
reduce the expression of NCX. Some substantial progress has been made, although further 
studies are still needed.  
For example, the extracellular Na+-dependent Ca2+ efflux was significantly inhibited in 
cultured mesenteric artery myocytes after 9 days AS-oligo treatment  (Slodzinski et al., 
1998b). Antisense treatment (5 μM for 48 hours) also reduced exchanger activity of primary 
cultured rat cardiac myocyte approximately 30-40% (Takahashi K. et al., 1995). Most single 
cultured myocytes exposed to 3 μM antisense oligodeoxynucleotide for 2 days showed 
neither an NCX current nor an increase of [Ca2+]i upon extracellular Na+ removal (Lipp et 
al., 1995). In primary cultured neonatal rat cardiomyocytes, ∼60% of the cells did not exhibit 
spontaneous Ca2+ transients or respond to Na+-free medium after 4 days treatment of AS-
oligo (0.5 μM), and NCX protein was reduced by ∼50% in cells treated with AS-oligos for 7 
days (Slodzinski et al., 1998a). 
Antisense approaches in functional tissues are more complicated compared to cell lines in 
that the tissues have to maintain functionality during a prolonged period of antisense 
incubation or methods of antisense delivery in vivo have to be developed. Neither of these 
approaches has been used for NCX to my knowledge. 
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2.1.6 SEA0400 
The structure of 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400) 
was shown in Figure 2.2.  SEA0400 was found to inhibit NCX and unlike KB-R7943 (see 
2.1.7) inhibits both forward and reverse mode with equal potency (Magee et al., 2003; 
Takahashi et al., 2003). On guinea-pig ventricular myocytes, the IC50 value for the inward 
and outward current was 40 nM and 32 nM respectively (Tanaka et al., 2002). However, it 
has been reported to be a much better tool for NCX inhibition with higher potency and 
greater selectivity than KB-R7943 (table 2.1). At the concentration inhibiting NCX in 
cultured astrocytes, SEA0400 showed negligible effect on Ca2+ channels, Na+ channels, and 
K+ channels, noradrenaline transporter, 14 receptors (adenosine A1 and A2; adrenergic α1, α2, 
β1, and β2; Glutamate AMPA, Kainate, and  N-methyl-D-aspartate (NMDA); mACh; 
Bradykinin B1, B2, LTB4, PAF), and did not have any effect on 5 enzymes (phospholipase 
A2, phospholipase C, 5-lipoxygenase, iNOS, and cNOS), store-operated calcium entry, NHE, 
Na+ pump, Ca2+ pump (Matsuda et al., 2001). It has also been viewed as a promising 
therapeutic strategy for myocardial ischemia-reperfusion cell damage (Akabas, 2004; Hobai 
et al., 2004; Iwamoto et al., 2004a; Matsuda et al., 2001; Ogata et al., 2003; Yoshiyama et 
al., 2004).  
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Figure 2.2 Molecular structure of SEA0400 
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Table 2.1 Comparison of the inhibitory effect of KB-R7943 and SEA0400 on NCX 
activity (All data are presented as IC50 values) 
Tissue SEA0400 KB-R7943 Reference 
Cultured neuron 33 nM 3.8 μM (Matsuda et al., 2001) 
Cultured astrocyte 5.0 nM 2.0 μM (Matsuda et al., 2001) 
Cultured microglia 8.3 nM 3.1 μM (Matsuda et al., 2001) 
Canine Cardiac 
sarcolemmal vesicles 
 
90 nM 7.0 μM (Takahashi et al., 2003) 
Rat Cardiomyocyte 92 nM 9.5 μM (Takahashi et al., 2003) 
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Figure 2.3 Molecular structure of KB-R7943 molecule 
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2.1.7 KB-R7943 
As discussed early in chapter 1.4.8, under physiological conditions, NCX mainly operates in 
forward mode to pump calcium out of the cell. However, the activity of NCX in reverse 
mode may be important with regard to the disease states, such as the cardiac ischemia-
reperfusion injury, where it mediates Ca2+ entry and the subsequent tissue hypercontracture 
(Philipson, 2002; Shigekawa et al., 2001; Sipido et al., 2002). This finding has prompted a 
search for the drug that selectively inhibits the NCX operating in reverse mode. A variety of 
benzyloxyphenyl derivatives were synthesized and tested. Among them, the isothiourea 
derivative (see Figure 2.3): 2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl] isothiourea (KB-R7943) 
has been widely used and extensively investigated (Kim et al., 1999; Kim et al., 2005). 
In most studies, it has been shown that KB-R7943 inhibits preferentially the reverse mode of 
NCX (Ladilov et al., 1999; Watano et al., 1996; Watano, 1998). For example, the IC50 value 
was 0.32 μM for the outward exchange current and 17 μM for the inward current in single 
cardiac ventricular cells (Watano et al., 1996); 1.2 - 2.4 μM for reverse mode and ≥ 30 μM 
for forward mode in cardiomyocytes, smooth muscle cells, and NCX1-transfected fibroblasts 
(Iwamoto et al., 1996b).  
Initial results suggested that KB-R7943 was relatively selective for NCX. KB-R7943 at 10 
μM did not affect Na+/H+ exchanger, passive Na+ uptake, sarcolemmal Ca2+-ATPase, Na+/ 
K+-ATPase in cardiomyocyte (Iwamoto et al., 1996b), and it has been used as a putative 
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selective inhibitor of NCX in some studies (Bondarenko, 2004; Chau et al., 2003; Iwamoto 
et al., 1996b; Ladilov et al., 1999; Watano et al., 1996).  
However, the selectivity of KB-R7943 was questioned by further studies. Both SEA0400 
(0.1 μM) and KB-R7943 (5 μM) were shown to depress the Ca2+ transient even in the 
absence of NCX in heart tube of knock out mouse (NCX-/-) (Reuter et al., 2002). 
Additionally, in acutely isolated rat hippocampal neurons, KB-R7943 blocked two distinct 
N-methyl-D-aspartate (NMDA) channels, IC50 values were 0.8 μM and 11 μM respectively 
(Sobolevsky et al., 1999). In cultured neurons and astrocytes, it inhibited the store-operated 
Ca2+ entry at the IC50 value of 7 μM (Arakawa et al., 2000), and in guinea-pig ventricular 
myocytes, it attenuated the sodium current, L-type calcium current, delayed rectifier 
potassium current and inwardly rectifying potassium current by more than 50% at the 
concentration of 10 μM (Tanaka et al., 2002). Furthermore, in single cardiac ventricular 
cells, it inhibited the voltage-gated Na+ current, Ca2+ current, and the inward rectifier K+ 
current with IC50 value of approximately 14, 8, and 7 μM respectively (Watano et al., 1996); 
and it blocked native and oocyte-expressed neuronal nicotinic receptors on bovine adrenal 
chromaffin cells at the IC50 value of 6.5 and 0.4 μM respectively (Pintado et al., 2000).  
Recently, a thorough investigation by Matsuda et al (Matsuda et al., 2001) has provided the 
full-spectrum view of the effects of KB-R7943 in cultured astrocytes. The inhibitory 
concentrations of KB-R7943 on the major ion channels (L-type calcium channel, N-type 
calcium channel, Na+ channel, and K+ channel), 4 ion transporters (NCX, NHE, NE and 
calcium pump), 14 receptors (adenosine A1 and A2; adrenergic α1, α2, β1, and β2; Glutamate 
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AMPA, Kainate, and  NMDA; mACh; Bradykinin B1, B2, LTB4, PAF) and 5 enzymes 
(phospholipase A2, phospholipase C, 5-lipoxygenase, iNOS, and cNOS) were about 30 μM 
or even higher. At the concentration of 3 μM, it affected only L-type Ca2+ channel; 
muscarinic acetylcholine, LTB4, and platelet-activating factor receptors; and noradrenaline 
transporter. 
The above discussion highlights some contradictory results with KB-R7943 in that in some 
tissues at concentrations in excess of 3 μM it appears to have some other biological actions 
than inhibition of NCX.  In the present study, KB-R7943 was the most selective inhibitor 
that was routinely available as the relevant pharmaceutical company refused SEA0400 
supplies.  To determine whether KB-R7943 could be used as a tool in cardiovascular tissue 
such as aorta, it was decided to investigate the effects of both 1 and 10 μM on a variety of 
Ca2+ mediated constrictor actions in the aorta.  This was considered necessary as the majority 
of non-selective effects were obtained in non-cardiovascular tissue and on systems that are 
not present in blood vessels (see Table 2.2). 
As summarized in table 2.3, KB-R7943 was used as a selective inhibitor at the concentration 
up to 10 μM in various types of VSMC. However, the selectivity of KB-R7943 was not 
tested in those studies; it remains still questionable if it is selective to NCX inhibition.  
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Table 2.2 Nonselective effect of KB-R7943 in variety of tissues (All data are presented 
as IC50 values) 
[KBR] for NCX 
inhibition 
Tissue 
Reverse 
mode 
Forward 
mode 
[KBR] causing 
nonselective 
inhibition 
Reference 
acutely isolated rat 
hippocampal neurons 
 
  0.8 μM (high 
affinity) & 11 μM 
(low affinity) 
(Sobolevsky et al., 
1999) 
cultured neurons and 
astrocytes 
 
3 μM  7 μM (Arakawa et al., 
2000) 
guinea-pig ventricular 
myocytes 
 
457 nM  10 μM (Tanaka et al., 
2002) 
bovine adrenal 
chromaffin cells 
 
5.5 μM  6.5 and 0.4 μM (Pintado et al., 
2000) 
heart tube of NCX-/- 
mouse 
 
5 μM   (Reuter et al., 
2002) 
cultured neurons; 
astrocytes; microglia 
 
3.8; 2.0; 
3.1 μM 
 ≥3 μM (Matsuda et al., 
2001) 
guinea pig single 
cardiac ventricular cells 
 
0.32 μM 17 μM ≥7 μM (Watano et al., 
1996) 
 
[KBR] indicates the concentration of KB-R7943. The 2nd column shows the concentration of 
KB-R7943 for inhibiting NCX; and the 3rd column shows the concentration of KB-R7943 for 
inhibiting other ion transportors other than NCX (nonselective inhibition). 
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Table 2.3 The inhibition of NCX (reverse mode) by KB-R7943 in a variety of smooth 
muscle cells 
Tissue tested [KBR]         (μM) Reference 
Human umbilical artery 5 (Rebolledo et al., 2006) 
Rat carotid artery 3.5 (IC50) (Takai et al., 2004) 
Rat aorta & cultured porcine 
aortic endothelial cells 
1 (Schneider et al., 2002a) 
Cultured rat mesenteric and 
aortic smooth muscle cells 
1-10 (Dong et al., 2006) 
Mouse aorta & mouse aortic 
endothelial cell 
10 (Kim et al., 2005) 
Human pulmonary artery 10 (Zhang et al., 2005b) 
 
[KBR] indicates the concentration of KB-R7943. 
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In conclusion, there are contradictory results regarding the selectivity of KB-R7943 in non-
smooth muscle cells. Also, there are some gaps in our knowledge about the selectivity of 
KB-R7943 in smooth muscle cells, which awaits further elucidation.  
2.1.8 Aims of the study 
One of the principal aims of the project was to develop insights into the operation of NCX in 
vascular tissue. Whilst we did receive some initial supplies of SEA0400, it became 
impossible to obtain ongoing supplies and we decided to use KB-R7943. However given its 
mixed and contradictory reports of selectivity for NCX (see 2.1.7), this present section was 
to assess its pharmacological actions in rat aorta on a variety of Ca2+ dependent systems 
including: voltage-gated calcium channels; store-operated channels; and α adrenergic 
receptors. The hypothesis to be investigated was that an appropriate concentration of KB-
R7943 could be found which was selective for NCX and which did not affect other 
contractile and Ca2+ transport mechanisms. 
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2.2 METHODS 
2.2.1 Tissue preparation for functional studies 
Male Sprague Dawley rats (5-7 weeks old, weighing 200-350 g) were anaesthetized with 
Pentobarbital sodium (60mg/kg, i.p. Sigma, St Louis, USA) and then killed by decapitation. 
The thoracic aorta was removed, placed in a cold physiological salt solution (see 2.2.2.1), 
cleaned of surrounding fat and connective tissue and cut into equal-size ring segments (4 
mM in length) with scissors. Two thin stainless-steel hooks were inserted through the lumen 
of aorta ring. The lower hook was connected to a tissue holder and the upper to an isometric 
force Grass FT03 displacement transducer. Each ring was suspended in an organ bath 
containing 2ml of physiological salt solution (PSS: A-F, see 2.2.2). Tissues were washed 
thoroughly by replacing the PSS repeatedly and were then allowed to equilibrate for a period 
of 45 minutes under 2g of resting tension. Supply reservoirs and organ baths were 
maintained at 37°C and were bubbled continuously with a mixture of 95%O2 and 5%CO2 to 
give rise to a pH of 7.4. Drugs and reagents were added directly to the bathing fluids using a 
micro syringe, and mixed thoroughly by repeated syringing with the bath solution and were 
allowed to reach a steady concentration in the incubation fluid within the tissue chamber. 
Baseline tone was readjusted when necessary.  
In some cases, the endothelium was removed by gentle rubbing of the luminal surface with a 
plastic rod.  
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2.2.2 Composition of physiological salt solution (PSS) (in mM):  
2.2.2.1 For functional studies (PSS-A): 
NaCl 118, KCl 4.7, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 11.1, MgSO4 1.2, CaCl2 2.5 
(mM).  
2.2.2.2 For phenylephrine studies (PSS-B): 
NaCl 118, KCl 4.7, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 11.1, MgSO4 1.2, CaCl2 2.5, 
L-ascorbic acid 0.14, Na2EDTA 0.067 (mM). Ascorbic acid and EDTA were added to 
prevent oxidation of phenylephrine. 
2.2.2.3 For Ca2+ free studies (PSS-C): 
NaCl 118, KCl 4.7, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 11.1, MgSO4 0.6, EGTA 10, 
L-ascorbic acid 0.14, Na2EDTA 0.067 (mM). Ascorbic acid and EDTA were added to 
prevent oxidation of phenylephrine. 
2.2.2.4 For studies using Bay K8644 (PSS-D): 
NaCl 108, KCl 14.7, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 11.1, MgSO4 1.2, CaCl2 2.5 
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(mM). The higher [K+]o was to partially constrict the vessel in order to facilitate the Bay 
K8644 action. 
2.2.2.5 For studies of 80 mM KCl (PSS-E): 
NaCl 43.73, KCl 78.97, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 11.1, MgSO4 1.2, CaCl2 
2.5 (mM). A depolarizing concentration of K+ (80 mM) was used to elicit vasoconstriction. 
2.2.2.6 For 25 mM Na+ and ouabain studies (PSS-F): 
Normal Na+ PSS-F: NaCl 118, KCl 4.7, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 11.1, 
MgSO4 1.2, CaCl2 2.5 (mM).  
Lower Na+ PSS-F: Choline chloride 118, KCl 4.7, KH2PO4 1.03, NaHCO3 25, D-(+)-glucose 
11.1, MgSO4 1.2, CaCl2 2.5 (mM). Lower Na+ PSS-F was obtained by replacing 118 mM 
NaCl with iso-osmolar amounts of Choline Chloride. 
 
2.2.3 The effect of KB-R7943 on the vascular responsiveness to phenylephrine in the 
presence of extracellular Ca2+ in rat aortic rings 
See 2.2.2.2 for the composition of bathing solution for this set of experiments. Following the 
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45-minute equilibration period, the viability of the tissues was assessed. Tissues which failed 
to produce 0.5 g increase in tension to phenylephrine (1 µM) were rejected. Successful 
removal of the endothelial cells was verified by lack of relaxant response to acetylcholine (1 
µM) in the presence of phenylephrine (1 µM) at the beginning of each experiment (<5% 
relaxation) (see Figure 2.4).  
Tissues were washed and allowed to equilibrate for a further 45 minutes, after which the first 
of two cumulative concentration-response curves to phenylephrine (1 nM – 10 µM) were 
performed, with approximately three minutes between subsequent additions of phenylephrine 
or until a steady-state constriction was achieved.  After subsequent washing with PSS-B and 
equilibrating for 30 minutes, aorta was incubated with KB-R7943 for 20 minutes, followed 
by the second cumulative concentration-response curves of phenylephrine (1 nM – 10 µM). 
In another aortic ring obtained from the same animal, the vehicle dimethyl sulfoxide 
(DMSO, 0.1%), instead of KB-R7943 was administered. The experiments were conducted 
on both endothelium denuded and intact vessels. 
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Figure 2.4 A typical trace of rat aorta rings 
The aorta rings in each channel are taken from separate rings in the same rat.  Y-axis 
indicates the constriction measured in grams.  The elapsed time on the experimental day 
is shown on X-axis (h:m:s).  Panel A: response to phenylephrine (1 µM) followed by 
acetylcholine (1 µM) in endothelium denuded aorta.  Panel B: response to phenylephrine 
(1 µM) followed by acetylcholine (1 µM) in endothelium intact aorta.  
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2.2.4 The effect of KB-R7943 on the vascular responsiveness to phenylephrine in the 
absence of extracellular Ca2+ in rat aortic rings  
After tissue viability and removal of endothelial cells had been assessed, the tissues were 
allowed to equilibrate for a further 45 minutes. Following these 45 minutes, the bathing 
solution was replaced with Ca2+ free PSS-C (see 2.2.2.3). After 5 minutes, the first 
cumulative concentration-response curve to phenylephrine (10 nM –10 µM) was performed. 
Once responses had reached a maximum the bathing solution was repeatedly replaced with 
fresh drug free, Ca2+ containing PSS-B until the baseline tension had been re-established. 
The tissues were again allowed to equilibrate for 45 minutes after which time the tissues 
were treated with the Ca2+ free PSS-C for 5 minutes and then the second cumulative 
concentration-response curve of phenylephrine (10 nM –10 µM) was conducted. 
2.2.5 The effect of KB-R7943 on Bay K8644-induced constriction in rat aortic rings 
Bay K8644, the L-type Ca2+ channel opener, was freshly made in ethanol as a stock solution 
(1 mM), kept on ice and further diluted with PSS. The experiment was carried out under 
light-protective environment: with no direct light exposure, the organ baths were wrapped 
with aluminum foil (Asano et al., 1986; Wanstall et al., 1989). 
See further in 2.3.3, Bay K8644 can acts as a L-type Ca2+ channel activator only under 
depolarized or partially depolarized conditions (Asano et al., 1999; Bechem et al., 1987; 
65 
Ferrante et al., 1989; Schramm et al., 1983). Preliminary experiments in normal PSS-A 
produced variable constriction to Bay K8644. Therefore, K+-enhanced PSS-D (see 2.2.2.4) 
was used throughout the experimental period.  PSS-D had the same composition with normal 
PSS, except equimolar substitution of 10 mM NaCl with 10 mM KCl, the total KCl 
concentration = 15.73 mM. Under the environment of K+-enhanced solution, because the 
endothelium-denuded aortae were partially constricted, the testing of 0.5-gram tension 
increment to 1 µM phenylephrine was not used.  
The cumulative phenylephrine concentration-effect curve was conducted. Following 20 
minutes pretreatment of either vehicle or KB-R7943 (1 µM or 10 µM), Bay K8644 
concentration-response curve was performed (10 nM -1 µM) in a cumulative manner. 
2.2.6 The effect of KB-R7943 on high K+-induced constriction in rat aortic rings  
PSS-E containing 80 mM KCl was prepared by replacing NaCl with equimolar KCl (see 
2.2.2.5).  The aorta bathing solution was replaced twice with this high (80 mM) K+ solution. 
After the high K+-induced constriction reaches its peak; the tissue was washed and re-
equilibrated. To examine the effects of KB-R7943 on contraction elicited by a depolarizing 
concentration of K+, the endothelium-denuded rat aortic rings were preincubated with KB-
R7943 (1 µM or 10 µM), and then challenged with 80 mM KCl the second time for 1h. All 
values were normalized as the percentage of the maximum constriction from the 1st round of 
80 mM KCl treatment. 
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2.2.7 The effect of KB-R7943 on CPA-induced constriction in rat aortic rings 
To assess the effect of KB-R7943 on constriction caused by release of Ca2+ from 
intracellular stores, we studied the effect of KB-R7943 (1 µM or 10 µM) on constriction 
induced by cyclopiazonic acid (CPA), a sarcoplasmic reticulum (SR) Ca2+ ATPases inhibitor 
in Ca2+-containing solution.  
A preliminary phenylephrine concentration-response curve (0.01 µM-10 µM) was carried 
out, after which vessels were washed with PSS-A and re-equilibrated. Then the tissue was 
incubated with either vehicle or KB-R7943 (1 μM) or KB-R7943 (10 μM) for 20 min, 
followed by the addition of CPA (10 µM) for 2h.  
2.2.8 The effect of KB-R7943 on low-Na+ induced constriction in rat aortic rings  
To estimate the capacity of KB-R7943 to inhibit the forward mode of NCX, the extracellular 
Na+ was withdrawn. Lower Na+ PSS-F was obtained by replacing 118 mM NaCl with iso-
osmolar amounts of Choline Chloride (see 2.2.2.6), the final concentration of [Na+] was 25 
mM. Following 20-minute pretreatment of either vehicle or KB-R7943 (10 µM), vessel was 
changed to 25 mM Na+ PSS-F, and observed for 30 minutes.  
2.2.9 The effect of KB-R7943 on ouabain-induced constriction in rat aortic rings 
In some experiments in endothelium denuded aorta, constriction was induced by ouabain 
(100 µM). KB-R7943 (1 µM) was administered 20 minutes before the application of 
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Ouabain.  
2.2.10 Drugs and materials 
The following drugs were used: L- Phenylephrine Hydrochloride, Acetylcholine Chloride, 
(S) (-) Bay K8644 and 9-(2-tetrahydrofuryl) adenine (SQ 22536) from Sigma (St Louis, 
USA), Cyclopiazonic acid (CPA) from RBI (Frederick, MD, USA), Verapamil-HCl from 
BIOMOL (Plymouth Meeting, USA), 2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl] isothiourea 
mesylate (KB-R7943 mesylate), from TOCRIS (Ellisville, USA), 2-[4-[(2,5-difluorophenyl) 
methoxy] phenoxy]-5-ethoxyaniline (SEA0400), a gift from Taisho Pharmaceutical Co., Ltd. 
(Saitama, Japan). Phenylephrine and acetylcholine were dissolved in distilled water, and the 
remaining drugs were dissolved in DMSO at 10 mM as a stock solution, and further diluted 
in PSS prior to use. The final concentration of vehicle was no more than 0.1% 
(volume/volume). Buffer salts and chemicals were obtained from Sigma (St Louis, USA) 
unless otherwise stated, include: NaCl, NaHCO3, KCl, KH2PO4, MgSO4⋅7H2O, D-
(+)Glucose, CaCl2⋅2H2O, L-ascorbic acid, Na2EDTA, EGTA, Choline Chloride. 
 
 
2.2.11 Data analysis 
All data were collected by a computerized data acquisition system (MacLab).  Results are 
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expressed as mean ± standard error of the mean, and were considered different when P 
values were less than 0.05.  Multiple comparisons were determined using analysis of 
variance in the GbStat package (version 7.0, Dynamic Microsystems, Inc., Silver Spring, 
MD, USA). One ring obtained from one animal was used for each experiment type, and 
therefore the number of experiments (n value) indicates the number of animals. Each aorta 
generated multiple rings (normally 4) to minimize the number of animals used. 
The number of animals used is not relevant except for reporting purposes for animal welfare.  
In all cases the number of different rings in each experimental group is recorded with the 
data in the thesis.   
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2.3 RESULTS 
2.3.1 The effect of KB-R7943 on the vascular responsiveness to phenylephrine in the 
presence of extracellular Ca2+ in rat aortic rings 
In rat denuded aortic rings, two concentration-response curves to phenylephrine (1 nM-10 
µM) were performed. When KB-R7943 (10 µM) was present for the second curve, the 
phenylephrine constriction was significantly reduced (Figure 2.5), compared to vehicle 
controls. A similar effect was observed in endothelium-intact aortic rings (Figure 2.6). 
2.3.2 The effect of KB-R7943 on the vascular responsiveness to phenylephrine in the 
absence of extracellular Ca2+ in rat aortic rings 
In Ca2+-free PSS with EGTA (10 mM), the phenylephrine-induced constriction was 
significantly smaller than that in the presence of Ca2+, see table 2.4. The transient 
contractions induced by phenylephrine in the absence of Ca2+ was not significantly affected 
by the application of KB-R7943 (10 µM) in both endothelium-denuded (Figure 2.7) and 
intact vessels (Figure 2.8). 
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Figure 2.5 Effect of KB-R7943 (10 µM) on phenylephrine concentration-response curve 
in endothelium-denuded rat aortic rings 
Two concentration-response curves to phenylephrine (1 nM-10 µM) were performed, and the 
responses in curve 2 were expressed as a percentage of the maximum in curve 1. Each point 
demonstrates mean ± s.e.mean. The absolute value of maximum constriction was shown in 
table 2.4. KB-R7943 (10 µM, n=7) or control (DMSO, 0.1%, n=5) was present for curve 2. * 
represents a significant difference between curves (CON and KBR), P<0.05, two way 
analysis of variance with repeated measures.  
 
 
71 
 
Table 2.4 Raw data of maximal constriction to vasoconstrictors in control group 
In PSS-B and PSS-C, both endothelium denuded and intact vessels were tested. In PSS-D, 
PSS-E, PSS-A, only endothelium denuded vessels were tested. The above raw data were the 
values in the presence of vehicle (0.1% volume/volume) instead of KB-R7943. Maximum 
constriction was achieved respectively during first phenylephrine concentration-response 
curve (1 nM – 10 µM) in PSS-B  and PSS-C; phenylephrine concentration-response curve 
(10 nM – 10 µM) in PSS-D; 80 mM KCl treatment for 20 minute in PSS-E; and 
phenylephrine concentration-response curve (10 nM -10 µM) in PSS-A. See sections 2.2.2.1 
- 6 for PSS composition. 
Experimental 
solution 
Endothelium 
Denuded(g) 
 
n 
Endothelium 
Intact(g) 
 
n 
Constrictor Figure 
PSS-A 0.99 ± 0.11 6   Phenylephrine 2.11 
PSS-B 1.32 ± 0.08 5 1.02 ± 0.23 5 Phenylephrine 2.5; 2.6 
PSS-C 0.20 ± 0.03 5 0.27 ± 0.05 5 Phenylephrine 2.7; 2.8 
PSS-D 1.11 ± 0.08 7   Bay K8644 2.9 
PSS-E 3.02 ± 0.16 7   80 mM K+ 2.10 
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Figure 2.6 The effect of KB-R7943 on phenylephrine concentration-response curve in 
endothelium-intact rat aortic rings 
Two concentration-response curves to phenylephrine (1 nM-10 µM) were performed, and the 
responses in curve 2 were expressed as a percentage of the maximum in curve 1. Each point 
represents mean ± s. e. mean. The absolute value of maximum constriction was shown in 
table 2.4. KB-R7943 (10 µM, n=7) or control (DMSO, 0.1%, n=5) were present for curve 2.  
* represents a significant difference between curves (CON and KBR), P<0.05, two way 
anova with repeated measures.  
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Figure 2.7 The effect of KB-R7943 on phenylephrine concentration-response curve in 
the absence of extracellular calcium in endothelium-denuded rat aortic rings 
Two concentration-response curves to phenylephrine (10 nM -10 µM) were performed, and 
the responses in curve 2 were expressed as a percentage of the maximum in curve 1. Each 
point represents mean ± s. e. mean. The absolute value of maximum constriction was shown 
in table 2.4. KB-R7943 (10 µM, n=8) or control (DMSO, 0.1%, n=5) was present for curve 
2. There were no significant differences between curves (CON and KBR) (P>0.05), two way 
analysis of variance. 
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Figure 2.8 The effect of KB-R7943 on phenylephrine concentration-response curve in 
the absence of extracellular calcium in endothelium-intact rat aortic rings 
Two concentration-response curves to phenylephrine (10 nM -10 µM) were performed, and 
the responses in curve 2 were expressed as a percentage of the maximum in curve 1. Each 
point represents mean ± s. e. mean. The absolute value of maximum constriction was shown 
in table 2.4. KB-R7943 (10 µM, n=5) or control (DMSO, 0.1%, n=5) was present for curve 
2. There were no significant differences between CON and KBR (P>0.05), two way analysis 
of variance. 
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2.3.3 The effect of KB-R7943 on Bay K8644 vasoconstriction in rat aortic rings 
In order to evaluate the involvement of L-type calcium channels in response to KB-R7943, 
constriction was evoked using the L-type Ca2+ channel opener: Bay K8644.  In preliminary 
experiments, Bay K8644 produced an inconstant constriction, therefore, further experiments 
were conducted with a K+ enhanced PSS-D (2.2.2.4) to partially depolarize the aorta (as has 
been previously reported) (Asano et al., 1999; Bechem et al., 1987; Ferrante et al., 1989; 
Schramm et al., 1983).  Cumulative addition of Bay K8644 (10 nM to 1 μM) in denuded 
aortic rings induced an increase in contractile force, see table 2.4 for absolute grams. KB-
R7943 (10 μM) significantly antagonized the effect of Bay K8644 (Figure 2.9).  However, 
KB-R7943 (1 μM) had no significant effect (Figure 2.9). 
2.3.4 The effect of KB-R7943 on K+ vasoconstriction in rat aortic rings 
KCl (80 mM) was used to constrict endothelium denuded rat aortic rings. The absolute 
constriction in grams is shown in table 2.4. KB-R7943 (10 μM, Figure 2.10) significantly 
inhibited the KCl depolarization-elicited constriction, whereas KB-R7943 (1 μM, Figure 
2.10) had no significant effect. 
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Figure 2.9 The effect of KB-R7943 on Bay K8644 -induced constrictions in 
endothelium-denuded rat aortic rings 
The concentration-response curve to phenylephrine (10 nM-10 µM) was performed. Then 
the responses of Bay K8644 were examined. Constriction was expressed as a percentage of 
the maximum in the curve of phenylephrine. Each point represents mean ± s. e. mean. KB-
R7943 (1 µM, n=7 or 10 µM, n=7) or control (DMSO, 0.1%, n=7) was present for the curve 
of Bay K8644.  * represents a significant difference between curves (CON and KBR 10), 
P<0.05, two way anova with repeated measures.  
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Figure 2.10 The effect of KB-R7943 on 80 mM KCl-induced constrictions in 
endothelium-denuded rat aortic rings 
Constriction in the second application of KCl was expressed as a percentage of the initial 
KCl-induced constriction. Each point represents mean ± s. e. mean. The absolute value of 
maximum constriction was shown in table 2.4. KB-R7943 (1 µM, n=5; or 10 µM, n=7) or 
control (DMSO, 0.1%, n=5) was present for each curve. * represents a significant difference 
between curves (CON and KBR 10), P<0.05, two way anova with repeated measures.  
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Figure 2.11 The effect of KB-R7943 on CPA-induced constrictions in endothelium-
denuded rat aortic rings 
The concentration response curve to phenylephrine was performed then a response to 
cyclopiazonic acid (CPA) was measured. Constriction to CPA was expressed as a percentage 
of the maximum in curve 2 to phenylephrine. Each point represents mean ± s. e. mean. The 
absolute value of maximum constriction was shown in table 2.4. KB-R7943 (1 µM, n=6; or 
10 µM, n=6) or control (DMSO, 0.1%, n=6) was present for each curve. * represents a 
significant difference between curves (CON and KBR 10), P<0.05, two way anova with 
repeated measures.  
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2.3.5 The effect of KB-R7943 on CPA-induced constriction in rat aortic rings 
In endothelium-denuded rat aortic rings, the SERCA inhibitor CPA (10 μM) incubated in 
PSS containing Ca2+ produced a pronounced constriction (see table 2.4, n=6, P<0.01).  
Pretreatment with KB-R7943 (1 μM) did not influence the CPA-induced constriction (Figure 
2.11), whereas, at higher concentration, KB-R7943 (10 μM) markedly attenuated the 
response (Figure 2.11). 
2.3.6 The effect of KB-R7943 on low-Na+ induced constriction in rat aortic rings 
In endothelium denuded rat aortic rings reducing [Na+]o from 143 mM to 25 mM induced 
immediate constriction, see (Table 2.4) for the absolute value of constriction. The maximum 
responses were seen within 8 minutes. At the concentration of 10 μM, KB-R7943 
significantly inhibited the low-Na+ induced effects (Figure 2.12).  
2.3.7 The effect of KB-R7943 on ouabain-induced constriction in rat aortic rings 
Ouabain (100 μM) elicited a long-lasting constriction in endothelium-denuded rat aortic 
rings (Figure 2.13). KB-R7943 (1 μM) showed significant inhibitory effect on ouabain-
induced constriction (Figure 2.13). 
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Figure 2.12 The effect of KB-R7943 on low Na+-induced constrictions in endothelium-
denuded rat aortic rings 
In each ring there was one cycle of constriction to low [Na+]. Each point represents mean ± s. 
e. mean. The number of experiments ranged from 5 to 11 different rings in each group. * 
represents a significant difference between CON and KBR, P<0.05, two way anova with 
repeated measures.  
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Figure 2.13 The effect of KB-R7943 on ouabain-induced constrictions in endothelium-
denuded rat aortic rings 
In each ring there was one cycle of constriction to ouabain. Each point represents mean ± s. 
e. mean. The number of experiments ranged from 4 to 5 different rings in each group. * 
represents a significant difference between CON and KBR, P<0.05 two way analysis of 
variance.  
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2.4 DISCUSSION 
In view of conflicting data about selectivity for NCX, preliminary experiments were 
conducted to characterize the actions of the NCX inhibitor KB-R7943 in rat aortic rings.  
The aim was to elicit constriction by a variety of mechanisms known to involve multiple 
Ca2+ mechanisms and examine two concentrations of KB-R7943: 10 μM where non-
selective actions have been suggested and 1 μM that in the literature appears selective (see 
Introduction 2.1.7). 
Phenylephrine is a relatively selective α1-adrenoceptor agonist (Guimaraes et al., 2001; 
Nishimaru et al., 2001; Toma et al., 1995). It is well established that α1-adrenoceptors 
induce biphasic constriction in rat aortic rings with an initial phasic constriction followed by 
sustained tonic constriction (Tanaka et al., 2000).  The initial triggering underlying the 
phasic constriction is the agonist-receptor binding and the following production of inositol 
1,4,5-trisphosphate (IP3) after cleavage of PIP2 by phospholipase C, which activates the 
internal calcium release from sarcoplasmic reticulum (See reviews Dimopoulos et al., 2007; 
Williamson et al., 1985). The concomitant production of DAG may activate PKC and 
subsequent protein kinase C signaling cascades to maintain constriction. The inhibition of 
myosin light chain phosphatase (MLCP) and the increased Ca2+ sensitivity are currently 
thought to play as important role as the Ca2+–dependent activation of myosin light chain 
kinase (MLCK) in the sustained tonic contraction (refer to 1.1.4) (See reviews Dimopoulos 
et al., 2007; Lincoln, 2007; Murthy, 2006).  
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In the present study we examined the steady phase constriction produced by phenylephrine 
which contains all components of the α1-adrenoceptor signaling.  In the present study the 
NCX inhibitor KB-R7943 (10 μM) inhibited the constriction to phenylephrine in rat aortic 
rings with or without endothelium.  This could indicate either that KB-R7943 was affecting 
some of the phenylephrine signaling or that NCX was involved in the α1-adrenoceptor 
response.  This latter observation is perhaps unlikely since under normal conditions NCX 
should be mediating Ca2+ exit from the smooth muscle (Schweda et al., 2001) as it normally 
operates in forward mode and so inhibition would have expected to enhance constriction.  
On the face of it at this concentration of 10 μM it is possible that KB-R7943 is non-selective 
for NCX.  Indeed in acutely isolated rat hippocampal neurons, guinea-pig ventricular 
myocytes, guinea pig single cardiac ventricular cells, KB-R7943 has been reported to inhibit 
multiple calcium-related mechanism (Sobolevsky et al., 1999; Tanaka et al., 2002; Watano 
et al., 1996).  It should be noted that KB-R7943 inhibited phenylephrine constriction also in 
the absence of endothelium in the present study.  Thus endothelial release of vasoactive 
substances is not involved. 
In order to isolate further the effect of KB-R7943, phenylephrine constriction was carried out 
in the absence of extracellular Ca2+, this should highlight the effects to the intracellular 
signaling pathways involving Ca2+ release from internal stores. In rat aortic rings, stimulation 
of the α1-adrenoceptors by phenylephrine induced a transient constriction in Ca2+-free 
solution, this has previously been shown to involve a transient increase in [Ca2+]i  due to Ca2+ 
release from intracellular Ca2+ pools by the activation of IP3 receptor on sarcoplasmic 
reticulum (Carafoli, 1987; Iwata et al., 2001; Marin et al., 1999; Tanaka et al., 2000). The 
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phenylephrine-induced transient increase in muscle tension was not affected by KB-R7943 
(10 μM).  This result suggests that 10 μM KB-R7943 may have little or no effect on the 
signal transduction of the α1-adrenoceptor IP3-induced Ca2+ release mechanism.  Indeed 
other workers have found no effect on components of this system at this concentration or 
higher in cultured astrocytes (Matsuda et al., 2001). This may suggest an effect of KB-
R7943 on Ca2+ entry in terms of α1-adrenoceptor constriction. 
Another way to look at internal Ca2+ release mechanisms is to use cyclopiazonic acid (CPA).  
CPA is an indole tetramic acid mycotoxin, was first produced from Penicillium Cyclopium 
Westling (Holzapfel, 1968). CPA can inhibit the ATP-dependent Ca2+ pumps of the 
sarcoplasmic reticulum (SR) or endoplasmic reticulum (ER) without affecting ATP-driven 
Ca2+ transport in plasma membrane (see 1.1.3.2). Treatment with CPA depletes stored [Ca2+] 
in the SR and increases cytosolic [Ca2+], a net effect presumably due to an endogenous Ca2+ 
leak while SR calcium reuptake is blocked (Seidler et al., 1989). It has been widely used in 
physiological studies since it can mimic the Ca2+-mobilization action of an agonist, an effect 
that is independent of both inositol phosphate production and stimulation of protein kinase C. 
In endothelium denuded rat aortic rings, KB-R7943 (10 μM) depressed CPA-stimulated 
constriction. Depletion of intracellular calcium stores in the SR/ER could activate Ca2+ influx 
into the cell through store-operated Ca2+ channels (SOC) (refer to 1.3). Our results suggest 
that KB-R7943, at high concentration (10 μM), may influence SOC activation caused by the 
Ca2+ store depletion, as reported previously (Arakawa et al., 2000).  However, in our hands 
KB-R7943 at a lower concentration (1 μM) had no such effect suggesting that this 
concentration may be a useful tool. 
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Ca2+ influx through L-type Ca2+ channels was studied directly using Bay K8644, a 
dihydropyridine derivative, which activates the channel (Asano et al., 1986; Cohen et al., 
1997; Ferrante et al., 1989; Tsien et al., 1986). The S and R enantiomers of Bay K8644 exert 
the opposing effect on the voltage sensitive slow calcium channel. In the present study, the S 
enantiomer was used.  
It has been previously shown that Bay K8644 did not induce a constriction in resting 
condition of normal physiological saline solution unless the K+ concentration in the bathing 
solution was increased to 15 mM and tissue was partly depolarized (Asano et al., 1999; 
Schramm et al., 1983).  Membrane depolarization increases Ca2+ influx by opening the L-
type Ca2+ channel to elevate [Ca2+]i  and finally induces constriction (Karaki et al., 1984; 
Preuss et al., 1985; Yu et al., 1991). In the current study, we observed comparatively less 
responses of Bay K8644 in normal PSS than 15.73 mM K+-depolarizing PSS (data not 
shown) and so adopted the protocol in all experiments that 15.73 mM K+-depolarizing PSS 
was used. 
In the present experiments in endothelium denuded rat aortic rings, KB-R7943 (10 μM) 
decreased the Bay K8644-evoked constriction but KB-R7943 had no effect at 1 μM.  This 
agrees with the study in cardiac ventricular cells of guinea pig which suggests that KB-
R7943 inhibits L-type Ca2+ channels at high concentrations (≥ 7 μM) (Watano et al., 1996). 
But the current data suggest that at 1 μM this may not be an issue. 
The preceding data discussed the non-NCX actions of KB-R7943 but it is also important to 
determine whether KB-R7943 can inhibit NCX mediated events.  In endothelium denuded 
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rat aortic rings, lowering extracellular [Na+] to 25 mM induced a vasoconstriction. This 
constriction has been shown by many workers to be due to Ca2+ entry via NCX (Bova et al., 
1990; Kim et al., 1999; Reuter et al., 1973; Schweda et al., 2001). KB-R7943 (10 μM) 
inhibited the vasoconstriction.  Further in the next chapter 3.3.1 we demonstrated that KB-
R7943 (1 and 10 μM) inhibited constriction of rat aortic rings induced by low Na+.  
Another means of activating NCX is to inhibit the smooth muscle Na/K-ATPase that reverses 
NCX action by causing a build up of intracellular Na+ and causing the inflow of Ca2+. This in 
part explains the constrictions to ouabain (Ashida et al., 1987; Espinosa-Tanguma et al., 
2004) although other mechanisms are also involved, such as sympathetic nerve activation 
(Karaki et al., 1977).  In the present study, ouabain constriction in endothelium denuded rat 
aortic rings was partially inhibited by KB-R7943 (1 μM). The effectiveness of 1 μM 
suggests that KB-R7943 may be a useful tool.  
The present research provided extensive investigation data of KB-R7943 in rat aortic rings. 
Our data showed that 10 μM KB-R7943 inhibited smooth muscle constriction by inhibiting 
calcium entry through L-type Ca2+ channel. Likewise, 10 μM KB-R7943 may affect the 
capacitative Ca2+ entry pathway. Nevertheless, KB-R7943, at the concentration that inhibited 
NCX (1 μM), did not affect the function of L-type Ca2+ channel, store-operated channel, and 
α adrenergic receptor. In conclusion, KB-R7943 can be used as a selective inhibitor of NCX 
at the concentration of 1 μM in rat aortic rings. The aorta was used as a simple model of 
vascular smooth muscle and it is assumed that the results are translatable to other tissues. 
Indeed in all previous studies with KB-R7943 reports of non selective actions occur in 
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concentrations in excess of this (see Table 2.2). 
 
 
 
88 
CHAPTER 3 THE EXISTENCE AND FUNCTION OF THE Na+/Ca2+ EXCHANGER 
IN RAT AORTAE 
3.1 INTRODUCTION 
3.1.1 Vascular endothelium 
The walls of arteries and veins are composed of three distinct layers: tunica intima (the 
innermost layer), tunica media (the middle layer) and tunica adventitia (the outermost layer) 
(see Figure 3.1) (Shepro et al., 1974; Tortora et al., 1981).  
The tunica intima is composed of endothelium underlain by a subendothelial layer of loose 
connective tissue, and the internal elastic lamina at its outer surface. The monolayer of 
endothelium lines the lumen of all vessels and separates the blood vessel from continuously 
flowing blood. 
The tunica media essentially comprises spirally arranged smooth muscle cells and sheets of 
elastin. The outer border is marked by external elastic lamina. This is the bulkiest layer in 
arteries, rich in vasomotor fibers that can cause vasoconstriction and vasodilation. 
The tunica adventitia is composed of a mixture of elastic and collagenic fibers; the latter 
protects the blood vessel from overexpansion and also contains axons of the vasomotor 
fibers. 
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Figure 3.1 The structure of a muscular artery. 
The illustration shows the structure of a typical arterial wall which consists of three layers: 
tunica intima, tunica media and tunica adventitia. 
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The vascular endothelium lines the blood vessel lumen and is composed of a monolayer of 
endothelial cells. Like other eukaryotic cells in the human body, endothelial cells have a 
nucleus, cytoplasm and all the organelles inside it, enclosed by a double-layer phospholipid 
membrane. There is a variety of contractile proteins in the cytoplasm including actin, 
myosin, tropomyosin, and α-actin. Some specialized structures made of contractile proteins 
comprise cortical web, the junction-associated actin filament system and the striated 
myofibril-like filament bundles or stress fibers (Esper et al., 2006).  
There is broad agreement that the vascular endothelium plays a pivotal role in the basic and 
dynamic control of circulation (Loscalzo et al., 1995). Sir John Vane named vascular 
endothelium ‘the maestro of blood circulation’ (Gryglewski, 2005).  
Located on the front line of blood vessel, endothelium acts as a sensor to chemical and 
physical stimuli. The delicate role of endothelium in circulatory control relies on its ability to 
release substances in response to the physiological stimuli (Esper et al., 2006; Verma et al., 
2003). One of the most common stimuli is shear stress, which is produced by the increased 
blood velocity. Endothelium responds with nitric oxide (NO) release and subsequent 
vasodilatation (refer to 3.1.2.1 and 3.1.2.2). 
Endothelial cells can release a variety of chemical substances. Among them, the most 
prominent vasoconstrictors are endothelin and thromboxane A2, the most prominent 
vasodilators are nitric oxide, endothelium-derived hyperpolarizing factor (EDHF) and 
prostacyclin (PGI2),  (see reviews Bredt et al., 1994; Denninger et al., 1999). Under normal 
physiological condition, there is a balance of endothelium-derived vasoactive substances 
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(Spieker et al., 2005; Verma et al., 2003). However, the endothelium predominantly releases 
substances to maintain the underlying smooth muscle in a relaxed state.  
When the endothelium is impaired (which is called “endothelial dysfunction”), the 
pathological states occur (Rikitake et al., 2005). For example, lipids and leukocytes invade 
the endothelium causing an inflammatory response, platelets aggregation, smooth muscle 
thrombogenesis or vascular occlusion. (See review Esper et al., 2006). Jones et al reported 
that endothelium release of NO maintains basal vascular tone, vasodilator reserve and 
resistance distribution, thereby endothelium dysfunction might cause hypertension (Jones et 
al., 1995). Apart from physical damage, endothelial cell dysfunction can manifest itself by 
impairment of release of the various chemical mediators and defects in endothelium-induced 
NO-mediated vasodilation have been shown in the condition of hypertension, diabetic 
angiopathies, reperfusion injury, hypercholesterolaemia and atherosclerosis (Dinerman et al., 
1993; Gryglewski, 2005; Semenza, 2005; Shelkovnikov et al., 2004; Spieker et al., 2005), 
(see review Loscalzo et al., 1995; Ruehlmann et al., 2000).  
3.1.2 Nitric oxide (NO) 
What was originally described as endothelium-derived relaxing factor (EDRF) is now 
identified to be nitric oxide (NO) (Gryglewski, 2005).  
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3.1.2.1 Production 
L-arginine, an endogenous amino acid, was discovered by Schultze in 1886. It attracts 
intense attention as the only substrate for the production of NO (Akopova et al., 2002; 
Wileman et al., 2003), Arginine has other functions in ammonia detoxification, the urea 
cycle, the formation of active enzyme centers, and the precursor of proteins, ornithine, urea 
and creatinine (Cylwik et al., 2005).   
The initial stimulus for endogenous NO release comes from the deformation of endothelium 
by mechanical force such as shear stress or stretch, or the activation of endothelial receptor 
by agonist such as acetylcholine or bradykinin (see 3.1.2.2.2). Upon stimulation, which is 
generally due to the elevation of intracellular Ca2+, nitric oxide synthase (NOS) catalyses the 
formation of NO from arginine (Binko et al., 1998; Molin et al., 2004). The chemical 
reaction is shown in Figure 3.2. NOS oxidizes the guanidine group of L-arginine in a process 
that consumes five electrons and gives rise to NO with stoichiometric formation of L-
citrulline (see Figure 3.2).  
3.1.2.2 Nitric oxide synthase (NOS) 
(1) Isoforms of NOS 
There are three known NOS isoforms: one inducible NOS and two constitutive ones. All of 
them contain heme, are dioxygenases and NADPH-dependent.  NOS cofactors include 
NADPH        
93 
NH2
+
NH
NH2
NH3
+
-
OOC
N
NH
NH2
NH3
+
-
OOC
OH
O
NH
NH2
NH3
+
-
OOC
ARGININE HYDROXY-ARGININE CITRULLINE
NADPH 1/2  NADPH
H2O H2OO2 O2
NO+ .
 
 
 
 
 
 
 
Figure 3.2 Chemical reaction for the production of nitric oxide 
One molecule of arginine is oxidized by NOS producing one molecule of nitric oxide and 
one molecule of citrulline. 
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NADPH, flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) (Bredt et al., 
1994; Martinez-Lemus et al., 2005). 
Constitutive NOS comprises two kinds: neuronal (nNOS) and endothelial (eNOS) NOS, (see 
review Semenza, 2005).  nNOS is mainly found in neurological tissue and encode by NOS-I. 
NOS-III encodes for eNOS that exists mainly in vascular endothelium and smooth muscle. 
Inducible NOS (iNOS) is expressed by inflammatory processes especially in macrophages, 
neutrophils and endothelial cells, encode by human NOS-II gene (Esper et al., 2006). Both 
constitutive NOS and inducible NOS are found in endothelial cells. 
Whilst constitutive NOS (eNOS, nNOS) are Ca2+/calmodulin dependent, iNOS is not. 
Constitutive NOS is activated by the augmented level of intracellular calcium induced by 
agonists (acetylcholine, bradikinin etc) producing NO for a short period. Inducible NOS is 
immunologically synthesized by cells after exposure to bacterial endotoxin (such as 
lipopolysaccharide) or pro-inflammatory cytokines and produces large quantities of NO for a 
longer period (Jones et al., 1995; Loscalzo et al., 1995; Muller et al., 1998; Ruehlmann et 
al., 2000; Wileman et al., 2003). 
(2) Regulation of NOS 
As a lipid-soluble and unstable gas, NO can not be stored thus biosynthetic regulation is 
important for NO. NOS is one of the most regulated enzymes.  
NOS enzymes can be discriminated by their regulation by calcium. In blood vessels, 
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acetylcholine binds to muscarinic receptors on endothelial cells to generate Ca2+, which 
stimulates NOS. Thus, the production of NO is under the control of calcium-regulated NOS 
(Bredt et al., 1994).  
In the cardiovascular system, the constitutively expressed enzyme: endothelial nitric oxide 
synthase (eNOS) controls the production of NO. And the activity of eNOS is inactivated by a 
structural protein: caveolin-1 in a specialized area of the membrane: caveolin. Upon 
stimulation of endothelial receptors or deformation of the endothelium by sheer stress from 
blood flow, eNOS can be activated via an enhanced level of intracellular [Ca2+] and/or 
protein kinase stimulation (Bryan et al., 2005). When intracellular Ca2+ increases, Ca2+ binds 
to calmodulin, Ca2+/calmodulin complex dissociates the NOS-caveolin complex and 
activates eNOS (Schneider et al., 2002b).  
3.1.2.3 NO donors 
NO is soluble in water (2 – 3 mM), but the solutions of authentic NO are unstable and 
difficult to handle. As a result, chemical compounds that can generate NO in situ are 
desirable for researchers. Many nitrogen-oxygen-bonded compounds can be decomposed, 
oxidized or reduced to produce reactive nitrogen species. Diversity of NO donors has been 
developed including organic nitrites (e.g. nitroglycerine), organic nitrates (e.g. glyceryl 
trinitrate), metal-NO complexes (e.g. sodium nitroprusside), and nitrosothiols (e.g. SNAP) 
etc (Mulsch et al., 2001; Wang et al., 2002a). NO donors are used as NO delivery agents in 
disease states that are related to impaired expression or activity of endothelial NO (Li et al., 
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2000; Maxwell, 2002). They all produce vasodilatation. 
Sodium nitroprusside (SNP) is a well-documented compound used as a NO carrier (Amoroso 
et al., 2000; Asano et al., 1995; Dainty et al., 1990; Perez-Vizcaino et al., 1999; van der 
Zypp et al., 1998). Its structure is depicted in Figure 3.3. Although it is extremely 
photosensitive, it can be kept stable for many years in a dry and photo-protective 
environment. Its therapeutic properties are related to NO release which occurs via its redox 
conversion to the one or two electron-reduced forms. The requirement for light or reductant 
to the transition from SNP to NO is clear, although the exact mechanism remains obscure 
(Smith et al., 2001; Wolak et al., 2003). It is a potent, rapid and efficient hypotensive agent 
being used clinically to reduce blood pressure (Smith et al., 2001; Wang et al., 2002a; Wolak 
et al., 2003). However, its undesired side effect at high concentration can cause cellular 
toxicity via cyanide release (Wang et al., 2002a). 
3.1.2.4 Inhibitors 
As discussed in 1.1.2.1, L-arginine is the substrate for the formation of NO. L-Nω-substituted 
arginines are the substrate analogs acting as competitive NOS inhibitors. L-Nω nitroarginine 
(L-NNA) is the most potent known inhibitor of the nNOS and eNOS (Ki  = 200-500 nM), and 
L-Nω aminoarginine (L-NAA) is the most potent blocker of the iNOS (Ki = 1-5 μM), (see 
review Bredt et al., 1994). In the present study, L-Nω-nitroarginine methyl ester (L-NAME) 
was used as the competitive inhibitor of eNOS (Mendizabal et al., 2000; Molin et al., 2004; 
Muller et al., 1998; Schuh et al., 2003). 
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Figure 3.3 Structure of SNP            
The molecular formula of SNP is: Na2[Fe(CN)5NO] 
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3.1.2.5 The biological functions of NO 
NO has been found to be a key signal agent playing a central role in the nervous, immune, 
and cardiovascular systems. Its wide spectrum of biological functions comprise smooth 
muscle relaxation, blood pressure regulation, neurotransmission, antithrombogenic, 
antiproliferative, leukocyte-adhesion inhibiting effects, and influences myocardial 
contractility (Denninger et al., 1999; Esper et al., 2006; Feelisch et al., 1999; Ignarro, 2002; 
Li et al., 2000; Spieker et al., 2005). 
The dysfunction in the NO pathway (such as decreased NO production and increased 
degradation of NO) is related to vascular diseases: hypertension, diabetic angiopathy, 
hypercholesterolaemia and atherosclerosis, (see review Li et al., 2000). 
Soluble guanylate cyclase is the principal target for NO. Guanylate cyclase can be classified 
as two isoenzymes: membrane-bound (particular) and cytosolic (soluble). The two proteins 
are quite distinct with different activation mechanisms. Whilst pGC is predominantly 
expressed in intestinal mucosa and retina, sGC in platelet, most tissues such as vascular 
smooth muscle contain both types. The main mode of action of NO is mediated via the 
stimulation of soluble guanylyl cyclase (sGC), which catalyses conversion of guanosine 
triphosphate (GTP) to cyclic guanosine-3’, 5’ –monophosphate (cGMP) (Denninger et al., 
1999; Munzel et al., 2005; Spieker et al., 2005). The key target enzyme of NO is soluble 
guanylate cyclase (sGC) (Lau et al., 2004; Munzel et al., 2005). Both NO gas and NO 
released from NO donors were shown to activate sGC by binding to iron in the heme (Miki 
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et al., 1977; Schultz et al., 1977). Soluble GC family consists of isoforms GC-Sα1-3β1-3.  
Mammalian particulate GC family consists of GC-A to GC-G, and retGC (Denninger et al., 
1999). Unlike sGC, pGC is activated with agents such as enterotoxin (Guerrant et al., 1980), 
atrial natriuretic factor (ANF) (Waldman et al., 1984a; Winquist et al., 1984) and hemin 
(Waldman et al., 1984b). It is not NO reactive. 
Actions of cGMP 
Vasodilators (such as acetylcholine, bradykinin, or histamine) act at receptors on endothelial 
cells causing an influx of calcium to activate eNOS. The newly synthesized NO diffuses into 
adjacent smooth muscle cells where it activates GC and subsequently enhances the 
concentration of cGMP. The key second messenger (cGMP) has three major targets: cGMP-
dependent protein kinases, cGMP-regulated phosphodiesterases (PDEs), and cGMP-gated 
ion channels (See reviews Birschmann et al., 2004; Lincoln et al., 1993). 
cGMP-dependent protein kinase is protein kinase G (PKG) (Lohmann et al., 1997). PKG is a 
homodimer that dissociation is not involved during activation. There are two isotypes of 
PKG that have been reported in mammalian tissues: type I and type II (Browner et al., 2004; 
Keef et al., 2001; Lincoln et al., 1993; Schroder et al., 2003). Type I PKG exists in a large 
amount in vascular smooth muscle cell, and includes two isoforms: type 1α and type 1β 
(Browner et al., 2004; Lincoln et al., 1993). Both type 1α and type 1β co-exist in rat aorta 
(Browner et al., 2004; Lincoln et al., 2001; Sekhar et al., 1992). Type II PKG exists mainly 
in intestine, kidney and brain (Lincoln et al., 1993; Lohmann et al., 1997). 
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Both cGMP and cAMP can activate PKG in VSMC (Pelligrino et al., 1998). PKG exerts its 
biological effect via the phosphorylation of serine and threonine residues on target proteins 
(Graves et al., 1999; Pelligrino et al., 1998). Although the exact mechanism by which  
cGMP induces vasodilatation via PKG is still not well understood, the following pathways 
are proposed: (1) acting on various ion transport systems, such as stimulating plasma 
membrane Ca2+ pump in rat aorta (Furukawa et al., 1988) and the sarcoplasmic reticulum 
Ca2+ pump in rat aorta (Twort et al., 1988), stimulating NCX in rat astrocyte (Asano et al., 
1995), (see also review Lincoln et al., 1993). (2) altering muscle contractility, such as the 
phosphorylation of myosin kinase in bovine aorta (Fukuta et al., 1997; Hathaway et al., 
1985). (3) reducing Ca2+ sensitivity of contractile system, such as reported in rat mesenteric 
artery (See reviews Nishimura, 2006; Nishimura et al., 1989).  
The degradation of cGMP (and cAMP) is catalyzed by phosphodiesterases (PDEs) via the 
hydrolysis of the 3’-phosphodiester bond of cAMP and cGMP to yield AMP and GMP 
respectively (Beavo et al., 1990; Degerman et al., 1997; Houslay et al., 1997; Lo et al., 
2005). In mammals, the PDE superfamily includes at least 10 isoforms: PDE1-PDE10. 
PDE5, PDE6 and PDE9 hydrolyze preferentially the cGMP rather than cAMP. PDE3 
exhibits affinity to both cGMP and cAMP (Degerman et al., 1997).  
The guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) was 
also used to block the cGMP-dependent effect of NO (Perez-Vizcaino et al., 1999; 
Shelkovnikov et al., 2004; Tsang et al., 2003). 
In addition to the cGMP-mediated action, NO has been reported to have direct effects on 
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vascular reactivity without requiring cGMP (Feelisch et al., 1999; Trottier et al., 1998). For 
example, NO was reported to activate directly tetrabutylammonium (TBA)-sensitive K+ 
channels in rat aorta (Muller et al., 1998); and activate calcium-dependent potassium 
channels (BKCa) in vascular smooth muscle (Bolotina et al., 1994). 
NO has an unpaired electron in its outer electron shell, and therefore possesses the radical 
character. As a free radical, NO can easily react with other members in the free radical 
family, such as superoxide anion (OO- or O2-). O2- can be produced under oxidative stress in 
the vascular wall, such as ischaemia-reoxygenation. O2- quickly inactivates NO and gives 
rise to peroxynitrite (ONOO-), chemical reaction is described  below.  
  
 
ONOO- is a potent oxidant and nitrating agent that can destroy proteins, lipids, and nucleic 
acids, trigger apoptosis of cell (Chakraborti et al., 1999), (see also review Dowell et al., 
1997). Accelerated breakdown of NO and the formation of O2- occurs in atherosclerosis in 
rat aorta (Minor et al., 1990). Owing to the central role of NO in the regulation of the 
vascular system, the decomposition of NO by OO- could have tremendous pathological 
effects in the vascular system (Bredt et al., 1994; Li et al., 2000; Maxwell, 2002).  
3.1.3 Prostacyclin 
Prostacyclin can be produced by endothelial cells. Prostacyclin was discovered in 1976 by a 
group of scientists while searching  for a  drug  producing  thromboxane A2 (TXA2) from 
O2-  +  NO  =  ONOO --   
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prostaglandin endoperoxides (PGG2 or PGH2) (Gryglewski et al., 1976; Moncada et al., 
1976). The common precursor for prostanoids is arachidonic acid (AA). The chemical 
reaction is as below (see Figure 3.4).  
Upon stimulation of hormones (such as arginine vasopressin), cytosolic lipases (e.g. 
phospholipase A2, phospholipase C, phospholipase D) catalyze the biosynthesis of 
arachidonic acid from plasma membrane phospholipids. Arachidonic acid has two metabolic 
fates. It is either converted into leukotrienes by lipoxygenases or by cyclooxygenase-1 and 
cyclooxygenase-2 (COX1/2) into prostaglandin G2 (PGG2) and further into prostaglandin H2 
(PGH2). PGH2 is the common precursor for a series of prostanoids (PGs): PGD2, 
prostacyclin (PGI2), PGE2, PGF2α and thromboxane (TXA2) which are formed by specific 
synthases. Prostanoids exert their effects through G protein- linked receptors, (see reviews 
Hanoune et al., 1997; Smith, 1992).  
Endothelial COX-2/PGIS generates vasoprotective prostacyclin (PGI2) causing platelet 
inhibition, vasodilation, and anti-inflammation. In distinct contrast to the former, COX-
1/TXAS produces vasotoxic thromboxane (TXA2) inducing platelet aggregation and 
vasoconstriction (Becker, 2005; Cheng et al., 2002). Nonsteroidal antiinflammatory drugs 
(NSAIDs), for example indomethacin and aspirin indiscriminately inhibit COX1 and COX2 
(Perez-Vizcaino et al., 1999; Vane et al., 1987). The inhibition of COX2 renders its 
therapeutic effects whereas the inhibition of COX1 provides the side effect of gastrotoxicity 
and bleeding (see review McAdam et al., 1999). 
The key target of prostacyclin is prostacyclin receptor which activates adenylate cyclase by a 
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G-protein dependent process (Hanoune et al., 1997; Schwede et al., 2000; Wedel et al., 
1997). Adenylate cyclase (ACs) catalyzes the transition of adenosine triphosphate (ATP) to 
cyclic adenosine-3’, 5’ –monophosphate (cAMP). 
Similar to cGMP, the level of cAMP is controlled not only by its synthesis via adenylate 
cyclase, also by its breakdown via PDEs as well (Bielefeldt, 1999; Lo et al., 2005). Amongst 
the 10 members in PDE superfamily, PDE4, PDE7, and PDE8 are specific for cAMP. 
cGMP-stimulated PDE2 and cGMP-inhibited PDE3 render the crosstalk between two kinds 
of cyclic nucleotides. 
The target protein for cAMP is protein kinase A (PKA). PKA is a tetramer, including two 
catalytic subunits and two regulatory subunits. cAMP can act on the regulatory subunits and 
dissociate them causing the activation of PKA (Pelligrino et al., 1998). Both isoforms of 
PKA (PKA-I and PKA-II) are expressed in vascular smooth muscle.  PKA  exerts its effect 
via the phosphorylation of serine and threonine residues on target proteins (Graves et al., 
1999; Pelligrino et al., 1998). cAMP produces a vasodilatation, and cAMP-producing drugs 
such as β-adrenergic hormones and forskolin presumably induce vasodilation through PKA 
by decreasing [Ca2+]i as well as sensitivity of the contractile apparatus to Ca2+ (Abe et al., 
1989; Nishimura et al., 1989). cAMP/PKA was reported to decrease vasoconstriction via 
activating Ca2+-activated K+ channels (Sadoshima et al., 1988), stimulating Ca2+ uptake into 
the intracellular stores (Mueller et al., 1979), and increasing sarcolemmal Ca2+ pump activity 
(Bulbring et al., 1987). Similar to cGMP, cAMP was reported to alter muscle contractility, 
such as the phosphorylation of myosin kinase in bovine aorta (Hathaway et al., 1985).
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Figure 3.4 Biosynthesis of prostanoids 
Phospholipases catalyzes the hydrolysis of phospholipid to form arachidonic acid. Under 
inflammatory condition, arachidonic acid is converted into leukotrienes. Under physiological 
condition, COX converts arachidonic acid into endoperoxides (PGG2 or PGH2). Finally, 
PGH2 is transformed into TXA2, PGI2, PGF2α, PGD2, and PGE2 respectively by TXA-
synthase, PGI2-synthase, PGF-synthase, PGD-synthase, and PGE-synthase (Cheng et al., 
2002; McAdam et al., 1999).    
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3.1.4 EDHF 
EDHF is a residual endothelium vasorelaxation after blockade of NOS and COX. It is due to 
the membrane hyperpolarization of the smooth muscle cells (Waldron et al., 1999). 
After it was found in the late 1980s and early 1990s, the mechanism of EDHF remains a 
mystery even now. Its complexity arises from the mechanisms of hyperpolarizing the 
membrane. EDHF may be a metabolite of arachidonic acid formed through activation of the 
enzyme of cytochrome P450 in some tissues such as bovine and porcine coronary arteries 
(Hecker et al., 1994). Bryan has suggested the following requirement for the definition of 
EDHF (Bryan et al., 2005): (1) requires endothelium; (2) is distinct from both endothelium-
derived nitric oxide or COX metabolites; (3) dilates by hyperpolarizing the vascular smooth 
muscle; and (4) involves potassium channel activation, most often calcium-activated 
potassium channels (KCa) (Chen et al., 1989). 
As a vasodilator, the effect of NO is of primary importance in systemic vasculature, and 
EDHF in smaller arteries and arterioles (Fukuta et al., 1997; Garland et al., 1995; Ogura et 
al., 2004). The vasodilation from EDHF might be up regulated when NO pathway is 
suppressed, such as in the stress states (e.g. hypertension) (Perez-Vizcaino et al., 1999). This 
protective response helps maintain the homeostasis under those pathological conditions (see 
review Bryan et al., 2005). 
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3.1.5 Aims of the study 
Given the important role of the vascular endothelium in modulating vascular smooth muscle 
contractility, the aim of the present study was to investigate whether the operation of NCX 
could be affected by the endothelium. NCX does have phosphorylation sites on its 
intracellular loop for both PKG and PKA (Caroni et al., 1983; DiPolo et al., 1987c; He et al., 
1998; Iwamoto et al., 1995; Mene et al., 1993; Yamanaka et al., 2003) and these cyclic 
nucleotides could therefore have an important role. 
It is likely that NCX normally operates to transport Ca2+ out of cells; however, this function 
is difficult to investigate in functional blood vessel studies. In the present study NCX 
operation was studied in reverse mode after lowering extracellular Na+ from 144.18 mM to 
1.18 mM (Kim et al., 1999; Rebolledo et al., 2006; Schweda et al., 2001). Whilst this is not 
the normal physiological operation, it is relevant to various pathological states such as 
ischaemia (Schweda et al., 2001) and importantly the vasoconstriction produced is relatively 
easy to measure.  
The specific questions that were asked using isolated rat aorta were: 
• Does the endothelium modulate NCX mediated constriction? 
• What endothelial factors are involved? 
• What is the mechanism of action? 
 
In the present study, NO/cGMP and prostacyclin/cAMP pathways were investigated in rat 
aortic rings to clarify the possible role for NCX modulation. 
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Figure 3.4a NO/cGMP pathway
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3.2 METHODS 
3.2.1 Tissue preparation for functional studies 
Male Sprague Dawley rats (5-7 weeks old, weighing 200-350 g) were anaesthetized with 
Thiopentone sodium (100 mg/kg, i.p. Sigma, USA) and then killed by decapitation. The 
thoracic aorta was removed, placed in a cold physiological salt solution (PSSA, see 3.2.3.1), 
cleaned of surrounding fat and connective tissue and cut into equal-size ring segments (4mm 
in length) with scissors. Two thin stainless-steel hooks were inserted through the lumen of 
aorta ring. The lower hook was connected to a tissue holder and the upper to an isometric 
force Grass FT03 displacement transducer. Each ring was suspended in an organ bath 
containing 2 ml of physiological salt solution. Tissues were washed thoroughly by replacing 
the physiological salt solution repeatedly and were then allowed to equilibrate for a period of 
60 minutes under 2 g of resting tension.  
For the study of NCX operating in reverse mode, the extracellular [Na+] was reduced from 
144.18 mM to 1.18 mM. Low Na+ PSS (PSSB, see 3.2.3.2) was obtained by substituting 
choline chloride for NaCl, bubbled with 100% O2 and the pH was adjusted to 7.4 with KOH. 
In the control group, the normal PSS (PSSA, see 3.2.3.1) was bubbled with 100% O2 and the 
pH was adjusted to 7.4 with NaOH (Horiguchi et al., 2001).  
Drugs and reagents were added directly to the bathing fluids using a micro syringe, and 
mixed thoroughly by repeated syringing with the bath solution and were allowed to reach a 
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steady concentration in the incubation fluid within the tissue chamber. Baseline tone was 
readjusted when necessary.  
In some cases, the endothelium was removed by gentle rubbing of the luminal surface with a 
plastic rod.  
3.2.2 Tissue viability and endothelium-denudation checking 
Following the 60-minute equilibration period, the viability of the tissues was assessed. 
Tissues, which failed to produce 0.5-g increase in tension to phenylephrine (1 µM), were 
rejected. Successful removal of the endothelial cells was confirmed by the inability of 
acetylcholine (1 µM) to induce relaxation in the presence of phenylephrine (see Figure 3.5). 
The tissue bathing solution was then replaced repeatedly with fresh drug free PSS until a 
stable baseline tension was achieved. The tension was re-adjusted to 2 g.   
3.2.3 Composition of physiological salt solution (PSS) (in mM): 
3.2.3.1 Normal physiological salt solution for NCX operating on reverse mode (PSSA): 
NaCl 143; KCl 4.7; NaH2PO4 1.18; MgSO4·7H2O 1.17; CaCl2·2H2O 2.5; glucose 11; and N-
2-hydroxy-ethylpiperazine-N-2-ethylsulphonic acid (HEPES) 5.   
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Figure 3.5 The typical traces of rat aortic rings  
The aortic rings in each channel are taken from separate rings in the same rat.  Y-axis 
indicates the constriction measured in grams.  The elapsed time on the experimental day is 
shown on X-axis (h:m:s).  Panel A: response to phenylephrine (1 μM) followed by 
acetylcholine (1 μM) in endothelium denuded aorta.  Panel B: response to phenylephrine (1 
μM) followed by acetylcholine (1 μM) in endothelium intact aorta.  
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3.2.3.2 Low Na+ physiological salt solution for NCX operating on reverse mode (PSSB): 
Choline chloride 143; KCl 4.7; NaH2PO4 1.18; MgSO4·7H2O 1.17; CaCl2·2H2O 2.5; glucose 
11; and HEPES 5.  
3.2.4 Experimental protocols 
3.2.4.1 Low Na+ constriction in rat aortic rings 
In this series of experiments, external [Na+] was lowered to 1.18 mM which is below the 
intracellular concentration, thereby turning the direction of calcium transport through NCX 
to an inward direction (Calcium Entry Mode or Reverse Mode) (Kim et al., 1999; Schweda 
et al., 2001). Extracellular [Na+] was replaced with isomolar choline chloride. 
Low [Na+]o may exert its effect by changing the neurotransmitter release from the 
perivascular nerve endings. Therefore, the same experiment was conducted in the presence 
of adrenergic neuron blocker: guanethidine. Guanethidine was reported to be an effective 
adrenergic neuron transmission blocker in rat aorta at the concentration of 3 μM (Toma et 
al., 1995)(Berry et al., 1992). Aortic rings were pretreated for 30 minutes with guanethidine 
(3 μM) before the manipulation of lowering [Na+]o. 
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3.2.4.2 The effect of ODQ on low Na+ constriction in rat aortic rings  
The soluble guanylate cyclase inhibitor: ODQ was used to determine whether nitric oxide-
linked processes might be involved in the modulation of NCX. In both endothelium denuded 
and intact vessels, ODQ (1 μM) was added for 10 minutes before the manipulation of 
lowering [Na+]o. 
3.2.4.3 The effect of L-NAME on low Na+ constriction in rat aortic rings 
The nitric oxide synthase inhibitor: L-NAME was used to determine whether NO-linked 
processes might be involved in the endothelial modulation of NCX. L-NAME (50 μM) was 
added to the rings for 20 minutes before the manipulation of lowering [Na+]o. 
3.2.4.4 The effect of SQ 22536 on low Na+ constriction in rat aortic rings 
In this set of experiments, the involvement of cAMP pathway was evaluated. SQ 22536, the 
adenylate cyclase blocker was used as a pharmacological tool to this end (Lo et al., 2005). In 
both endothelium denuded and intact vessels, the aortic rings were incubated with SQ 22536 
(100 μM) for 30 minutes before reducing [Na+]o. At the concentration of 100 μM, SQ 22536 
was reported to be an effective inhibitor of adenylate cyclase in rat aorta (Lo et al., 2005; 
Morello et al., 2006; Wu et al., 2005). 
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3.2.4.5 The effect of Indomethacin on low Na+ constriction in rat aortic rings 
In order to ascertain if there is any alternative pathway of endothelial modulation of NCX 
apart from NO, the production of prostacyclin was inhibited using the COX inhibitor: 
indomethacin. In the endothelium intact vessels, the aorta strips were pretreated with 
indomethacin (10 μM) for 30 minutes prior to the withdrawal of [Na+]o. At the concentration 
of 10 μM, indomethacin was reported to be an effective inhibitor of COX in rat aorta (Molin 
et al., 2004)(Ashraf et al., 2004; Rapoport et al., 2000; Sofola et al., 2003). In vehicle group, 
0.1% Na2CO3 (v/v) was used.  
3.2.4.6 The relaxant effect of Sodium Nitroprusside (SNP) in rat aortic rings after 
constriction to U46619 or low Na+ 
In an attempt to gather direct evidence of the involvement of nitric oxide in the operation of 
NCX, the NO donor SNP was studied. These experiments were designed to determine 
whether the method of preconstriction altered the ability of SNP to relax endothelium 
denuded rat aortic rings. 
Rat denuded aortic rings were exposed to different types of pre-constriction. The 
thromboxane A2 agonist U46619 (0.1 μM), or Na+ PSS (1.18 mM) was used to induce 
vasoconstriction. In control group, vehicle (0.1% Ethanol) was used. After the tension 
reached its peak, SNP (30 nM) was applied to elicit vasodilatation. 
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3.2.4.7 The relaxant effect of SNP in rat aortic rings after constriction to 80 mM KCl or 
low Na+  
In a separate series of experiments, the denuded aortic rings were pre-constricted with either 
KCl (80 mM) or low Na+, and then challenged with SNP (30 nM). At the even lower 
concentration of 60 mM, high K+ was shown to effectively induce membrane depolarization 
and vasoconstriction in rat aorta (Iwata et al., 2001; O'Donnell et al., 1987).  In control 
group, vehicle (0.1% DMSO) was used. 
3.2.5 Drugs and materials 
The following drugs were used: L-phenylephrine hydrochloride, acetylcholine chloride, 9-(2-
tetrahydrofuryl) adenine (SQ 22536), indomethacin, guanethidine monosulfate, sodium 
nitroprusside dihydrate (SNP), Nω-nitro-L-arginine methyl ester (L-NAME) from Sigma (St 
Louis, USA), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) from Cayman Chemical 
(MI, USA), KB-R7943 (2-2-[4-(4-nitrobenzyloxy) phenyl] ethyl isothiourea 
methanesulphonate), from TOCRIS (Ellisville, USA), 9,11-Dideoxy-9α, 11α-methanoepoxy 
prostaglandin F2α (U46619) from BIOMOL (Plymouth Meeting, USA). Phenylephrine and 
acetylcholine were dissolved in distilled water, and the remaining drugs were dissolved in 
DMSO at 10 mM as a stock solution, and further diluted in PSS prior to use. The final 
concentration of vehicle was no more than 0.1% (v/v). Buffer salts and chemicals were 
obtained from Sigma (St Louis, USA) unless otherwise stated, include: NaCl, NaHCO3, KCl, 
KH2PO4, MgSO4⋅7H2O, D-(+)Glucose, CaCl2⋅2H2O, EGTA, HEPES, Choline Chloride. 
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3.2.6 Data analysis 
Results are expressed as mean ± standard error of the mean, and were considered different 
when P<0.05.  Multiple comparisons were determined using ANOVA in GbStat package 
(version 7.0, Dynamic Microsystems, Inc., Silver Spring, MD, USA). 
 
 
3.3 RESULTS 
3.3.1 Constriction in rat aortic rings induced by low Na+   
In endothelium denuded rat aortic rings, lowering extracellular [Na+] to 1.18 mM induced 
immediate constriction and spontaneous constrictor activity (vessel motion), as seen in the 
original traces  (Figure 3.6). Group data are shown in Figure 3.7. The low Na+ did not 
produce constriction after the employment of NCX inhibitor KB-R7943, at the concentration 
of 10 μM (Figure 3.7) and 1 μM (Figure 3.8).  
The adrenergic neuron blocker guanethidine (3 μM) showed no effect on low-Na+ induced 
constriction in endothelium denuded rat aortic rings (Figure 3.7) indicating that sympathetic 
nerves were not involved. 
In endothelium intact vessels, lowering [Na+]o  did not constrict the aortic rings significantly 
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(Figure 3.9). 
3.3.2 The effect of ODQ on constriction in rat aortic rings induced by low Na+  
In endothelium intact rat aortic rings, the guanylate cyclase inhibitor ODQ (1 μM) greatly 
amplified the vasoconstriction to lowering extracellular Na+, but had no effect on the low 
Na+ constriction when the endothelium was removed (Figure 3.10). The typical trace was 
shown in Figure 3.11. 
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Figure 3.6 The representative trace in the experiment of low-Na+ induced effect 
The endothelium denuded aortic ring in each channel was taken from separate ring in the 
same rat. Y-axis indicates the constriction measured in gram, and X-axis indicates the 
elapsed time on the experimental day (h:m:s). Panel A: response to vehicle (0.1% DMSO). 
Panel B: response to [Na+]o lowering from 144.18 mM  to 1.18 mM. 
A
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Figure 3.7 Effect of KB-R7943 (10 μM) and guanethidine (3 μM) on constriction in 
endothelium  denuded rat aortic rings induced by lowering [Na+]o from 144.18 mM (CON) 
to 1.18 mM (low Na+)  
In each ring there was one cycle of constriction to low [Na+]. Either vehicle or drug (KB-
R7943 or guanethidine) was present before the constriction. Mean and s.e. mean are shown 
in the columns. The number of experiments ranged from 6 to 8 different rings in each group. 
* represents a significant differencefrom respective constriction before lowering of Na+ 
(CON), P<0.05 Student’s t-test. # represents that guanethidine had no significant effect on 
low Na+ constriction, P>0.05, two way analysis of variance. 
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Figure 3.8 Effect of KB-R7943 (1 μM) on constriction in endothelium  denuded rat 
aortic rings induced by lowering [Na+]o from 144.18 mM (CON) to 1.18 mM (low Na+)  
In this series of experiments, lower concentration of KB-R7943 (1 μM) was used. In each 
ring there was one cycle of constriction to low [Na+]. Mean and s.e. mean are shown in the 
columns. The number of experiments was 6 different rings in each group. * represents a 
significant difference from respective constriction before lowering of Na+ (CON), P<0.05 
Student’s t-test. # represents significant inhibition by KB-R7943 (1 μM), P<0.05, two way 
analysis of variance. 
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Figure 3.9 The influence of the endothelium on constriction induced by lowering [Na+]o 
from 144.18 mM (control) to 1.18 mM (low Na+) in rat aortic rings 
In each ring there was one cycle of constriction to low [Na+]. Mean and s.e. mean are shown 
in the columns. The number of experiments ranged from 5 to 9 different rings in each group. 
* represents a significant differencefrom respective constriction before lowering of Na+ 
(CON), P<0.05 Student’s t-test. 
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Figure 3.10 Effect of ODQ on constriction in rat aortic rings induced by lowering [Na+]o 
from 144.18 mM (control) to 1.18 mM (low Na+) 
In each ring there was one cycle of constriction to low [Na+]. Mean and s.e. mean are shown 
in the columns. The number of experiments ranged from 5 to 8 different rings in each group. 
* represents a significant differencefrom respective constriction before lowering of Na+ 
(CON), P<0.05 Student’s t-test. 
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Figure 3.11 The representative trace in the experiment of ODQ and SQ 22536 on low Na+ 
-induced effect in endothelium intact rat aortic rings 
The aortic rings in each channel are taken from separate rings in the same rat.  Y-axis in each 
channel represents the constriction of aortic rings measured in grams. X-axis represents the 
elapsed time of the day (h:m:s). Comment line indicates where the treatments started. Panel 
A: response to lowering extracellular Na+ in the presence of SQ 22536 (100 μM) in 
endothelium intact aortic rings; Panel B: response to lowering extracellular Na+ alone in 
endothelium intact aortic rings; Panel C: response to lowering extracellular Na+ in the 
presence of ODQ (1 μM) in endothelium intact aortic rings. 
A
 B
 C
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3.3.3 The effect of L-NAME on constriction in rat aortic rings induced by low Na+  
In endothelium intact rat aortic rings, L-NAME (50 μM) greatly amplified the 
vasoconstriction to lowering extracellular Na+, it had no effect in endothelium denuded 
aortic rings (Figure 3.12). The typical trace was shown in Figure 3.13. 
3.3.4 The effect of SQ 22536 on constriction in rat aortic rings induced by low Na+  
The adenylate cyclase blocker: SQ 22536 (100 μM) showed no significant effect on low-Na+ 
induced vasoconstriction in either endothelium denuded or intact aortic rings (Figure 3.14). 
The typical trace was shown in Figure 3.11. 
3.3.5 The effect of indomethacin on constriction in rat aortic rings induced by low Na+  
Indomethacin (10 μM), the COX inhibitor, had no effect on low Na+-induced 
vasoconstriction in endothelium intact aortic rings (Figure 3.15). The typical trace was 
shown in Figure 3.13. 
3.3.6 The effect of Sodium Nitroprusside (SNP) in rat aortic rings after preconstriction 
with low Na+ or U46619 
Endothelium denuded rat aortic rings were preconstricted to the same extent with different 
means: low Na+ (1.18 mM), or the thromboxane A2 agonist U46619 (0.1 μM). The absolute 
values of maximum constriction were shown in table 3.1. There was no significant difference 
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between the pre-constriction induced by distinct means (P>0.05, Student’s t-test). SNP (30 
nM) was added in each of these conditions and produced a vasorelaxation.  The 
vasorelaxation in low Na+ constriction was significantly greater than that in U46619 (Figure 
3.16).   
3.3.7 The effect of SNP in rat aortic rings after preconstriction with low Na+ or high K+ 
In another series of experiments, endothelium denuded rat aortic rings were preconstricted to 
the same extent with either low Na+ (1.18 mM) or high K+ (80 mM). The absolute values of 
maximum constriction were shown in Table 3.2. There was no significant difference between 
the pre-constriction induced by distinct means (P>0.05, Student’s t-test). SNP (30 nM) was 
added in each of these conditions and produced a vasorelaxation.  The vasorelaxation in low 
Na+ constriction was significantly greater than that in high K+ (Figure 3.17). 
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Table 3.1 The maximum constriction induced by different vasoconstrictors in rat aortic 
rings (in grams) 
Name of vasoconstrictor Constriction (gram) 
low Na+ (1.18 mM) 1.19 ± 0.18 
U46619 (0.1 μM) 1.32 ± 0.19 
 
 
Table 3.2 The maximum constriction induced by low Na+ or high K+ in rat aortic rings 
(in grams) 
 
Name of vasoconstrictor Constriction (gram) 
Low Na+ (1.18 mM) 0.83 ± 0.12 
High K+ (80 mM) 1.09 ± 0.10 
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Figure 3.12 Effect of L-NAME on constriction in endothelium intact rat aortic rings 
induced by lowering [Na+]o from 144.18 mM (control) to 1.18 mM (low Na+)  
In each ring there was one cycle of constriction to low [Na+]. Mean and s.e. mean are shown 
in the columns. The number of experiments ranged from 5 to 9 different rings in each group. 
* represents a significant differencefrom respective constriction before lowering of Na+ 
(CON), P<0.05 Student’s t-test. 
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Figure 3.13 The representative trace in the experiment of L-NAME and Indomethacin on 
low Na+ -induced effect in endothelium intact rat aortic rings 
The aortic rings in different channels are taken from separate rings in the same rat. Y-axis in 
each channel represents the constriction of aortic rings measured in grams. X-axis represents 
the elapsed time of the day (h:m:s). Comment line indicates where those treatments started. 
Panel A and D are the traces for the treatment of lowering Na+ in the presence of L-NAME 
(50 μM). Panel B is the trace for the treatment of lowering Na+ in the presence of 
indomethacin (10 μM). Panel C is the trace for the treatment of indomethacin (10 μM) alone.  
 A
 C
B
   D
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Figure 3.14 Effect of SQ 22536 on constriction in rat aortic rings induced by lowering 
[Na+]o from 144.18 mM (control) to 1.18 mM (low Na+) 
In each ring there was one cycle of constriction to low [Na+]. Mean and s.e. mean are shown 
in the columns. The number of experiments ranged from 6 to 7 different rings in each group. 
* represents a significant differencefrom respective constriction before lowering of Na+ 
(CON), P<0.05 Student’s t-test. 
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Figure 3.15 Effect of Indomethacin (10 μM) on constriction in endothelium intact rat 
aortic rings induced by lowering [Na+]o from 144.18 mM (control) to 1.18 mM (low Na+) 
In each ring there was one cycle of constriction to low [Na+]. Mean and s.e. mean are shown 
in the columns. The number of experiments ranged from 6 to 9 different rings in each group. 
There was no significant difference from respective constriction before lowering of Na+ 
(CON), P>0.05 Student’s t-test. 
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Figure 3.16 The relaxation effect of SNP (30 nM) in endothelium denuded rat aortic rings 
preconstricted with U46619 or low Na+  
In each ring there was one cycle of constriction to low [Na+]. SNP was added after the 
constriction had plateaued. Mean and s.e. mean are shown in the columns. The number of 
experiments ranged from 4 to 6 different rings in each group. * represents a significant 
difference of SNP-induced vasorelaxation in low Na+ (1.18 mM) from that in U46619 (0.1 
μM), P<0.05 Student’s t-test. 
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Figure 3.17 The relaxation effect of SNP (30 nM) in endothelium denuded rat aortic rings 
preconstricted with high K+ or low Na+  
In each ring there was one cycle of constriction to low [Na+]. SNP (30 nM) was added after 
the constriction had plateaued. Mean and s.e. mean are shown in the columns. The number of 
experiments was 5 different rings in each group. In control group (CON), SNP relaxation in 
the presence of vehicle (0.1% DMSO) instead of constrictor was used. * represents a 
significant difference of SNP-induced vasorelaxation in low Na+ (1.18 mM) from that in 
high K+ (80 mM), P<0.05 Student’s t-test. 
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3.4 DISCUSSION 
The existence of NCX has been shown in a variety of vascular smooth muscle cells, such as 
in cultured rat aortic VSMC (Juhaszova et al., 1994; Nakasaki et al., 1993; Wakimoto et al., 
2000; Zhu et al., 1994), in rat mesenteric artery myocytes (Slodzinski et al., 1998b; 
Slodzinski et al., 1995), in myocytes of rat mesenteric artery (Juhaszova et al., 1994), in 
VSMC of both normal and hypertensive rats (Taniguchi et al., 2004), in rat pulmonary artery 
VSMC (Wang et al., 2000), in cultured rat cortical neurons, astrocytes, aortic endothelial, 
aortic VSMC (Quednau et al., 1997), in either bovine or porcine smooth muscle sarcolemmal 
membrane vesicle (Slaughter et al., 1989) and in cultured human pulmonary artery VSMC 
(Zhang et al., 2005b). 
The present study was to investigate the role of the vascular endothelium in modulating 
vasoconstriction mediated by the Na+/Ca2+ exchanger (NCX).  In endothelium denuded rat 
aorta, lowering extracellular [Na+] from 144.18 mM to 1.18 mM induced an immediate 
constriction.  Other studies have also demonstrated a constriction induced by lowering Na+ 
such as in rat thoracic aorta and bovine tail artery (Ashida et al., 1987), in human umbilical 
artery smooth muscle cells (Rebolledo et al., 2006), in rat isolated skeletal muscle small 
arteries and mesenteric small arteries (Horiguchi et al., 2001), in guinea-pig aortic strips 
(Bova et al., 1988), in guinea pig tracheae (Espinosa-Tanguma et al., 2003), in canine 
coronary artery (Maseki et al., 1990), in rabbit aortic strip and pulmonary artery (Reuter et 
al., 1973), and in single myocyte of rabbit middle cerebral artery (Kim et al., 1999).  The 
constriction is most likely due to the inflow of Ca2+ through NCX as reducing the Na+ 
gradient across the membrane makes the exchanger operate in reverse mode (Horiguchi et 
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al., 2001; Schweda et al., 2001; Takai et al., 2004). Indeed in the present study the 
constriction was blocked by the NCX inhibitor KB-R7943 (1 μM and 10 μM). A key feature 
is the effectiveness of KB-R7943 at 1 μM, since at this concentration other non-NCX actions 
appear minimal (see chapter 2.1.7). Other studies have also shown that low Na+ 
vasoconstriction is blocked by NCX inhibitors such as in rat cremaster arterioles ( present 
studies Chapter 4.3.3), human umbilical artery smooth muscle cells (Rebolledo et al., 2006), 
rat carotid arterial myocyte (Takai et al., 2004), single myocyte of rabbit middle cerebral 
artery (Kim et al., 1999) rat intrapulmonary arteries (Becker et al., 2007) and rat renal 
resistance artery (Schweda et al., 2001). 
As NCX is also present in neurons, other workers have suggested alternate mechanisms of 
vasoconstriction such as the stimulation of sympathetic nerve endings in rabbit aorta (Karaki 
et al., 1977). Nevertheless in the present protocol the adrenergic neuron blocking drug 
guanethidine had no effect on low Na+ constriction excluding this possibility. This agrees 
with the observation that low Na+ vasoconstriction was maintained in the presence of the α 
adrenoceptor blocker phentolamine in rat aorta (Ashida et al., 1987). 
A key question is what role the vascular endothelium may play in this low Na+ induced 
constriction. It has been well established that the vascular endothelium by releasing nitric 
oxide has an important buffering effect on vasoconstrictor agents (see reviews Bredt et al., 
1994; Gryglewski, 2005). In the present study in endothelium intact rat aorta, lowering 
extracellular [Na+] from 144.18 mM to 1.18 mM induced a far smaller constriction than 
when the endothelium was removed. To the best of my knowledge, this is the first report on 
the different vasoconstriction effect induced by Na+ removal between endothelium-denuded 
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and intact vessels.  
The constriction in the presence of the endothelium due to low Na+ was nonsignificant (0.20 
gram). In early studies constriction was reported as significant, e.g. 0.11 gram in rat aorta 
(n=2) and 0.45 gram (n=4) in bovine tail artery (Ashida et al., 1987), but the sample numbers 
were small. In most of those studies, endothelium status was not mentioned or assessed and 
it may be that the endothelium was not entirely intact, namely, the endothelium may be 
partially damaged during tissue preparation. Indeed, endothelium damage is often 
encountered in functional studies and this was the discrepancy of the diversity of 
endothelium dependent vasorelaxation (Meininger et al., 1992). The other possibility is that 
the role of endothelium varies between tissues.  
One explanation for the lack of constriction to NCX is that the release of vasodilator 
substances from the endothelium inhibits NCX operation in the smooth muscle.  
Endothelium exerts its regulatory effect on vessel contractility through the release of 
intermediate substances. Among these, the best identified are prostacyclin, nitric oxide and 
endothelium-derived hyperpolarizing factor, and this is discussed in depth in section 3.1.1. 
Some of these were examined in the present study. 
It is known that prostacyclin can be released from endothelial cells upon stimulation by 
hormones (such as arginine vasopressin), (see reviews Bredt et al., 1994; Denninger et al., 
1999).  Prostacyclin activates G-protein linked prostacyclin receptors (Wedel et al., 1997) on 
vascular smooth muscle and these receptors stimulate adenylate cyclase to produce cAMP 
which in turn activates PKA (Cheng et al., 2002; McAdam et al., 1999). There are identified 
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sites (on the intracellular loop) for the regulation of PKA phosphorylation of NCX (see 
review Blaustein et al., 1999), along with some conflicting reports regarding the modulation 
of NCX by cAMP/PKA pathway, e.g. the up-regulatory effect (He et al., 1998; Perchenet et 
al., 2000; Yamanaka et al., 2003), and down-regulatory effect (Mene et al., 1993). However 
in the present study the adenylate cyclase inhibitor: SQ 22536 (Lo et al., 2005) did not affect 
low Na+ vasoconstriction in endothelium intact rat aorta. Prostacyclin is synthesized from 
membrane phospholipids by the action of PLA2 to release arachidonic acid which is 
converted to prostacyclin by the sequential action of cyclooxygenase and prostacyclin 
synthase (Hanoune et al., 1997; Smith, 1992). Indomethacin (Molin et al., 2004) blocks both 
isoforms of COX (COX1, COX2) (Perez-Vizcaino et al., 1999; Vane et al., 1987) and in the 
present study had no effect on low Na+ constriction in endothelium intact rat aorta. These 
results rule out the involvement of prostacyclin in endothelial modulation of low Na+ 
vasoconstriction.  
The most prominent endothelium-dependent vasodilator is nitric oxide which is formed by 
nitric oxide synthase and released by the vascular endothelium to activate soluble guanylate 
cyclase in the vascular smooth muscle (Bredt et al., 1994; Denninger et al., 1999).  The 
synthesis and release of nitric oxide from endothelium is due to activation of nitric oxide 
synthase after being stimulated by a rise in intracellular calcium (Binko et al., 1998; Molin et 
al., 2004). In the present study two sets of results confirmed that this mediator was in fact 
involved in the diminished low Na+-induced vasoconstriction when the endothelium was 
present.  Firstly, ODQ, a soluble guanylate cyclase inhibitor (Shelkovnikov et al., 2004), 
potentiated the low-Na+ induced constriction in aortas with intact endothelium to a level 
similar to that observed in endothelium denuded rat aorta. In the absence of endothelium the 
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low Na+ constriction was not affected by ODQ.  This indicates that soluble guanylate cyclase 
was involved in the response and suggests that NO release was involved. This was confirmed 
when the nitric oxide synthase inhibitor L-NAME also enhanced the low-Na+ induced 
constriction in aortas with intact endothelium. To my knowledge this is the first report of 
nitric oxide inhibition of NCX mediated vasoconstriction. 
There are several mechanisms whereby this could occur.  The first is that NCX may be 
present in vascular endothelium.  Indeed this has been shown in a variety of endothelial cells 
(refer to 1.4.8.2). Therefore, lowering Na+ may release nitric oxide from the endothelium as 
inflow of Ca2+ has been shown to increase nitric oxide production and release in endothelial 
cells, such as in rat aortic endothelial cells (Ogura et al., 2004; Schneider et al., 2002a), in 
porcine aortic endothelial cells (Teubl et al., 1999), in cardiac microvascular endothelial 
cells (Kaye et al., 1999), in rat intestinal microvasculature endothelial cells (Zani et al., 
2005), in human pulmonary arterial endothelial cells (Mizuno et al., 2002) and in pig 
coronary arterial endothelial cells (Szewczyk et al., 2007). Indeed, NCX appears involved in 
this response as the NO release due to intracellular Na+ loading is blocked by KB-R7943 
(Schneider et al., 2002a). Thus low Na+ constriction may be inhibited by the concomitant 
NO release. 
The other possibility that could occur is simply that the normal basal physiological release of 
nitric oxide from the endothelium could inhibit NCX operation.  It is well established that 
there is a basal release of nitric oxide from the endothelium (see reviews Bredt et al., 1994; 
Li et al., 2000; Maxwell, 2002). The question is whether NO could somehow antagonize low 
Na+ constriction. To test this hypothesis, the endothelium was removed and nitric oxide 
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added to the system in the form of sodium nitroprusside. In these experiments the ability to 
relax endothelium denuded rat aortic rings was compared after preconstriction by a variety of 
means: U46619 a thromboxane A2 mimetic which operates through the phospholipase C/ IP3 
signaling pathway (Streefkerk et al., 2002), high K+ which depolarized smooth muscle and 
opens voltage dependent Ca2+ channels (Mendizabal et al., 2000; O'Donnell et al., 1987) as 
well as the low Na+ vasoconstriction via the NCX mechanism.  Each constrictor mechanism 
produced an equivalent constriction, however SNP produced a more marked vasorelaxation 
in the low Na+ induced constriction than with the other agents.  This observation is unique 
and has several important consequences.  It suggests that NCX operation is uniquely 
sensitive to NO or that NCX downstream vasoconstrictor mechanism is different to the other 
methods. If this latter case is true then there must be some spatial separation in the signaling 
since all means of vasoconstriction work through an elevation in intracellular Ca2+. High K+ 
might inhibit EDHF and contribute to the reduced extent of vasodilation of SNP. However, 
the intracellular IP3 mediated process (U46619) gave the same results as the Ca2+ channel 
opening mechanism (high K+). The most likely explanation is that NCX is tightly controlled 
by NO pathways compared to the other mechanisms, which is consistent with other reports 
(Amoroso et al., 2000; Asano et al., 1995; Azatian et al., 1998; Nagano et al., 2005). 
The question arises how this could occur? As introduced in 1.4.7.2, NCX can be regulated by 
direct phosphorylation. NCX was shown to be augmented by cGMP in nonvascular smooth 
muscle cells, such as in cultured rat astrocytes and neuronal preparations (Asano et al., 
1995), in guinea-pig ventricular myocytes (Hinde et al., 1999), and in squid axons and heart 
cells (Caroni et al., 1983; DiPolo et al., 1987b). In rat aorta, cGMP was also shown to 
augment the activity of NCX, e.g. in cultured rat aortic vascular smooth muscle cell 
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(Furukawa et al., 1991). A similar result (Iwamoto et al., 1995) demonstrated that cGMP 
activates the activity of NCX through the PKC-dependent protein phosphorylation in 
quiescent and growth factor-stimulated cultured rat aortic vascular smooth muscle cells. 
These results suggest that an enhanced cGMP mediated phosphorylation of NCX can not 
account for SNP inhibition of the NCX constriction, as it has a stimulating instead of 
inhibiting effect and leading to a constriction not relaxation. Therefore another explanation 
must be found. 
NCX can be modulated indirectly through Na+/K+ ATPase.  Both Na+ pump and NCX 
localize to plasma membrane overlying junctional SR in smooth muscle cells, refer to 1.4.8.1 
and see review (Blaustein et al., 1999). This noteworthy colocalization discloses some clue 
of the interaction of these two plasma membrane transporters (Juhaszova et al., 1996)(Pittner 
et al., 2006). As introduced early in chapter 1.4.5, 2.4 and further in chapter 4.4, NCX-
mediated Ca2+ influx can be increased by an enhanced Na+ gradient through Na+/K+ ATPase 
inhibition or extracellular Na+ removal. cGMP through PKG can stimulate Na+/K+ ATPase 
(Eva et al., 2006; Tagaya et al., 2001). Thereby the Na+ gradient is decreased, and the 
forward mode of NCX is activated to extrude Ca2+ and decrease the intracellular Ca2+ level. 
The process is shown in Figure 3.18 (Nishimura, 2006). Our hypothesis is corroborated by 
the result in mouse aorta stating that Na+/K+ ATPase inhibits endothelium-dependent 
relaxation by activating NCX (Kim et al., 2005). 
Taking this result back to the present study where the endothelium effectively dampened low 
Na+ vasoconstriction, an important component could be an effect of the NO indirectly via 
Na+/K+ ATPase. This implies a tonic role for NO on the Na+/K+ ATPase inhibiting NCX 
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operations. 
An alternative explanation is that the endothelium effectively dampened low Na+ 
vasoconstriction through decreasing the sensitivity of the contractile process to Ca2+. As 
discussed earlier in this chapter 3.1.2.5, cGMP can reduce the Ca2+ sensitivity, and therefore, 
the subsequent vasoconstriction induced by NCX would be decreased (See reviews 
Nishimura, 2006; Nishimura et al., 1989)(Somlyo et al., 2003). 
Since both ODQ and NAME amplified the effect of low Na+ vasoconstriction to the same 
extent as endothelium removal in the present study, it suggests that NO is the sole 
endothelial modulator of NCX operations and that EDHF is not involved.  
Our result is supported by (Teubl et al., 1999) demonstrating that membrane depolarization 
did not play a role in the activation of eNOS. This is also consistent with the knowledge that 
EDHF-induced vasodilatation is not as prominent in aorta as in microvessels, its importance 
increases with decreasing diameter of vessels (Fukuta et al., 1997; Ogura et al., 2004). 
3.4.1 Conclusion 
Our results suggest that endothelium modulates the NCX operation via the guanylate 
cyclase, not the adenylate cyclase system; the release of nitric oxide, not prostacyclin is 
involved.  Thus NCX may be another mechanism by which the endothelium-derived nitric 
oxide modulates contractility in vascular smooth muscle. 
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Figure 3.18 Model for the activation of NCX by the cGMP through Na+/K+ ATPase 
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CHAPTER 4 THE ROLE OF Na+/Ca2+ EXCHANGER ON MYOGENIC RESPONSE 
IN MICROVESSEL 
4.1 INTRODUCTION 
4.1.1 Definition of myogenic response 
The phenomena of myogenic response were first observed by Bayliss in 1902 (Bayliss, 
1902). Myogenic response refers to the acute reaction of a blood vessel wall in response to 
transmural pressure changing. Generally speaking, vessels constrict in response to increased 
intraluminal pressure and dilate in response to decreased intraluminal pressure (see review 
Meininger et al., 1992).  
4.1.2 Features of myogenic response 
One of the main features of myogenic response (or myogenic tone, basal tone, or 
spontaneous tone, or intrinsic tone), is that it is inherent, and independent of external neural, 
metabolic, and hormonal influences. It is noted that endothelial cells are not required for 
normal myogenic response (see review Davis et al., 1999). A typical myogenic response is 
shown in Figure 4.1. 
The strength and importance of the myogenic response is inversely related to the diameter of 
vessel (see review Davis et al., 1999). In general, small vessels possess a relatively stronger 
myogenic response compared to large vessels. Furthermore, in different vascular beds, the 
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strength of the myogenic response is different. For example, myogenic response in rat small 
mesenteric vessels was smaller than that in a similar sized cerebral (Osol et al., 1991) or  
skeletal muscle vessels (Watanabe et al., 1993). 
The myogenic tone represents a sustained, partial smooth muscle contraction. The 
physiological significance of the mechanism is that it allows the vessel to further 
contract/dilate to maintain an adequate blood perfusion to the tissue. For example in reduced 
pressure conditions, tissue perfusion would be expected to decrease but myogenic relaxation 
compensates for this and maintains perfusion. In raised pressure conditions, tissue perfusion 
would be expected to increase and the myogenic constriction would attenuate this to 
maintain balance.  
4.1.3 Isometric versus isobaric studies 
The most commonly used experimental approaches in the investigation of vascular 
contractions or constrictions are: isometric and isobaric. Under isometric conditions, the 
diameter is held constant. As such, when the smooth muscle contracts, the diameter is kept 
constant and tension in the vessel wall increases. The studies on aortic rings using the organ 
bath techniques in chapter 2 and chapter 3 are good examples of isometric method (Angus et 
al., 2000).  
Under isobaric conditions the equivalent transmural pressure is held constant. This is 
accomplished by sealing the vessel at one end and maintaining a constant internal pressure 
using
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Figure 4.1 The prototypical graph for isobaric constriction 
With in vitro isobaric vessel preparation, the above prototypical graph shows a two-phase 
myogenic response (see review Davis et al., 1999). A step increase produced experimentally 
in intraluminal pressure induces an initial, passive vessel distension, which is followed by 
two phases of constriction: transient and sustained. After releasing the pressure step 
experimentally, the arteriole transiently constricts, and then dilates (Zou et al., 1995). 
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Figure 4.2 The pressure-diameter relationship in both active and passive condition 
Curve A indicates the pressure-diameter relationship in active condition in which vessel 
transiently dilates and then constricts in response to the increment of transmural pressure 
(Zou et al., 1995). This is the myogenic response when Ca2+ is present. Curve B indicates the 
pressure-diameter relationship in passive condition in which vessel progressively dilates in 
response to the increment of transmural pressure until a maximum diameter (passive tone) 
reaches (Zou et al., 1995). This is when Ca2+ is absent and the myogenic response 
eliminated. It represents pressure-induced passive distention (See review Davis et al., 1999). 
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using a gravity pressure head. What is measured in this case is a change in vessel diameter. 
The present study using cremaster arteriole is a typical example of isobaric method (Murphy 
et al., 2002a; Potocnik et al., 2000; Schiffrin et al., 1997).  
4.1.4 Active versus passive condition for the studies of myogenic response 
In comparison to the normal active condition in the presence of external Ca2+ (Figure 4.1), 
passive state refers to the condition in the absence of external Ca2+ in the bath solution. As 
depicted in Figure 4.2, the pressure-diameter relationship in the active condition is different 
from that in the passive condition. Without Ca2+, vessel progressively dilates as the pressure 
increases (see reviews Davis et al., 1999; Hill et al., 2006). This indicates that the influence 
of Ca2+ is fundamental to myogenic tone. 
4.1.5 Regulation of blood flow 
There are three major types of blood vessels: artery, capillary, and vein. Arteries and veins 
act as conduits for blood. Arteries carry blood away from the heart to peripheral tissues, and 
form smaller and smaller branches. As the smallest division of arteries, arterioles feed into 
the capillary beds of tissues. They are often called resistance arteries due to their 
responsibility for a large proportion of peripheral vascular resistance, as small change in 
arteriolar diameter can affect pressure and blood flow (see review Thomas et al., 2004). 
Blood flow into the capillary beds is determined largely by arteriole diameter, which varies 
in response to changing neural stimuli and local chemical influences. The interweaving 
networks of the microscopic capillaries are the place where exchanges between the blood 
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and tissue cells take place. 
The equation below depicts the relationship between blood flow, blood pressure and 
resistance. If the difference in blood pressure increases, blood flow speeds up and vice versa. 
In contrast, if the resistance increases, the blood flow decreases and vice versa. 
Blood flow (F) = difference in blood pressure (ΔP) / peripheral resistance (R) 
There is a rich investigation with respect to the regulation of blood flow, and this is well-
documented in the exercising skeletal muscle. Multiple signaling pathways including 
nervous system, blood-borne metabolites and autacoids feedback system, and myogenic 
response interact to regulate short-term blood flow (see reviews Dora et al., 2005; Segal, 
2005). The long-term control of blood flow (e.g. in hypertensive condition) is beyond the 
scope of present discussion. 
4.1.5.1 The autonomic regulation 
There are rich nerve supplies surrounding the arteries, arterioles and their terminal branches. 
The autonomic regulation of blood flow in skeletal muscle is dominated by sympathetic 
nervous system irrespective of at rest or during exercise. Sympathetic effect is stimulatory 
through the release of norepinephrine in most tissues except the skeletal muscle (Gantt et al., 
1996; Marieb et al., 1998; Shepro et al., 1974). Norepinephrine is a potent agonist of α 
adrenoreceptor and has little effect on β2 adrenoreceptor; therefore it constricts all resistance 
vessels, increases the peripheral vascular resistance and reduces the blood flow (see book 
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Gantt et al., 1996; Marieb et al., 1998; Shepro et al., 1974) and (see review Thomas et al., 
2004). Exceptionally, the sympathetic efferents (vasomotor fibers) in skeletal muscles may 
release acetylcholine instead of norepinephrine to induce vasodilation (Gantt et al., 1996; 
Marieb et al., 1998; Shepro et al., 1974). Furthermore, there is a parallel activation of both 
somatic motor and autonomic nervous system during exercise, the former causes the 
contractions of skeletal muscle which activate the local vasodilator signals and cause the 
relaxation of blood vessel and a local hyperemia (relaxation) (see review Thomas et al., 
2004). At rest, sympathetic vasoconstriction renders the vessel a tonic state; During exercise, 
the sympathetic vasoconstriction is mainly in the proximal arterioles and feed arteries 
maintaining the systemic arterial blood pressure and restricting the functional hyperemia (see 
reviews Segal, 2005; Thomas et al., 2004). Without such protective sympathetic 
vasoconstriction, it would be unable to maintain adequate blood flow to the vital organs 
(such as brain) during strenuous exercise. By contrast, in the distal arterioles, sympathetic 
and local mechanism inducing vasodilation prevail to meet the metabolic needs and facilitate 
the oxygen supplies (see reviews Segal, 2005; Thomas et al., 2004).  
4.1.5.2 Auto regulation 
Autoregulation refers to the automatic adjustment of blood flow to each tissue in proportion 
to its requirements at any point in time. Organs regulate their own blood flow by varying the 
resistance of their arterioles, which is accomplished by modifying the diameter of local 
arterioles feeding the capillaries. It has been proposed that auto regulation is achieved 
through several mechanisms: metabolic control and myogenic control (see review Schubert 
et al., 1999) and (Gantt et al., 1996; Marieb et al., 1998; Shepro et al., 1974).  
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The metabolic control is based on the balance between the oxygen delivery and metabolic 
demand of the tissue. For example, during exercise the reduced oxygen, pH, increased CO2 
and lactate are the common metabolic stimuli which can cause the immediate vasodilation of 
the arteriole so the blood flow to local area increases. The possible local vasodilators for 
metabolic control include: adenosine, NO, prostacyclin and endothelial-derived 
hyperpolarization factor (EDHF) (see reviews Boushel, 2003; Ito et al., 1995). Other 
chemicals that are also involved in the short-term control of blood flow include the atrial 
natriuretic peptide (ANP), angiotensin II, antidiuretic hormone (ADH), they can be produced 
by the atria of heart, kidneys, and hypothalamus respectively in response to the inadequate 
tissue perfusion (Gantt et al., 1996; Marieb et al., 1998; Shepro et al., 1974). Apart from the 
above mentioned chemicals, some inflammatory substances such as histamine and kinins are 
involved as well. 
Myogenic control is discussed further in 4.1.6. 
4.1.6 Physiological significance of myogenic response 
It is well defined that the stimulus for myogenic response is vessel wall tension (Schubert et 
al., 1999). Large conduit vessels cannot change their diameter substantially to offset the 
alteration in hemodynamic forces. In contrast, small arteries respond directly to increased 
intravascular pressure with increased tone (see Figure 4.1), to resist the stretch. Decreased 
intravascular pressure in small arteries, on the other hand, induces vasodilation and 
enhancement of blood flow to the tissue. The myogenic control relies exclusively on smooth 
muscle cells in the vessel wall, not nerves, endothelium or any other factors (refer to 4.1.2). 
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This myogenic control keeps the blood supply to tissues fairly constant in spite of variations 
in systemic pressure (see review Dora et al., 2005). Although the exact mechanism is still 
unknown, the myogenic response of small arteries and arterioles has been shown to be 
critically important in the auto regulation of local blood flow, the setting of basal peripheral 
vascular resistance, and the regulation of capillary hydrostatic pressure (see reviews Davis et 
al., 1999; Hill et al., 2001). Owing to the specific impact of myogenic response on vascular 
smooth muscle cell, it has fueled interest in its implication in pathological conditions, such as 
hypertension and diabetic vascular complications (see reviews Izzard et al., 2005; Paulson et 
al., 1990; Wiernsperger, 2001). 
4.1.7 Cellular mechanism underlying myogenic response 
All cells live in a changeable environment where they are subject to physical forces, such as 
pressure, shear-stress, flow, stretch, and compression. As we know, myogenic response is the 
ability of vessel wall to adjust its diameter in response to the change of wall tension. This 
occurs by a variety of signalling processes. The cascade of signaling processes may starts on 
the extracellular matrix, and then is transmitted to cell surface triggering ion channel events 
and the ensuing membrane depolarization (Hill et al., 2006; Potocnik et al., 2004). The first 
step or requirement is that the change of wall tension needs to be sensed or detected by the 
vessel (mechanosensitivity) which is followed by the conversion of sensing signal into 
cellular signal (mechanotransduction) (see review Schubert et al., 1999). There exist several 
hypotheses about the sensor element which detects the stimulus of pressure alteration, 
coupled to calcium mobilization, and ultimately initiates the myogenic response (see reviews 
Davis et al., 2001; Koller, 2002).  
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Evidence suggests that stretch-activated channels (SACs) on vascular smooth muscle or 
endothelium play a important role in the mechanosensitivity and mechanotransduction (see 
reviews Kalapesi et al., 2005; Meininger et al., 1992). The characterized non-selective cation 
stretch-activated channels (NSCCs), with a relative permeability of K+ ≥ Na+ > Ca2+ (see 
reviews Davis et al., 1992; Kalapesi et al., 2005), are reported to be the likely candidates 
(see reviews Albert et al., 2002b; Davis et al., 1992; Hill et al., 2001; Kirber et al., 1988; 
Meininger et al., 1992), as reported for guinea-pig urinary bladder myocytes (Wellner et al., 
1994), vascular smooth muscle cells dissociated from toad stomach (Kirber et al., 1988), 
dispersed vascular smooth muscle cells from porcine coronary artery (Davis et al., 1992), 
and guinea-pig mesenteric arterial cells (Setoguchi et al., 1997). It is assumed that inward 
current flowing through stretch-activated channels would depolarize the cell membrane, and 
activate VGCC (Wellner et al., 1994) (see also review Hill et al., 2006).  
Apart from the ionic channels aforementioned, there are other potential mechanosensors 
reported. Membrane-bound enzymes including phospholipase A2, phospholipase C, and 
tyrosine kinases were reported to be involved in mechanosensitivity (see review Kalapesi et 
al., 2005), and cytoskeletal proteins such as actin and intermediate filaments, by virtue of 
their support to cell membrane and the linkage to extracellular matrix, are viewed as  
potential mechanosensors (see review Kalapesi et al., 2005). 
Integrins, refer to a family of membrane-spanning glycoproteins. There is a growing 
evidence showing that they may be important elements in the mechanosensitivity and 
mechanotransduction of myogenic response, due to their linkage to both extracellular matrix 
and cytoskeleton inside vascular smooth muscle cell and their ability to initiate cellular 
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responses to stretch (see reviews Davis et al., 2001; Kalapesi et al., 2005). For example, an 
integrin-specific peptide was shown to directly inhibit the myogenic tone in injured rat 
cremaster arteriole (Mogford et al., 1996).  
The generation of myogenic constriction: 
There is consensus that sustained increase of intracellular calcium level is necessary for the 
occurrence and maintenance of myogenic response once it is initiated. As described in 
chapter 1, multiple mechanisms contribute to the calcium homeostasis, such as voltage-
operated calcium channels, store-operated calcium channels, calcium pump, and the 
Na+/Ca2+ exchanger (refer to 1.1). 
According to the prevailing thought, myogenic contraction is initiated by the depolarization 
of vascular smooth muscle cell which then allows Ca2+ entry through voltage-operated 
calcium channel (Davis et al., 1999) This is buttressed by solid evidence (Brayden et al., 
1992; Harder, 1984; Knot et al., 1995; Kotecha et al., 2005; Potocnik et al., 2000),  which 
indicate that the pressure-induced electrical signaling mediated Ca2+ influx. Furthermore, 
blockers of L-type voltage-operated Ca2+ channels, including nifedipine, verapamil and 
nicardipine, have been shown to greatly reduce myogenic responses (Knot et al., 1995; 
Potocnik et al., 2000; Wesselman et al., 1996). But there may be other mechanisms involved. 
Interestingly, the contribution of IP3 and subsequent calcium release from intracellular stores 
during myogenic responses has attracted strong attention (Nakayama, 1982; Nakayama et al., 
1986). Some authors argue that repetitive SR Ca2+ release might be linked with the 
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aforementioned ionic event (L-type voltage-operated Ca2+ channels) contributing to the 
initial Ca2+ rise in myogenic response, or even predominating over in some cases (Lee et al., 
2001; Meininger et al., 1992; Zhang et al., 2002). 
As introduced in 1.1.4, the modulation of vasoconstriction can result from changing Ca2+ 
sensitivity. Likewise, the mechanism of myogenic constriction could involve Ca2+ 
sensitivity. Decreased Ca2+ sensitivity via the inhibition of Rho kinase resulting in decreased 
myogenic tone has been reported in rat cerebral artery (Lagaud et al., 2002)(Jarajapu et al., 
2005), in porcine coronary artery (Randriamboavonjy et al., 2003), in rat ophthalmic artery 
(Ito et al., 2007), and in rat basilar artery (Ahn et al., 2007). However, there was a 
controversy over the contribution of protein kinase C pathway, another factor affecting Ca2+ 
sensitivity to myogenic response. It was reported to play a minimal role in the myogenic 
response in rat ophthalmic artery (Ito et al., 2007), in rat cerebral artery (Jarajapu et al., 
2005) and in small porcine coronary artery (Randriamboavonjy et al., 2003). In contrast, it 
was shown to play a role in the myogenic response in rabbit facial vein (Laher et al., 1989), 
in rat cerebral artery (Lagaud et al., 2002), and in rat cremaster arteriole (Bakker et al., 1999; 
Hill et al., 1990a). 
Ultimately, the increase of the intracellular calcium concentration and Ca2+ sensitivity finally 
activates myosin light chain kinase, which phosphorylates the 20-kDa regulatory myosin 
light chain leading to smooth muscle constriction (1.2.2). 
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4.1.8 Aims of the current study 
Collectively, with the limitations in experimental techniques and major deficiencies in our 
knowledge of myogenic signaling pathways, the true cellular mechanism underlying 
myogenic response remains to be unequivocally established. There are other calcium 
regulators apart from ion channels that contribute to the calcium homeostasis in vascular 
smooth muscle cell as discussed in the previous chapter (1.1). NCX has a central role in 
regulating calcium levels through forward mode and/or reverse mode. Its contribution in 
myogenic response needs to be intensively investigated. 
4.1.8.1 Choice of cremaster arterioles for the present study 
Recognizing the regional and longitudinal differences in reactivity in the peripheral 
vasculature, in particular, that a large proportion of the total vascular resistance resides in 
microvessels (Henrion, 2005; Thomas et al., 2004), the current study  progressed from 
macrovessels into microvessels. In particular, the myogenic response is more pronounced in 
microvessel than macrovessel, microvessel is the most appropriate tissue to study. 
Due to the complicated interactions among parenchymal cells, vascular smooth muscle cells, 
endothelial cells, and the autonomic nerves in vivo, effort has been made to develop in vitro 
preparations to simplify the study of myogenic response of vascular smooth muscle. Among 
a variety of in vitro preparations, cremaster muscle microvessels have been extensively used 
since the early report of (Grant, 1964) as a classical model for the study of skeletal muscle 
microvascular hemodynamics and reactivity. Apart from the studies with cremaster muscle 
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arterioles in other laboratories, Hill et al developed a successful method for the dissection, 
cannulation, tone development, and Ca2+ fluorescent imaging of cremaster muscle arterioles 
in our laboratory in the past studies, and collected much data of cremaster muscle arterioles 
which were shown in previous publications in our laboratory (Kotecha et al., 2005; Murphy 
et al., 2002a; Murphy et al., 2002b; Potocnik et al., 2004; Potocnik et al., 2001; Potocnik et 
al., 2000). Hence, cremaster muscle arteriole is a ready model for the current study. 
4.1.8.2 The hypothesis of the present study 
In the previous chapters (chapter 2 and chapter 3), it was demonstrated that decreasing 
extracellular Na+ leads to Ca2+ entry in rat aorta, indicating pharmacological functionality of 
NCX in arterial smooth muscle, this is consistent with other reports in many laboratories 
(Bova et al., 1990; Kim et al., 1999; Reuter et al., 1973). However, the investigation of NCX 
on vascular smooth muscle cell is mainly conducted in large vessels, much less evidence is 
available for small resistance vessels (see review Sheu, 1986). It has been reported that 
myogenic response is entirely dependent upon extracellular calcium (Duling et al., 1981; 
Meininger et al., 1991; Uchida et al., 1969; Zou et al., 1995; Zou et al., 2000), and the 
development of the myogenic response probably involves multiple Ca2+ mediated 
mechanisms (Hill et al., 2001).  As one such mechanism, NCX may play a role in the 
modulation of myogenic response either in participating in Ca2+ entry or by removing 
intracellular Ca2+ (see reviews Blaustein, 1989; Blaustein et al., 1999; Reuter et al., 1973).   
It is unclear from data at present how important NCX activity is for construiction in 
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microvessels and that was one of the goals of the study. Therefore the goals of the present 
study in chapter 4 were to examine (1) whether withdrawal extracellular Na+ mediates Ca2+ 
entry and constriction in rat cremaster arterioles, (2) whether NCX is involved in the 
modulation of arteriolar tone and myogenic constriction. Experiments were conducted using 
manipulation of extracellular Na+ as well as two inhibitors of NCX: KB-R7943 (Satoh et al., 
2000) and SEA0400 (Takahashi et al., 2003).   
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4.2 METHODS 
4.2.1 Animals 
The present study used male Sprague-Dawley rats, aged 6-9 weeks weighing 200-350 gram. 
Before experiments, rats were housed in a dedicated animal facility with a 12:12 h light-dark 
cycle. During this period, rats were allowed free access to a standard rat chow and drinking 
water. All procedures were approved by the RMIT Animal Ethics Committee. 
4.2.2 Isolation of arteriole preparation 
The current applied method comprises optical instruments, fabrication procedures, and 
dissection methodology as described previously (Angus et al., 2000).  
Rats were anaesthetized (100mg kg−1 Pentothal, Abbott Australasia), and the right or left 
cremaster muscle was exteriorized, excised from the animal and placed in a temperature-
controlled chamber (4°C) containing dissection buffer (see 4.2.3) (Duling et al., 1981). The 
dissection was carried out at 4°C, to avoid tissue spasm and vessels becoming unresponsive. 
Segments of the main intramuscular arteriole (1A) (Hill et al., 1990b) were dissected under a 
microscope as previously described (Meininger et al., 1991). The cremaster muscle has 
relatively long unbranched lengths of arterioles making it easy to cut the desirable length of 
single vessel for the present study. Isolated arterioles were then cannulated at both ends with 
glass micropipettes (filled with physiological salt solution), secured using 10-0 
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monofilament suture and mounted in a 5 ml volume tissue chamber. The vessel preparation 
was positioned on the stage of an inverted microscope (Olympus) and the arterioles 
continuously superfused (2-4 ml min-1) with a physiological salt solution (PSS) (see 4.2.3). 
Arteriole segments were gradually pressurized from 50mmHg to 60mmHg, and then to 70 
mmHg, and warmed to 33°C-34°C during a 60-min equilibration period. Arteriole with 
significant leaks or branches was discarded; this was tested by closing a stopcock 
disconnecting to the perfusion pipette without any diameter decrease during a 30-second leak 
test period (Duling et al., 1981). Only vessels that exhibited stable spontaneous basal tone 
(gradually developed tone, around 60% of the initial diameter after 60-min equilibration 
period) were studied further under isobaric conditions (Figure 4.3). In order to result in 
optimal myogenic responsiveness, before the development of spontaneous tone, the vessel 
length was adjusted by increasing segment length such that pressure steps to 120 mmHg did 
not cause a lateral bowing of the vessel. Diameter of the arterioles was measured with a 
video camera and displayed on a monitor screen (Angus et al., 2000). Data was recorded and 
stored using a MacLab A-D system. 
To exclude the possible vasorelaxing influence of the endothelium via release of vasodilator 
autacoids (e.g., nitric oxide and prostacyclin) on myogenic constriction of smooth muscle 
cells, the current study was conducted on endothelium denuded arterioles. Meininger and 
Davis criticized the chemical denudation methods (using chemicals e.g. nonionic detergent 
to disrupt endothelium) for its vascular smooth muscle cell damage effect (Meininger et al., 
1992). In order to avoid the possible tissue damage arising from chemical denudation 
method, in the present study air was passed through the lumen to remove the endothelium 
mechanically. 
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4.2.3 Preparation of buffers  
4.2.3.1 Dissection Buffer:  
Composition (in mM): 3-N-morpholino propanesulphonic acid (MOPS) 3; NaCl 145; KCl 5; 
CaCl2  2.5; MgSO4 1; NaH2PO4 1; EDTA 0.02; pyruvate 2; glucose 5 and 1% albumin. 
The pH of dissection buffer was adjusted with 1 N NaOH at room temperature to 7.4, which 
will make the final pH 7.35 ~ 7.4 when chilled to 4°C. 
4.2.3.2 Physiological salt solution (PSS):  
Composition (in mM): NaCl 111, NaHCO3 25.7, KCl 4.9, CaCl2 2.5, MgSO4 1.2, KH2PO4 
1.2, glucose 11.5 and 2-N-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) 10. 
The pH of PSS was adjusted with 1 N NaOH at room temperature to 7.27, which will make 
the final pH 7.4 when warmed to 33°C ~ 34°C. Before the experiment, the PSS was bubbled 
with 95% O2 and 5% CO2 for 1 hour. 
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Figure 4.3 Cremaster arteriole before (A) and after (B) tone development 
The same arteriole was shown for A (before tone development) and B (after tone 
development). Arteriole was gradually pressurized from 50mmHg (20 minutes) to 60mmHg 
(20 minutes), and then to 70mmHg (20 minutes), and warmed to 33°C ~ 34°C during a 60-
min equilibration period. Only vessels that exhibited gradually developed stable spontaneous 
basal tone (B) which was around 60% of the initial diameter (A) were used. Initial internal 
diameter for cremaster muscle arteriole ranged from 150 ~ 250 μm (Angus et al., 2000). 
 
 A                           B
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4.2.4 Fluorescent Ca2+ indicators 
Calcium-sensitive indicators have proven to be very useful in monitoring the changes of 
calcium during smooth muscle contraction. This has stirred an interest in searching for 
specific indicators of calcium. 
A BAPTA derivative: quin2, was synthesized and tested as a fluorescent Ca2+ indicator 
(Morgan et al., 1982; Tsien, 1980). The excitation wavelength (339 nm) of quin2 is so short 
that it needs to overcome cell autofluorescence. Thereby, the second generation of indicators 
including fura-2 and indo-1 were developed (DeFeo et al., 1987; Grynkiewicz et al., 1985; 
Smith et al., 1987; Takeuchi et al., 1989). In spite of the acknowledged advantage of 30-fold 
brighter fluorescence than quin2, these indicators are not membrane-permeable. To increase 
permeability, an acetoxymethyl radical is attached to these indicators. After loading smooth 
muscle cells with the acetoxymethyl esters of these indicators, the acetoxymethyl moiety is 
cleaved by endogenous esterases and the indicator is trapped in the cell. Therefore, fura 2-
acetoxy methylester (fura 2-AM) instead of fura-2 is used as Ca2+ indicator (DeFeo et al., 
1987; Goldman et al., 1994; Smith et al., 1987; Takeuchi et al., 1989).  
The present study used the hydrolysis of the membrane-permeant acetoxymethyl ester of 
fura-2 for calcium imaging (Meininger et al., 1991; Paltauf-Doburzynska et al., 2000; 
Pritchard et al., 1986; Yamanaka et al., 2003). 
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4.2.5 Imaging of Ca2+ 
To measure the changes in [Ca2+]i, vessels were loaded (60 min, room temperature) with the 
calcium indicator: 2 μM fura 2-AM (Molecular Probes, Eugene, U.S.A.) in PSS containing 
0.2% DMSO and 0.01% pluronic acid (Molecular Probes, Eugene, U.S.A.) (Goldman et al., 
1994; Paltauf-Doburzynska et al., 2000; Yamanaka et al., 2003). During the 60-min 
incubation time, sample illumination was prevented, with no direct light exposure and the 
aluminum foil covering the monitor. After loading, the vessels regained the spontaneous tone 
during 30-min wash period. Digital imaging of Ca2+ indicator fluorescence in arterioles at 
excitation wavelengths of 340, and 380 nm were performed using a spinning filter wheel 
operating at 20Hz with emisiion detection at 510 nm. Simultaneous transillumination with 
wavelengths greater than 610 nm provided a non-fluorescent image which enabled 
measurement of internal arteriolar diameter while fluorescence intensities were measured. A 
beam splitter directed the high wavelength image to a charge-coupled device (CCD) camera. 
This procedure did not interfere with measurements of Ca2+-related fluorescence. 
Fluorescent image intensities were expressed as the 340:380 nm ratio to allow quantitative 
estimates of changes in arteriolar wall [Ca2+]i. Details of these procedures have been 
presented in previous publications (Potocnik et al., 2000; Zou et al., 1995).   
4.2.6 Drugs and materials 
KB-R7943 2-2-[4-(4-nitrobenzyloxy) phenyl] ethyl isothiourea methanesulphonate), from 
TOCRIS (Ellisville, USA), was made as a 10 mM stock solution in DMSO, and further 
diluted in PSS prior to use. SEA0400: 2-[4-[(2,5-difluorophenyl) methoxy] phenoxy]-5-
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ethoxyaniline, (Taisho Pharmaceutical Co., Ltd, Japan), was dissolved in DMSO at 10 mM 
as a stock solution and diluted before using. The final concentration of vehicle was no more 
than 0.1% (volume/volume). Buffer salts and chemicals were obtained from Sigma (St 
Louis, USA) unless otherwise stated, include: NaCl, NaHCO3, KCl, KH2PO4, MgSO4⋅7H2O, 
D-(+)Glucose, CaCl2⋅2H2O, EGTA, HEPES, Choline Chloride.  
4.2.7 Statistical analysis 
Data are expressed as mean ± standard error of the mean, and were considered different 
when P<0.05.  Statistical tests were performed using GbStat package (version 7.0, Dynamic 
Microsystems, Inc., Silver Spring, MD, USA). 
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4.3 RESULTS 
4.3.1 Relationship of pressure and calcium level 
This is one of the standard preliminary experiments to show the technique works and 
demonstrate some basic features of myogenic response. To define the relationship between 
intraluminal pressure and intracellular calcium concentration in isolated cremaster muscle 
arterioles exhibiting myogenic tone, step-wise increase of pressure was conducted. Steady-
state [Ca2+]i, as measured by the 340/380 nm fluorescence ratio (R340/380), was found to 
increase with increasing intraluminal pressure from 30, 50, 70 to 120 mmHg consecutively 
(Figure 4.4). Similar results have been published in previous studies (Potocnik et al., 2004; 
Potocnik et al., 2001; Potocnik et al., 2000; Spurrell et al., 2003; Spurrell et al., 2000; Zou et 
al., 1995). Time control experiments were conducted in the previous studies in our 
laboratory (Potocnik et al., 2000; Spurrell et al., 2000; Zou et al., 1995), data showed that 
the pressure- induced change in calcium level is not a function of time. 
4.3.2 Pressure-diameter relationships under passive conditions 
This set of standard preliminary experiments was to show the pressure-diameter relationship 
under passive conditions, in which arterioles were superfused with PSS containing 2 mM 
EGTA and 0 Ca2+. The cremaster muscle arterioles responded passively to increasing 
intraluminal pressure in the absence of Ca2+ (please refer to 4.1.4 and Figure 4.2). 
Additionally, to decide whether vessel diameter was affected by the incubation of fluorescent 
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dye: fura 2-AM (2 μM), fura 2 loaded arteriolar diameter responses to increasing 
intraluminal pressure from 30, 50, 70 to 120 mmHg were measured in the absence of 
extracellular Ca2+. No measurable difference in the vessel diameters in the absence and 
presence of fura 2-AM loading was detected (Figure 4.5).  
4.3.3 Na+ lowering experiment 
In order to identify the functional presence of NCX, we examined the arteriolar response to 
lowering extracellular Na+.  This was explored in cremaster muscle arterioles by removing 
[Na+]o abruptly.  The extracellular Na+ was reduced stepwise from 137 to 75 and then 25 
mM.  The Na+ was replaced with choline to maintain osmolarity.  Reducing extracellular Na+ 
resulted in a graded decrease in arteriolar diameter with a maximal reduction of 83.9 ± 5.0% 
at 25 mM Na+ (Figure 4.6).  When the NCX inhibitors KB-R7943 (1 μM) and SEA0400 (1 
μM) were present, they did not affect arteriolar diameter at 137 mM Na+, but at 25 mM Na+ 
they significantly increased arteriolar diameter (Figure 4.6) indicating that the 
vasoconstriction at 25 mM Na+ was inhibited by NCX inhibitors.  
4.3.4 The effect of NCX on myogenic response 
To further study the physiological effect of NCX in cremaster arterioles, we tested the role of 
NCX in the myogenic response.  
Myogenic responses were induced by an intra-lumen pressure increase from 70 mmHg to 
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120 mmHg. The diameter was significantly decreased to 88.3 ± 2.4% of initial (n=5, 
Student’s t-test, P<0.05).  The pressure-induced constriction was prevented by NCX 
inhibitor: 1 μM SEA0400 (Fig. 4.7), indicating that NCX was involved. In fact the pressure 
increment resulted in vasodilatation (Fig. 4.7). 
Simultaneously, we observed the digital fluorescence video imaging of arterial wall [Ca2+] 
change (Figure 4.8). In fura 2-AM loaded arterioles the increases in lumen pressure from 70 
mmHg to 120 mmHg was accompanied by a rise in intracellular [Ca2+] to 115.8 ± 3.3% of 
initial (n=5, Student’s t-test, P<0.05), and this rise was attenuated by SEA0400 (1 μM) to 
106.8 ± 2.0% of initial (n=5, Student’s t-test, P<0.05). 
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Figure 4.4 The effect of intraluminal pressure on [Ca2+]i  levels expressed as the 340/380 
nm fluorescent ratio (R340/380) in rat cremaster arterioles  
Steady-state Ca2+ value were obtained within a 5-min period. Ca2+ ratio (R340/380) was 
expressed as a percentage of the control (basal diameter at 70 mmHg). The number of 
experiments equaled 8 arterioles in each group (n=8). Mean and s.e. mean are shown in the 
columns. * represents a significant difference from the 70 mmHg (P < 0.05, one-way 
analysis of variance followed by Dunnett’s test). 
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Figure 4.5 Pressure-diameter relationships obtained under passive (0 mM Ca2+ - 2 mM 
EGTA superfusate) conditions in rat cremaster arterioles 
Data were shown for fura and nonfura rat cremaster arterioles. Diameter was presented as a 
percentage of respective diameter at 70 mmHg (control). The number of experiments ranged 
from 4 to 8 arterioles in each group. Mean and s.e. mean are shown in the columns. There 
were no significant differences between groups: fura 2 loaded and non-fura 2 loaded 
arterioles (P>0.05, Student’s t-test). 
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Figure 4.6 The effect of lowering extracellular Na+ on vessel diameter in rat cremaster 
arterioles 
The isolated arterioles were pressurized to 70 mmHg and myogenic tone allowed to develop 
during a 60- min equilibration period.  Subsequently the extracellular Na+ was reduced from 
137 mM to 75 and then 25 mM by replacing the physiological salt solution until a new 
baseline diameter reached. Diameter was presented as a percentage of respective control at 
normal [Na+] (137 mM) before the addition of either vehicle (DMSO 0.1%, n=6) or KB-
R7943 (1 μM, n=5) or SEA0400 (1 μM, n=5). Each point represents mean and s.e. mean. 
The number of experiments ranged from 5 to 6 arterioles in each group. * represents a 
significant difference at the 25 mM [Na+] between vehicle and SEA0400 (P<0.05, Student’s 
t-test), and between vehicle and KB-R7943 (P<0.05, post hoc bonferroni test after two way 
analysis of variance).  
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Figure 4.7 The effect of SEA0400 on myogenic response in rat cremaster arterioles  
The intraluminal pressure was stepwisely increased from 70 mmHg to 120 mmHg to induce 
myogenic response in the presence of either vehicle (DMSO, 0.1%, n=5) or SEA0400 
(SEA0400, 1 μM, n=5). Diameter was expressed as a percentage of respective control at 70 
mmHg (5 mins. after pressure changing). Each point represents means and s.e. means. The 
number of experiments equalled 5 arterioles in each group. * signifies a significant 
difference between 70 and 120 (P <0.05, paired t-test).  
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Figure 4.8 The effect of SEA0400 on calcium level in rat cremaster arterioles 
Isolated single vessels were loaded with acetoxymethyl ester form of fura-2 (2 μM, 60min, at 
room temperature). Ca2+ ratio (R340/380) was expressed as a percentage of the respective 
control at 70 mmHg. In each experiment, either vehicle (DMSO, 0.1%) or SEA0400 (1 μM) 
was present. Each point represents means and s.e. means. The number of experiments 
equalled 5 arterioles in each group. * signifies a significant change of Ca2+ ratio after 
pressure increase (P<0.05, paired t-test). # represents significant differences between groups: 
vehicle and SEA0400 at 120 mmHg (P <0.05, paired t-test).  
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4.4 DISCUSSION 
4.4.1 Myogenic response in cremaster muscle arteriole 
The exact cellular signalling mechanism underlying the arteriolar myogenic response 
remains unclear, however, it is a widely accepted fact about arteriolar myogenic response 
through which arteriole constricts being accompanied by an overall increase of [Ca2+]i when 
the transmural pressure is enhanced (see reviews Davis et al., 1999; Hill et al., 2006; Hill et 
al., 2001; Meininger et al., 1992). This was demonstrated in the present study using the 
calcium indicator fura 2-AM. In the present study in endothelium-denuded rat cremaster 
arterioles, the intracellular [Ca2+] increased with increasing intraluminal pressure from 30, 
50, 70, to 120 mmHg consecutively (see Figure 4.4). The similar results were previously 
shown in cremaster muscle arteriole (Potocnik et al., 2000; Zou et al., 1995) and in rat 
cerebral artery (Jaggar, 2001). 
As introduced in section 4.1.4, extracellular Ca2+ is fundamental to myogenic response. This 
was further confirmed by the abolishment of myogenic constriction in the absence of 
extracellular Ca2+, in which arteriole dilated progressively with increasing intraluminal 
pressure from 30, 50, 70, to 120 mmHg consecutively (see Figure 4.5). This is consistent 
with previous results in cremaster muscle arteriole (Potocnik et al., 2001; Spurrell et al., 
2000; Zou et al., 1995). We also showed that there was no influence of Ca2+ indicator: fura-2 
AM in this case due to the abolishment of myogenic constriction irrespective of fura-2 
loading in passive condition (see Figure 4.5), which is consistent with the result by (Potocnik 
172 
et al., 2001). 
4.4.2 Functional studies of NCX in cremaster muscle arteriole 
In the studies of NCX in smooth muscle, the most used functional response has been the 
observation of tension in response to alterations in Na+ electrochemical gradient (ΔūNa) 
(Blaustein, 1989; Friedman et al., 1959), since decrease extracellular Na+ will cause NCX to 
expel intracellular Na+ in exchange for extracellular Ca2+ and therefore increase intracellular 
Ca2+. Increasing intracellular Na+ will also alter the Na+ gradient to allow Ca2+ to enter. The 
history of functional studies of NCX can be tracked back to 1957, when a endeavor was 
made to clarify the role of Na+ in regulating the tension in vascular smooth muscle cells 
(Leonard, 1957).  It has been demonstrated that tonic contraction (now known to be through 
NCX) could be induced by Na+ pump inhibition (increase intracellular Na+), either by K+ 
removal (Broekaert et al., 1973; Chin et al., 1993; Goldman et al., 1994; Karaki et al., 1977; 
Pritchard et al., 1986) or addition of cardiac glycosides (Leonard, 1957; Maseki et al., 1990; 
Ozaki et al., 1979; Wakimoto et al., 2000). Alternative way to cause Ca2+ entry and 
vasoconstriction through NCX is to reduce extracellular Na+ (Ashida et al., 1987; 
Bondarenko, 2004; Bova et al., 1988; Chau et al., 2003; Goldman et al., 1994; Hinke et al., 
1962; Kim et al., 1999; Maseki et al., 1990; Nazer et al., 1998; Pritchard et al., 1986; 
Rebolledo et al., 2006; Reuter et al., 1973; Tang et al., 2000; Tsang et al., 2003). The low 
Na+-induced vasoconstriction was previously reported in rat aortic rings in chapter 2 and 
chapter 3.  
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Consistent with the above studies, in the present study the low Na+-induced vasoconstriction 
after reducing extracellular Na+ from 137 to 75, and then to 25 mM was apparent in 
cremaster muscle arteriole (Figure 4.6) indicating the functionality of NCX (refer to 3.4), this 
was confirmed by the inhibition from NCX inhibitors: SEA0400 (1 μM) and KB-R7943 (1 
μM).  
In the present study, reduced Na+ electrochemical gradient induced constriction.  In other 
systems this has been shown to be due to an enhanced level of intracellular calcium, such as 
in cultured aortic vascular smooth muscle cell (Zhu et al., 1994) and (Poburko et al., 2006), 
in human umbilical arterial vascular smooth muscle cell (Rebolledo et al., 2006), in rat aortic 
and mesenteric arterial vascular smooth muscle cell (Bova et al., 1990), in rabbit aortic and 
pulmonary arterial vascular smooth muscle cell (Reuter et al., 1973), in rat pulmonary 
arterial vascular smooth muscle cell (Wang et al., 2000), and in rat carotid arterial myocytes 
(Takai et al., 2004).  
The question arises as to how reducing extracellular Na+ can elevate intracellular Ca2+? The 
involvement of voltage-gated Ca2+ channels in low Na+-induced vasoconstriction has been 
discussed in 3.4. The results from (Ozaki et al., 1979), (Ashida et al., 1987), (Goldman et al., 
1994) and (Sekine et al., 1984) suggested that this possibility could be ruled out, because of 
the observation of contractions induced by reduced Na+ electrochemical gradient in the 
presence of Ca2+ channel blockers (e.g. verapamil). Also, studies  indicated that there were 
no significant change of membrane potential after [Na+]o  lowering from 143 mM to 1.2 mM 
in rat mesenteric artery and femoral artery (Horiguchi et al., 2001), and in rabbit aorta and 
pulmonary artery (Reuter et al., 1973). Thereby, it seems unlikely that low Na+-induced 
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vasoconstriction is through voltage-gated Ca2+ channels. 
Another possibility is that low [Na+]o exerted its effect via the inhibition of Na+/H+ 
exchanger (NHE) by the production of acidosis. If this were true, the opposite effect would 
have been expected. Removal of extracellular Na+ would induce the accumulation of 
intracellular proton through the down-regulated Na+/H+ exchanger. Decreased pHi is related 
to the decrease of intracellular calcium concentration and vasodilation instead of constriction 
(Aalkjaer et al., 1997; Chen et al., 1995; Saesue et al., 2004). This contradicts with our 
result. Further the NCX inhibitors SEA0400 (1 μM) and KB-R7943 (1 μM) do not affect the 
NHE activity at the concentration used that appears selective for NCX (refer to 2.1.6 and 
2.1.7). 
In chapter 1 the general formula for NCX operation (refer to 1.4.5) showed that the activity 
and direction of NCX was dependent on the concentration gradient for Na+ (Blaustein et al., 
1999).  It normally operates in forward mode. Only in conditions with intracellular sodium 
concentrations exceeding [Na+]o, NCX operates in reverse-mode (Ca2+ entry mode). 
However, tonic arterioles pressurized to physiological levels (70 mmHg) are in an active 
state with membrane potential level at a less negative level which was reported to be around 
-40 mV in cremaster arteriole (Harder, 1984; Potocnik et al., 2000; Smeda et al., 1987). As 
introduced in 1.4.4, NCX is electrogenic owing to the coupling ratio of 3 Na+ : 1 Ca2+. On the 
forward mode of NCX an inward current flows into the cell, whilst an outward current exists 
on the reverse mode. The electrogenic property of NCX was postulated to favour Ca2+ entry 
mode (reverse mode) when membrane potential is more positive. In addition, this myogenic 
tone is also thought to involve Na+ influx through stretch-activated channel (see review Hill 
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et al., 2001). Thereby, an increase in the local subsarcolemmal [Na+]i would be expected 
while the overall [Na+]i may remain unchanged. If the intracellular [Na+] was elevated then 
the extracellular [Na+] concentrations required to switch from forward mode operation to 
reverse mode would be less than in normal inactivated cells.  Thus two mechanisms in 
arterioles may favour reverse mode NCX operation. 
In the present study, lowering extracellular Na+ generated constriction. It may be that these 
extracellular Na+ reductions were sufficient to switch the exchanger to operate in reverse 
mode even though in other tissues a far lower extracellular [Na+] was required before the 
change in direction occurred.  Indeed the NCX inhibitors: SEA0400 (1 μM) and KB-R7943 
(1 μM) reduced the constriction produced by low Na+ (25 mM). Consistent with these 
results, Saesue et al demonstrated that SEA0400 effectively inhibited the activity of NCX in 
rat cerebral arteriole (Saesue et al., 2004), and Ren et al reported that KB-R7943 (30 μM) 
blocked NCX function in rabbit afferent arteriole (Ren et al., 2003). Furthermore, Zani et al 
showed that KB-R7943 (50 μM) blocked NCX activity in rat intestinal microvasculature 
(Zani et al., 2005).  In the present study chapter 2, it is suggested that KB-R7943 is selective 
only at concentrations below 1 μM in vascular smooth muscle so the present study provides 
better evidence than the literature for the involvement of NCX.  With regard to SEA0400, 
available literature suggests that it is more selective than KB-R7943 for NCX (refer to 2.1.6) 
and at 1 μM it has been shown to be selective for NCX in cultured rat aortic smooth muscle 
cell and mesenteric small artery (Matchkov et al., 2007), and cerebral arteriole (Saesue et al., 
2004). One issue arising from this experiment is that NCX inhibitors did not affect the initial 
basal tone under normal Na+ condition (Figure 4.6). As introduced in chapter 1 (1.4.7.1), 
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NCX can only be turned on when the intracellular Ca2+ binds to the Ca2+ regulatory site, and 
at normal resting [Ca2+]i NCX is only partially activated. Furthermore, there were a increase 
in the subsarcolemmal [Na+]i in pressurized arteriole, the activity of NCX was depressed. 
Hence, before the manipulation of Na+ removal the inhibitory effect of NCX inhibitors 
(SEA0400 and KB-R7943) on the partially-activated NCX, if any, would be expected to be 
negligible. 
To sum up, the presence of functional NCX in pressurized cremaster arteriole was confirmed 
by the constriction in response to removal of [Na+]o. The hypothesis promoted in the present 
study is that tonic vessels have elevated local intracellular Na+ and this depressed the NCX at 
normal extracellular Na+ levels and induces it to operate on reverse mode when extracellular 
Na+ is lowered. 
4.4.3 The study of NCX on myogenic response (myogenic tone) 
In line with the result shown in Figure 4.4 (refer to 4.4.1), the data in control group in Figure 
4.7 demonstrated a myogenic vasoconstriction and the accompanying increase of 
intracellular Ca2+ level (Figure 4.8) after increasing the transmural pressure from 70 to 120 
mmHg in cremaster muscle arteriole.  
It is well established that myogenic response requires an extracellular Ca2+ supply (Jaggar, 
2001; Potocnik et al., 2001). Removal of extracellular Ca2+, the vessel exhibits a state of 
passive distention because of the abolishment of tone (as illustrated in Figure 4.2). In order 
to generate myogenic response, the [Ca2+ ]i must be increased and maintained above the 
contraction threshold for long periods of time (Zhang et al., 2002). 
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The question arises as to how the Ca2+ elevation occurs.  There are competing theories 
regarding the mechanism of the elevation of Ca2+ during myogenic constriction (see 4.1.7). 
There is convincing body of evidence showing that L-type calcium channel (LTCC) is a 
major contributor of Ca2+ entry in tonically activated vascular smooth muscle as nifedipine 
reduced myogenic constriction (Davis et al., 1999; Horiguchi et al., 2001; Jaggar, 2001; 
Wesselman et al., 1996). The pressure enhancement-induced membrane depolarization could 
lead to Ca2+ influx via L-type calcium channel and the subsequent myogenic constriction 
(Harder, 1984; Knot et al., 1998). However, Blaustein and co-workers (Zhang et al., 2002) 
opened a new look at the generation of myogenic tone. They suggested that store-operated 
Ca2+ channel was the key elements in intact rat mesenteric artery. While much of the trigger 
Ca2+ may enter the cells via L-type calcium channel (Hagiwara et al., 1967), store-operated 
Ca2+ channels may also contribute to the overall increase of intracellular Ca2+ during 
myogenic response.  
The contribution of NCX to the Ca2+ entry in this case needs to be clarified. As introduced 
earlier (refer to 4.1.7.1), stretch-activated channels (SAC), namely the non-selective cation 
channel (NSCC) with a permeability to Na+ play a key role in detecting stimulus and initiate 
myogenic response (see reviews Hill et al., 2006; Hill et al., 2001). Na+ entry through this 
pathway is postulated to cause the accumulation of intracellular Na+ and then reduce the Na+ 
electrochemical gradient (ΔūNa) and as suggested in the present study activating reverse 
mode NCX. 
Under normal physiological condition, NCX is assumed to operate in forward mode to 
mediate Ca2+ exit (see 1.4.5). However, after the increase of transmural pressure and the 
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activation of L-type calcium channel and/or store-operated Ca2+ channels, it may be in an 
active condition. As introduced in 1.4.4, NCX is electrogenic owing to the coupling ratio of 
3 Na+ : 1 Ca2+. On the forward mode of NCX an inward current flows into the cell, whilst an 
outward current exists on the reverse mode. The electrogenic property of NCX was 
postulated to favour Ca2+ entry mode (reverse mode) at a more positive membrane potential 
after the depolarization of cell. 
Furthermore, evidence showed a Na+ entry pathway mediated by store-operated Ca2+ channel 
in cultured rat mesenteric artery (Arnon et al., 2000), and rabbit inferior vena cava (Lee et 
al., 2001). Likewise, Na+ entry through store-operated Ca2+ channel is postulated to reduce 
the Na+ electrochemical gradient (ΔūNa) activating reverse mode NCX (see also 1.3.2). 
Collectively, NCX (in reverse mode) is postulated to be activated through multiple pathways 
during increasing transmural pressure and play a role in the elevation of intracellular Ca2+ 
during myogenic vasoconstriction. The schematic diagram illustrating the cellular 
mechanism underlie myogenic response is depicted in Figure 4.9.  The current data fitted 
nicely with our hypothesis and confirmed that part of the elevation in [Ca2+]i is through NCX 
as the NCX inhibitor SEA0400 decreased the elevation in intracellular Ca2+ level after a 
pressure increasing from 70 to 120 mmHg by about 50% (Figure 4.8).  The corresponding 
functional change replaced a myogenic constriction with a myogenic relaxation (Figure 4.7).  
This suggests that the pressure increase may have also activated underlying vasodilator 
pathways which are normally obscure, in addition to activating a constriction or that passive 
distension occurs. With respect to the contribution of NCX to myogenic tone, there are gaps 
in the current knowledge and scarce evidence has been presented. Schweda et al 
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demonstrated that the extracellular Na+ removal increased the renal vscular resistance in rat 
indicating the functional role of NCX in the regulation of renal vascular resistance (Schweda 
et al., 2001), Horiguchi et al demonstrated that the extracellular Na+ removal enhanced the 
myogenic response in rat mesenteric and skeletal muscle small arteries (Horiguchi et al., 
2001), Similarly, the extracellular Na+ removal enhanced the myogenic response in rabbit 
urethra smooth muscle strips which was inhibited by NCX inhibitor SEA0400 (Bradley et 
al., 2006). Fang Y et al reported that NCX was the potential underlying mechanism for 
hypoxia-depressed myogenic constriction in CK1.4 cells (Fang et al., 1997); likewise, 
Lydrup et al reported that NCX might be involved in cyanide-induced myogenic reduction. 
Bychkov et al reported that NCX affected myogenic relaxation indirectly via spontaneous 
transient outward potassium current (STOC) in human coronary artery (Blaustein et al., 
2006; Bychkov et al., 1997, And further more, the involvement of NCX in the regulation of 
myogenic tone and blood pressure was discussed at length in the review papers by {Reuter, 
1973 #639; Zhang et al., 2005a; Zwadlo et al., 2006). Consistent with the aforementioned, 
our result adds more evidence to the existing knowledge. However, further studies are 
required in order to unequivocally establish the exact mechanism of myogenic response.  
4.4.4 Conclusion 
Previous data has shown for cremaster arterioles a role for VGCC (De Clerck et al., 1989; 
Hill et al., 1994; Potocnik et al., 2000), SOC (Potocnik et al., 2001) and SAC (Sun et al., 
1995) in the myogenic response. In conclusion, the generation and maintenance of myogenic 
response in cremaster arteriolar include multiple mechanisms. The underlying pathways may 
involve stretch-activated channel, voltage-gated calcium channel, and store-operated Ca2+ 
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channel. The contribution from NCX through the reverse mode needs to be especially 
considered in cremaster arterioles, and this may also apply to other small arteries.   
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Figure 4.9 The potential mechanisms underlie the myogenic response 
The increase of transmural pressure initiated the mechanosensitivity and 
mechanotransduction process via the activation of stretch-activated channel (SACs), non-
selective cation channels (NSCCs) in particular, which mediated Na+ entry. Na+ entry had 
multiple effects: 1. caused the depolarization of cell membrane and the following opening of 
L-type calcium channel (LTCCs) which mediated Ca2+ flux; 2. activated the reverse mode 
NCX which mediated Ca2+ flux. Also, depolarization activated the reverse mode NCX. In 
parallel with the aforementioned mechanisms, the increase of transmural pressure activated 
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store-operated Ca2+ channels (SOCs) releasing Ca2+ from sarcoplasmic reticulum, and 
activated the reverse mode NCX. 
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Appendix 
Conference communications arising from the thesis 
J. Zhao, S Rajanayagam & H Majewski. Modulation by nitric oxide donor on Na+/Ca2+ 
exchanger in rat isolated aorta. XVth World Congress of Pharmacology, Poster Abstract 
P110059 
J. Zhao & H Majewski. Modulation of smooth muscle Na+/Ca2+ exchanger in rat isolated 
aorta by endothelium. J APSA/ASCEPT annual scientific meeting, Poster Abstract 1-5  
J. Zhao & H Majewski. Modulation of the Na+/Ca2+ exchange in rat isolated aorta. 1st 
International Conference on Frontiers in Vascular Medicine, Poster Abstract P46 
J. Zhao, S Rajanayagam & H Majewski. KB-R7943 a Na+/Ca2+ exchange inhibitor inhibits 
multiple modes of vasoconstriction in rat isolated aorta.  ASCEPT 2004 Melbourne Regional 
Meeting,  
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A192, 2004  
J. Zhao, T V Murphy, H Majewski & M A Hill. The role of the Na+/Ca2+ Exchanger on 
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